Case number 1:18-cv-01675
Astellas US LLC et al v. Hospira, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 21, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the Court's Opinion at D.I. [947] has been replaced with a pdf that contains a corrected listing of counsel of record. (nmf) |
| Jun 21, 2022 | 984 | Redacted Document (17) Docket Text: REDACTED VERSION of [973] Reply Brief by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 21, 2022 | 985 | Redacted Document (11) Docket Text: REDACTED VERSION of [974] Declaration of Christopher A. Vellturo, Ph.D. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 14, 2022 | 975 | SO ORDERED (2) Docket Text: SO ORDERED, re [972] STIPULATION TO EXTEND TIME Hospira to file the redacted, public version of D.I. 964 and any reply thereto, and for Plaintiffs to file the redacted version of their opposition to D.I. 964, is extended to three days after the Court issues a decision, filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 6/14/2022. (kmd) |
| Jun 13, 2022 | 972 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Hospira to file the redacted, public version of D.I. 964 and any reply thereto, and for Plaintiffs to file the redacted version of their opposition to D.I. 964, is extended to three days after the Court issues a decision on Hospiras motion to redact portions of the May 17, 2022 teleconference transcript to - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Jun 10, 2022 | 971 | SO ORDERED (2) Docket Text: SO ORDERED, re [970] STIPULATION TO EXTEND TIME redactions to D.I. 957, 966-969 to three days after decision on D.I. 964, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 6/10/2022. (kmd) |
| Jun 9, 2022 | 970 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME redactions to D.I. 957, 966-969 to three days after decision on D.I. 964 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 7, 2022 | 965 | USCA Notice of Docketing ROA (4) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [956] Notice of Appeal (Federal Circuit) filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. USCA Case Number 2022-1878. (nmf) |
| Jun 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [963] MOTION for Pro Hac Vice Appearance of Attorney Paul Hughes, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 6/3/2022. (kmd) |
| Jun 3, 2022 | 963 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paul Hughes - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 2, 2022 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [956] Notice of Appeal (Federal Circuit) filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. ( Filing fee $505, receipt number ADEDC-3886887.) (Oakes, Robert) |
| Jun 2, 2022 | N/A | Appeal Notification to Reporter Archer (0) Docket Text: Notification regarding [956] Notice of Appeal (Federal Circuit) sent to Reporter Archer. (srs) |
| Jun 2, 2022 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [956] Notice of Appeal (Federal Circuit). (srs) |
| Jun 2, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [962] STIPULATION TO EXTEND TIME redaction deadline for D.I. 949 to see order, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 6/2/2022. (kmd) |
| Jun 1, 2022 | 954 | Judgment (2) Docket Text: FINAL JUDGMENT in favor of Hospira, Inc. against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (CASE CLOSED) Signed by Judge Colm F. Connolly on 6/1/2022. (nmf) |
| Jun 1, 2022 | 955 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,106,183; RE 47,301 E; 8,524,883. (Attachments: # (1) Final Judgment)(nmf) |
| Jun 1, 2022 | 955 | Final Judgment (2) |
| Jun 1, 2022 | 956 | Notice of Appeal (Federal Circuit) (3) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [879] Order, [874] Memorandum and Order,, [947] Opinion, [954] Judgment . Appeal filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 1, 2022 | 961 | Proposed Order (1) Docket Text: PROPOSED ORDER to Motion to Enjoin re [957] MOTION to Enjoin Hospira from Launching its Generic Product while Appeal is Pending by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 1, 2022 | 962 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME redaction deadline for D.I. 949 to see order - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 1, 2022 | 956 | Notice of Appeal* (1) |
| May 31, 2022 | 953 | Main Document (3) Docket Text: REDACTED VERSION of [950] Letter, by Hospira, Inc.. (Attachments: # (1) Exhibit A, # (2) Certificate of Service)(Gattuso, Dominick) |
| May 31, 2022 | 953 | Exhibit A (11) |
| May 31, 2022 | 953 | Certificate of Service (1) |
| May 26, 2022 | 951 | Notice (Other) (2) Docket Text: NOTICE of Intent to Request Redaction of May 17 2022 Teleconference Transcript by Hospira, Inc. (Gattuso, Dominick) |
| May 26, 2022 | 952 | Proposed Order (2) Docket Text: PROPOSED ORDER Final Judgment by Hospira, Inc.. (Gattuso, Dominick) |
| May 19, 2022 | 947 | Opinion (80) Docket Text: OPINION Signed by Judge Colm F. Connolly on 5/19/2022. (nmf) (Main Document 947 replaced on 6/21/2022) (nmf, ). |
| May 19, 2022 | 948 | Order (1) Docket Text: ORDER: IT IS HEREBY ORDERED that the parties shall submit no later than May 26, 2022, a proposed order by which the Court may enter final judgment consistent with the Opinion issued this day. Signed by Judge Colm F. Connolly on 5/19/2022. (nmf) |
| May 18, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 5/18/2022. (Court Reporter Bonnie Archer.) (nmf) |
| May 17, 2022 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Telephone Conference is set for 5/18/2022 at 09:00 AM before Judge Colm F. Connolly. Counsel for Defendant to coordinate the call and email the dial-in information to chambers. (kmd) |
| May 17, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 5/17/2022. (Court Reporter Bonnie Archer.) (nmf) |
| May 16, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: Counsel for Defendant to coordinate the call and email the dial-in information to chambers.( A Telephone Conference is set for 5/17/2022 at 09:00 AM Telephonically before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 5/16/2022. (nmf) |
| Apr 29, 2022 | 946 | Main Document (4) Docket Text: REDACTED VERSION of (943 in 1:18-cv-01675-CFC-CJB) Letter, to The Honorable Christopher J. Burke from Christopher Viceconte in Further Opposition to Plaintiffs' Request for Premature Discovery by Curia Global, Inc., Curia Missouri Inc.. (Attachments: # (1) Exhibit A)(Viceconte, Christopher) |
| Apr 29, 2022 | 946 | Exhibit A (3) |
| Apr 28, 2022 | 945 | Main Document (5) Docket Text: REDACTED VERSION of (41 in 1:22-cv-00199-CFC-CJB, 942 in 1:18-cv-01675-CFC-CJB) Letter to Honorable Christopher J. Burke by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Oakes, Robert) |
| Apr 28, 2022 | 945 | Exhibit A (12) |
| Apr 28, 2022 | 945 | Exhibit B (17) |
| Apr 27, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the pending motion regarding a discovery and protective order dispute between Plaintiffs and Curia Missouri, Inc. and Curia Global, Inc. (collectively, "Curia," who are third parties in Civil Action No. 18-1675-CFC-CJB and Defendants in Civil Action No. 22-199-CFC-CJB), (Civil Action No. 18-1675-CFC-CJB, D.I. 937; Civil Action No. 22-199-CFC-CJB, D.I. 34), and the related briefing, (Civil Action No. 18-1675-CFC-CJB, D.I. 938, D.I. 939, D.I. 942, D.I. 943; Civil Action No. 22-199-CFC-CJB, D.I. 35, D.I. 36, D.I. 41, D.I. 42,), hereby ORDERS that Plaintiff's request to modify the protective order in the 18-1675 action to allow two documents to be used in the 22-199 action, or alternatively for the two documents to be produced via expedited discovery in the 22-199 action, is DENIED. Today's teleconference is hereby CANCELLED. The Court has considered the balancing test and various factors set out in Pansy v. Borough of Stroudsburg, 23 F.3d 772, 786-90 (3d Cir. 1994) as to the part of Plaintiffs' request that attempts to show good cause to modify the protective order in the 18-1675 case to allow for such use, and has considered the three good cause factors regarding provision of expedited discovery set out in Williams v. Ocwen Loan Servicing, LLC, Civil Action No. 14-1096-LPS-CJB, 2015 WL 184024, at *2 (D. Del. Jan. 13, 2015). Plaintiffs have not shown good cause, for the following reasons: (1) First and most importantly, the request is premised on the assertion that Plaintiffs need to use the two documents because the documents "unequivocally show that Curia is infringing an additional patent [the 595 patent.]" (D.I. 35 at 1) But Plaintiffs make no attempt at all to show the Court why the documents are relevant to the 22-199 case (i.e., what those two documents have to do with the infringement question as to the 595 patent, or how they might plausibly show such infringement). (D.I. 36 at 2; D.I. 41 at 2; D.I. 42 at 1) There would not be good cause to allow for use of the documents unless the documents were actually germane to a key question in the 22-199 case. Plaintiffs failure to explain why that is so alone dooms the request.; (2) Second, Plaintiffs have had the two documents for months; if the documents were so important, one would think Plaintiffs would have sought their use months ago. (D.I. 36 at 1, 2) Plaintiffs say they did not do so sooner because they did not become aware that Curia was infringing the 595 patent until recently. (D.I. 41 at 2) But Plaintiffs make no attempt to actually demonstrate to the Court how or why they only recently came to this realization.; and (3) Third, no preliminary injunction motion has yet been filed in the 22-199 case, and it is still uncertain if one will need to be filed and/or when it might need to be filed. If such a motion does ultimately need to be filed imminently, and Plaintiffs still do not have the ability to use the two documents at that point, then their ability to demonstrate good cause at that time might be stronger than it is now. Ordered by Judge Christopher J. Burke on 4/27/2022. Associated Cases: 1:18-cv-01675-CFC-CJB, 1:22-cv-00199-CFC-CJB(dlb) |
| Apr 21, 2022 | 941 | Main Document (5) Docket Text: REDACTED VERSION of (35 in 1:22-cv-00199-CFC-CJB, 938 in 1:18-cv-01675-CFC-CJB) Letter by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Oakes, Robert) |
| Apr 21, 2022 | 941 | Exhibit 1 (12) |
| Apr 21, 2022 | 941 | Exhibit 2 (1) |
| Apr 21, 2022 | 941 | Exhibit 3 (1) |
| Apr 21, 2022 | 941 | Exhibit 4 (20) |
| Apr 21, 2022 | 941 | Exhibit 5 (21) |
| Apr 21, 2022 | 941 | Exhibit 6 (4) |
| Apr 14, 2022 | 939 | Main Document (5) Docket Text: Letter to The Honorable Christopher J. Burke from Christopher Viceconte regarding Curia's Letter Brief in Opposition to Plaintiffs' Request for Premature Discovery - re (936 in 1:18-cv-01675-CFC-CJB) Order Setting Teleconference,,,,,,. (Attachments: # (1) Text of Proposed Order)(Viceconte, Christopher) |
| Apr 14, 2022 | 939 | Text of Proposed Order (2) |
| Apr 11, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| Apr 11, 2022 | 937 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION to Resolve Discovery Dispute re (33 in 1:22-cv-00199-CFC-CJB) Order Setting Teleconference,,,,,, - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Del Dotto, Kelly) |
| Apr 7, 2022 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' April 5, 2022 letter requesting a discovery dispute teleconference regarding several discovery disputes. (C.A. No. 18-1675, D.I. 935) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order will be modified as follows: (1) The parties shall file a joint "Motion for Teleconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab of Judge Burke's page on the District Court's website.; (2) A discovery dispute teleconference is set for April 27, 2022 at 12:00 PM before Judge Christopher J. Burke.; (3) By April 14, 2022, each side should file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and their positions on those issues. By April 22, 2021, each side may file a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, in response.; (4) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; (5) By no later than April 25, 2022, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call; and (6) The Court may choose to resolve the disputes prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Christopher J. Burke on 4/7/2022. Associated Cases: 1:18-cv-01675-CFC-CJB, 1:22-cv-00199-CFC-CJB(dlb) |
| Apr 5, 2022 | 935 | Letter (2) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding request for discovery teleconference. (Oakes, Robert) |
| Mar 25, 2022 | 934 | Redacted Document (22) Docket Text: REDACTED VERSION of [931] POST Trial Brief Regarding Infringement of the '183, '883, and '301 Patents by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 24, 2022 | 933 | Main Document (21) Docket Text: REDACTED VERSION of [932] POST Trial Brief on Invalidity by Hospira, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Mar 24, 2022 | 933 | Certificate of Service (1) |
| Mar 18, 2022 | 927 | Redacted Document (30) Docket Text: REDACTED VERSION of [923] Proposed Findings of Fact regarding Validity by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Mar 18, 2022 | 928 | Redacted Document (30) Docket Text: REDACTED VERSION of [924] POST Trial Brief regarding Validity by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Mar 18, 2022 | 929 | Main Document (38) Docket Text: REDACTED VERSION of [925] POST Trial Brief on Non-Infringement by Hospira, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Mar 18, 2022 | 929 | Certificate of Service (1) |
| Mar 18, 2022 | 930 | Main Document (53) Docket Text: REDACTED VERSION of [926] Proposed Findings of Fact on Non-Infringement by Hospira, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Mar 18, 2022 | 930 | Certificate of Service (1) |
| Mar 9, 2022 | 922 | Main Document (1) Docket Text: REDACTED VERSION of [921] Letter by Hospira, Inc.. (Attachments: # (1) Exhibit A)(Gattuso, Dominick) |
| Mar 9, 2022 | 922 | Exhibit A (6) |
| Feb 25, 2022 | 917 | Redacted Document (30) Docket Text: REDACTED VERSION of [913] POST Trial Brief by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 25, 2022 | 918 | Redacted Document (30) Docket Text: REDACTED VERSION of [914] Proposed Findings of Fact by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 25, 2022 | 919 | Main Document (40) Docket Text: REDACTED VERSION of [915] POST Trial Brief by Hospira, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Feb 25, 2022 | 919 | Certificate of Service (1) |
| Feb 25, 2022 | 920 | Main Document (55) Docket Text: REDACTED VERSION of [916] Proposed Findings of Fact by Hospira, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Feb 25, 2022 | 920 | Certificate of Service (1) |
| Feb 16, 2022 | 911 | Redacted Document (2) Docket Text: REDACTED VERSION of [907] Letter to Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 16, 2022 | 912 | Redacted Document (2) Docket Text: REDACTED VERSION of [908] Letter to The Honorable Christopher J. Burke from Christopher Viceconte in further opposition to Motion to Modify Protective Order by Curia Global, Inc., Curia Missouri Inc.. (Viceconte, Christopher) |
| Feb 11, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the pending motion regarding a protective order dispute between Plaintiffs and third-parties Curia Missouri, Inc. and Curia Global, Inc. (collectively, "Curia"), (D.I. 866), and the related briefing and supplemental submissions, (D.I. 836; D.I. 846; D.I. 849; D.I. 884; D.I. 886; D.I. 907; D.I. 908; D.I. 909), hereby ORDERS that Plaintiffs' request for relief from the Protective Order so that they can file a complaint (one premised in part on answers that Plaintiffs obtained in this case from a deposition of a Curia employee, Stephen Hancock) alleging that Curia infringes the '567 patent is GRANTED-IN-PART and DENIED-IN-PART in the manner set out below, for the reasons that follow: (1) Paragraph 5 of the Protective Order provides in part, that "Confidential Information received from a Producing Party" may only be used in this case; however, paragraph 29 of the same Order allows that a party may apply to the Court for relief from this requirement (as Plaintiffs do here). (D.I. 51 at paras. 5, 29(c); see also D.I. 849 at 1); (2) Modification of a protective order requires the moving party to show good cause, using a balancing test and various factors set out in Pansy v. Borough of Stroudsburg, 23 F.3d 772, 786-90 (3d Cir. 1994). See also PhishMe, Inc. v. Wombat Sec. Techs., Inc., Civil Action No. 16-403-LPS-CJB, 2017 WL 4138961, at *2 (D. Del. Sept. 8, 2017).; (3) Here, nearly all of the relevant Pansy factors, see Arnold v. Pa., Dept. of Transp., 477 F.3d 105, 108 (3d Cir. 2007) (listing the factors), either favor Plaintiffs' position, or, at minimum, do not really hurt their position. More specifically: (i) As to the first Pansy factor (the interest in privacy of the party seeking protection), Curia said almost nothing in its briefing as to how significant privacy interests would likely be violated here. (D.I. 846 at 2) The fact that Curia is an API supplier or that it is alleged to have infringed the '567 patent are not confidential facts. (D.I. 836 at 2) And to the extent that certain information that may be properly considered confidential might be referenced in a complaint or in filings in the subsequent case (i.e., relating to the specifics of the API that Curia has made at particular times), the parties can make use of a courts sealing procedures or utilize a protective order to address that issue (if warranted). (D.I. 849 at 1-2); (ii) As to the second Pansy factor (whether the information is being sought for a legitimate purpose or an improper purpose), this factor favors Plaintiffs. If an entity has properly obtained evidence that purportedly shows that its patent is being infringed, then an important interest is at stake. (D.I. 836 at 2) (The Court, of course, comes to no conclusions as to whether Curia is actually infringing the '567 patent; both sides have made arguments and pointed to evidence to suggest that patent infringement has or has not allegedly occurred.). (D.I. 836 at 1; id., ex. 1; id., ex. 2 at 152-55; id., ex. 3; D.I. 846 at 2; D.I. 908 at 1) Curia suggested that Plaintiffs' request here is improper because, as to some of the Hancock deposition testimony, Plaintiffs' counsel deliberately asked questions that were outside the permitted scope of the deposition or that were irrelevant to supplemental discovery issues in this case. (D.I. 846 at 1; D.I. 884 at 1-2) If that occurred, then there would not be good cause to permit Plaintiffs to abrogate the Protective Order so as to use the answers to such questions in another lawsuit. (D.I. 880) And candidly, even after hearing an explanation from Plaintiffs, (D.I. 886 at 1-2), the Court is uncertain as to whether many of Plaintiffs' counsel's questions in the deposition were within the proper scope of supplemental discovery in this case. Yet the Court is convinced that the questions and answers on pages 152:18 to 155:25 of the Hancock deposition were not improper. (D.I. 836, ex. 2 at 152-55) Those questions either: (a) relate to an August 2021 API batch that is directly relevant to the DMF Amendment at issue in this case; or (b) were permissible questioning to establish that a near-in-time additional batch did not have "connection to the recent DMF efforts[.]" (D.I. 886 at 2; see also D.I. 849, ex. 6 at 3-4) This is the material that the Court will permit Plaintiffs to use in a new case without violating the Protective Order (hereafter, the "relevant material").; (iii) As to the third Pansy factor (the prevention of embarrassment, and whether that embarrassment would be particularly serious), Curia does not argue that the information at issue is embarrassing. (D.I. 846 at 3) So this factor favors Plaintiffs, or at least is neutral.; (iv) With regard to the fourth (whether the information is important to public health and safety) and seventh (whether the case involves issues important to the public) Pansy factors, it is asserted by Plaintiffs (and not really disputed by Curia) that the underlying drug at issue, Lexiscan, is an vital drug used to help patients participate in certain cardiac stress tests when they might not otherwise be able to do so. (D.I. 836 at 2-3; id., ex. 1 at paras. 17-18 & ex. B) So it seems like the subject matter at issue does have some real importance to public healthand so would a case about whether a patent on that drug was being infringed or was valid.; (v) As to the fifth Pansy factor (whether sharing of the information among litigants would promote fairness and efficiency), Curia argues that granting the motion would be antithetical to fairness and efficiency, because "Plaintiffs sought this discovery beyond the appropriate scope of the [Rule] 30(b)(6) deposition [at issue]." (D.I. 846 at 3) However, at least as to the relevant material, the Court disagrees. And in the end, the Court is not sure that the concepts of "fairness" and "efficiency" meaningfully tip the scales one way or the other here.; and (vi) Pansy factor six (whether the party benefitting from the order is a public entity or official) does not apply here, and so the factor has little impact.; (4) To be sure, the eighth Pansy factor (regarding reliance by the original parties on the confidentiality order) supports Curia's position. When Curia provided third-party deposition testimony in this case, it surely knew there was some possibility (re: paragraph 29 of the Protective Order) that any testimony provided might later be used outside of this case. But in light of paragraph 5s otherwise broad language, Curia no doubt reasonably figured that the likelihood of this happening was not high. (D.I. 846 at 3 (citing In re Intel Microprocessor Antitrust Litig., Civil Action Nos. 05-441-JJF, 05-485-JJF, 2008 WL 4861544, at *19 (D. Del. Nov. 7, 2008)); see also Genentech, Inc. v. Amgen Inc., Consol. Civ. No. 17-1407-CFC, 2019 WL 1349464, at *2 (D. Del. Mar. 26, 2019).; and (5) In the end, use of the relevant material serves important interests, the amount of the material to be used is cabined, and the use of that material will not cause undue harm to Curia. Therefore, after weighing the Pansy factors, the Court finds that Plaintiffs have shown good cause to modify the Protective Order to: (a) permit use of the questions and answers on pages 152:18 to 155:25 of the Hancock deposition; (b) in a new complaint regarding the '567 patent, or otherwise in that new case. Ordered by Judge Christopher J. Burke on 2/10/2022. (dlb) |
| Feb 7, 2022 | 906 | SO ORDERED (3) Docket Text: SO ORDERED, re [905] Stipulation Schedule for Post-trial briefing, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Set Briefing Schedule: Opening Brief due 2/18/2022. Answering Brief due 3/11/2022. Reply Brief due 3/18/2022. See Order for further details. Signed by Judge Colm F. Connolly on 2/7/2022. (kmd) |
| Feb 4, 2022 | 905 | Stipulation (3) Docket Text: STIPULATION Schedule for Post-trial briefing by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Feb 1, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER denying as moot[900] MOTION to Seal Portions of Trial filed by Curia Missouri Inc., Curia Global, Inc. Ordered by Judge Colm F. Connolly on 2/1/2022. (nmf) |
| Jan 31, 2022 | N/A | Bench Trial - Completed (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial completed on 1/31/2022. (Court Reporter B. Archer.) (kmd) |
| Jan 28, 2022 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 1/28/2022. (Court Reporter B. Archer.) (kmd) |
| Jan 28, 2022 | 904 | SO ORDERED (2) Docket Text: SO ORDERED, re [903] STIPULATION of Dismissal as to defendant Apotex, Inc. Party Apotex Inc. terminated. Signed by Judge Colm F. Connolly on 1/28/2022. (nmf) |
| Jan 27, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [898] MOTION for Pro Hac Vice Appearance of Attorney Andrew S. Roper, filed by Curia Missouri Inc., Curia Global, Inc. Ordered by Judge Colm F. Connolly on 1/27/2022. (kmd) |
| Jan 27, 2022 | N/A | Bench Trial - Begun (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 1/27/2022. (Court Reporter B. Archer.) (kmd) |
| Jan 27, 2022 | 899 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to International Medication Systems, Ltd by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jan 27, 2022 | 900 | Main Document (5) Docket Text: MOTION to Seal Portions of Trial - filed by Curia Global, Inc., Curia Missouri Inc.. (Attachments: # (1) Text of Proposed Order)(Viceconte, Christopher) |
| Jan 27, 2022 | 900 | Text of Proposed Order (2) |
| Jan 27, 2022 | 901 | SO ORDERED (2) Docket Text: SO ORDERED, re [899]STIPULATION of Dismissal as to International Medication Systems, Ltd., Party International Medication Systems, Limited terminated. Signed by Judge Colm F. Connolly on 1/27/2022. (nmf) |
| Jan 27, 2022 | 902 | SO ORDERED (5) Docket Text: SO ORDERED, re [893] STIPULATION and Order Regarding Evidence. Signed by Judge Colm F. Connolly on 1/27/2022. (nmf) |
| Jan 27, 2022 | 903 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to defendant Apotex, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jan 26, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [897] STIPULATION of Dismissal as to Dr. Reddy's Laboratories, Ltd and Dr. Reddy's Laboratories, Inc., [896] STIPULATION of Dismissal as to Sun Pharma Global FZE, Sun Pharmaceutical Industries, Ltd. Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc. terminated. Signed by Judge Colm F. Connolly on 1/26/2022. (nmf) |
| Jan 26, 2022 | 896 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Sun Pharma Global FZE, Sun Pharmaceutical Industries, Ltd. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jan 26, 2022 | 897 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Dr. Reddy's Laboratories, Ltd and Dr. Reddy's Laboratories, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jan 26, 2022 | 898 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrew S. Roper - filed by Curia Global, Inc., Curia Missouri Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Certification)(Viceconte, Christopher) |
| Jan 26, 2022 | 898 | Text of Proposed Order (1) |
| Jan 26, 2022 | 898 | Certification (1) |
| Jan 25, 2022 | 895 | Main Document (32) Docket Text: REDACTED VERSION of [891] Proposed Pretrial Order,,,, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10A, # (11) Exhibit 10B, # (12) Exhibit 10C, # (13) Exhibit 10D, # (14) Exhibit 10E, # (15) Exhibit 10F, # (16) Exhibit 10G, # (17) Exhibit 10H, # (18) Exhibit 11, # (19) Exhibit 12, # (20) Exhibit 14)(Oakes, Robert) |
| Jan 25, 2022 | 895 | Exhibit 1 (21) |
| Jan 25, 2022 | 895 | Exhibit 2 (134) |
| Jan 25, 2022 | 895 | Exhibit 3 (288) |
| Jan 25, 2022 | 895 | Exhibit 4 (33) |
| Jan 25, 2022 | 895 | Exhibit 5 (88) |
| Jan 25, 2022 | 895 | Exhibit 6 (8) |
| Jan 25, 2022 | 895 | Exhibit 7 (17) |
| Jan 25, 2022 | 895 | Exhibit 8 (237) |
| Jan 25, 2022 | 895 | Exhibit 9 (54) |
| Jan 25, 2022 | 895 | Exhibit 10A (37) |
| Jan 25, 2022 | 895 | Exhibit 10B (25) |
| Jan 25, 2022 | 895 | Exhibit 10C (16) |
| Jan 25, 2022 | 895 | Exhibit 10D (12) |
| Jan 25, 2022 | 895 | Exhibit 10E (10) |
| Jan 25, 2022 | 895 | Exhibit 10F (8) |
| Jan 25, 2022 | 895 | Exhibit 10G (18) |
| Jan 25, 2022 | 895 | Exhibit 10H (14) |
| Jan 25, 2022 | 895 | Exhibit 11 (13) |
| Jan 25, 2022 | 895 | Exhibit 12 (20) |
| Jan 25, 2022 | 895 | Exhibit 14 (28) |
| Jan 24, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The bench trial set to begin on Thursday, January 27, 2022 is available to the public by telephone. Phone: 1-855-747-8824 / Public code: 8975254786. Audio or video reproduction of the proceeding is strictly prohibited. Ordered by Judge Colm F. Connolly on 1/24/2022. (kmd) |
| Jan 24, 2022 | 894 | Main Document (11) Docket Text: REDACTED VERSION of [888] Statement,, Plaintiffs' Proffer by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20)(Oakes, Robert) |
| Jan 24, 2022 | 894 | Exhibit 1 (56) |
| Jan 24, 2022 | 894 | Exhibit 2 (65) |
| Jan 24, 2022 | 894 | Exhibit 3 (32) |
| Jan 24, 2022 | 894 | Exhibit 4 (112) |
| Jan 24, 2022 | 894 | Exhibit 5 (20) |
| Jan 24, 2022 | 894 | Exhibit 6 (10) |
| Jan 24, 2022 | 894 | Exhibit 7 (2) |
| Jan 24, 2022 | 894 | Exhibit 8 (2) |
| Jan 24, 2022 | 894 | Exhibit 9 (26) |
| Jan 24, 2022 | 894 | Exhibit 10 (25) |
| Jan 24, 2022 | 894 | Exhibit 11 (26) |
| Jan 24, 2022 | 894 | Exhibit 12 (20) |
| Jan 24, 2022 | 894 | Exhibit 13 (25) |
| Jan 24, 2022 | 894 | Exhibit 14 (30) |
| Jan 24, 2022 | 894 | Exhibit 15 (30) |
| Jan 24, 2022 | 894 | Exhibit 16 (30) |
| Jan 24, 2022 | 894 | Exhibit 17 (2) |
| Jan 24, 2022 | 894 | Exhibit 18 (2) |
| Jan 24, 2022 | 894 | Exhibit 19 (3) |
| Jan 24, 2022 | 894 | Exhibit 20 (5) |
| Jan 22, 2022 | 893 | Stipulation (5) Docket Text: STIPULATION and Proposed Order Regarding Evidence by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jan 21, 2022 | N/A | Pretrial Conference - Final (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Final Pretrial Conference held on 1/21/2022. (Court Reporter Bonnie Archer.) (nmf) |
| Jan 21, 2022 | 892 | Transcript (16) Docket Text: Official Transcript of Telephone Conference held on January 13, 2022 before Chief Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer,Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/11/2022. Redacted Transcript Deadline set for 2/22/2022. Release of Transcript Restriction set for 4/21/2022. (Archer, Bonnie) |
| Jan 20, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Natasha L. White for Apotex Inc., Dr. Reddy's Laboratories Ltd., and Dr. Reddy's Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jan 20, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Natasha L. White for Apotex Inc.,Dr. Reddy's Laboratories Ltd.,Dr. Reddy's Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Jan 19, 2022 | N/A | Remark (0) Docket Text: The parties are directed to submit two hard copies of the Revised Sealed Proposed Pretrial Order at D.I. [891] to the Court as soon as possible. (nmf) |
| Jan 18, 2022 | 889 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding a proposal on Defendants' trial time. (Phillips, John) |
| Jan 18, 2022 | 890 | Main Document (4) Docket Text: REDACTED VERSION of [886] Letter, Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Oakes, Robert) |
| Jan 18, 2022 | 890 | Exhibit A (3) |
| Jan 18, 2022 | 890 | Exhibit B (2) |
| Jan 18, 2022 | 890 | Exhibit C (160) |
| Jan 14, 2022 | N/A | Remark (0) Docket Text: Remark: The filer should submit (2) courtesy copies of the document filed January 11, 2022 at D.I. 886 by close of business today. The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/judge/magistrate-judge-christopher-j-burke(dlb) |
| Jan 14, 2022 | 887 | Main Document (4) Docket Text: REDACTED VERSION of [884] Letter, by Curia Global, Inc., Curia Missouri Inc.. (Attachments: # (1) Exhibit 1 - Redacted)(Viceconte, Christopher) |
| Jan 14, 2022 | 887 | Exhibit 1 - Redacted (17) |
| Jan 13, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 1/13/2022. (Court Reporter Bonnie Archer.) (nmf) |
| Jan 13, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Regarding Scheduling Order Deadlines: The Final Pretrial Conference will be held Telephonically on 1/21/2022 at 02:00 PM before Judge Colm F. Connolly., The Bench Trial will be held Remotely beginning on 1/27/2022 at 08:30 AM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 1/13/2022. (nmf) |
| Jan 10, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [883] Letter, ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. ( A Telephone Conference is set for 1/13/2022 at 10:30 AM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 1/10/2022. (nmf) |
| Jan 10, 2022 | 885 | Main Document (16) Docket Text: REDACTED VERSION of [878] Objections, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11)(Oakes, Robert) |
| Jan 10, 2022 | 885 | Exhibit 1 (8) |
| Jan 10, 2022 | 885 | Exhibit 2 (6) |
| Jan 10, 2022 | 885 | Exhibit 3 (6) |
| Jan 10, 2022 | 885 | Exhibit 4 (176) |
| Jan 10, 2022 | 885 | Exhibit 5 (104) |
| Jan 10, 2022 | 885 | Exhibit 6 (104) |
| Jan 10, 2022 | 885 | Exhibit 7 (119) |
| Jan 10, 2022 | 885 | Exhibit 8 (8) |
| Jan 10, 2022 | 885 | Exhibit 9 (5) |
| Jan 10, 2022 | 885 | Exhibit 10 (3) |
| Jan 10, 2022 | 885 | Exhibit 11 (4) |
| Jan 7, 2022 | 883 | Letter (2) Docket Text: Letter to the Honorable Colm F. Connolly from John C. Phillips, Jr. regarding Pretrial Conference and Trial. (Phillips, John) |
| Jan 5, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the pending motion regarding a protective order dispute between Plaintiffs and third-party intervenors Curia Missouri Inc. and Curia Global, Inc. (collectively, "Curia"), (D.I. [866]), (the "Motion"), and the briefing related thereto, (D.I. 836; D.I. 846; D.I. 849), notes that after considering the parties' positions, it is inclined to believe that the Pansy factors militate in favor of granting Plaintiffs' request for relief from the Protective Order and permitting Plaintiff to be able to file the new complaint. That said, one of Curia's main arguments in opposition is that when Plaintiffs' counsel asked certain questions during the deposition of a Curia witness (questions producing answers that, in turn, motivated Plaintiffs' proposed new complaint) Plaintiffs were seeking information that was outside the scope of its subpoena to Curia i.e., information that was purportedly obtained improperly and in "bad faith[.]" (D.I. 846 at 1-3) The Court takes a charge like that seriously. But Curia did not provide much in the way of explanation about why the questions at issue went outside the bounds of the subpoena deposition topics, or about what questions in particular demonstrated this conduct. The Court could use more information on this issue from Plaintiffs too, such as a more fulsome explanation as to why particular questions at issue were within the bounds of particular deposition topics (and why those questions could have been expected to lead to information relevant to this case). (D.I. 849 at 1 & n.1) In the end, before it grants the Motion, the Court just wants to be sure that in doing so, it is not encouraging future litigants to ask improper/outside-the-scope questions at a deposition, obtain confidential information in response to those questions, and then use that information to overturn a protective order and file new lawsuits. To this end, the Court ORDERS that Curia may file a supplemental letter brief of no more than two (2) single-spaced pages on this issue by no later than January 7, 2022. Plaintiffs may file a responsive supplemental letter brief of no more than two (2) single-spaced pages on this issue by no later than January 11, 2022. Ordered by Judge Christopher J. Burke on 1/5/2022. (mlc) |
| Jan 5, 2022 | 881 | Main Document (2) Docket Text: REDACTED VERSION of [877] Letter by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Attachment)(Phillips, John) |
| Jan 5, 2022 | 881 | Attachment (5) |
| Jan 5, 2022 | 882 | Main Document (33) Docket Text: REDACTED VERSION of [873] Proposed Pretrial Order,,,, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10A, # (11) Exhibit 10B, # (12) Exhibit 10C, # (13) Exhibit 10D, # (14) Exhibit 10E, # (15) Exhibit 10F, # (16) Exhibit 10G, # (17) Exhibit 10H, # (18) Exhibit 11, # (19) Exhibit 12, # (20) Exhibit 13, # (21) Exhibit 14, # (22) Exhibit 15)(Oakes, Robert) |
| Jan 5, 2022 | 882 | Exhibit 1 (21) |
| Jan 5, 2022 | 882 | Exhibit 2 (143) |
| Jan 5, 2022 | 882 | Exhibit 3 (307) |
| Jan 5, 2022 | 882 | Exhibit 4 (33) |
| Jan 5, 2022 | 882 | Exhibit 5 (88) |
| Jan 5, 2022 | 882 | Exhibit 6 (8) |
| Jan 5, 2022 | 882 | Exhibit 7 (17) |
| Jan 5, 2022 | 882 | Exhibit 8 (237) |
| Jan 5, 2022 | 882 | Exhibit 9 (54) |
| Jan 5, 2022 | 882 | Exhibit 10A (37) |
| Jan 5, 2022 | 882 | Exhibit 10B (25) |
| Jan 5, 2022 | 882 | Exhibit 10C (15) |
| Jan 5, 2022 | 882 | Exhibit 10D (12) |
| Jan 5, 2022 | 882 | Exhibit 10E (10) |
| Jan 5, 2022 | 882 | Exhibit 10F (8) |
| Jan 5, 2022 | 882 | Exhibit 10G (16) |
| Jan 5, 2022 | 882 | Exhibit 10H (13) |
| Jan 5, 2022 | 882 | Exhibit 11 (13) |
| Jan 5, 2022 | 882 | Exhibit 12 (20) |
| Jan 5, 2022 | 882 | Exhibit 13 (13) |
| Jan 5, 2022 | 882 | Exhibit 14 (27) |
| Jan 5, 2022 | 882 | Exhibit 15 (7) |
| Jan 4, 2022 | 879 | Order (1) Docket Text: ORDER OVERRULING [878] Objections, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 1/4/2022. (nmf) |
| Dec 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [852] MOTION for Pro Hac Vice Appearance of Attorney Natasha L. White filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc. Signed by Judge Colm F. Connolly on 12/29/2021. (nmf) |
| Dec 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [875] STIPULATION TO EXTEND TIME deadline to file redactions to Pretrial Order (D.I. 873) to January 5, 2022, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 12/27/2021. (kmd) |
| Dec 27, 2021 | 876 | Main Document (3) Docket Text: REDACTED VERSION of [870] Letter, Plaintiffs' Supplemental Letter to Honorable Christopher J. Burke in Opposition to Defendant Apotex's Motion to Strike by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Oakes, Robert) |
| Dec 27, 2021 | 876 | Exhibit 1 (20) |
| Dec 27, 2021 | 876 | Exhibit 2 (7) |
| Dec 27, 2021 | 876 | Exhibit 3 (6) |
| Dec 27, 2021 | 876 | Exhibit 4 (4) |
| Dec 27, 2021 | 876 | Exhibit 5 (4) |
| Dec 27, 2021 | 876 | Exhibit 6 (3) |
| Dec 22, 2021 | 875 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME deadline to file redactions to Pretrial Order (D.I. 873) to January 5, 2022 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Dec 21, 2021 | 872 | Main Document (23) Docket Text: REDACTED VERSION of [869] Letter with Exhibits A-D by Hospira, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Dec 21, 2021 | 872 | Certificate of Service (1) |
| Dec 20, 2021 | N/A | Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Motion Hearing held via teleconference on 12/20/2021 regarding D.I. [824] MOTION to Strike Portions of Plaintiffs' Second Supplemental Infringement Contentions and Expert Reports filed by Hospira, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd., International Medication Systems, Limited, D.I. [830] MOTION to Strike Portions of Plaintiffs' Supplemental Infringement Contentions and Expert Reports filed by Apotex Inc. After hearing the parties regarding the motions, (D.I. 824; D.I. 830), the Court took the motions under advisement. (Court Reporter Stacy Ingram (Hawkins). Clerk, Bryant-Alvarez) APPEARANCES: D. McCann and E. Flanagan for Astellas; M. Velez for Gilead; J. Phillips, Jr., J. Jaros, and C. Galligan for Apotex; D. Gattuso, J. Wong, A. King, and C. Fundakowski, for Hospira; N. Hoeschen, J. Bennett, and A. McDonough for IMS. (mlc) |
| Dec 20, 2021 | 871 | Main Document (1) Docket Text: REDACTED VERSION of [867] Letter, by Hospira, Inc.. (Attachments: # (1) Exhibit 1, A-D, # (2) Certificate of Service)(Gattuso, Dominick) |
| Dec 20, 2021 | 871 | Exhibit 1, A-D (24) |
| Dec 20, 2021 | 871 | Certificate of Service (1) |
| Dec 15, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Resetting Scheduling Order Deadlines: (The Final Pretrial Conference is rescheduled for 1/21/2022 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly., The Bench Trial is rescheduled for 1/27/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 12/15/2021. (nmf) |
| Dec 15, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has reviewed Defendants' December 13, 2021 letter, (D.I. [867]), requesting leave to file a supplemental letter brief in support of their respective motions to strike, (D.I. 824; D.I. 830). Defendants' motion is GRANTED, and the Court hereby ORDERS that by no later than December 17, 2021, Plaintiffs may, if they wish, file a responsive supplemental letter brief, not to exceed one (1) single-spaced page, in no less than 12-point font.Ordered by Judge Christopher J. Burke on 12/15/2021. (mlc) |
| Dec 3, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' November 16, 2021 letter, (D.I. 841), and Apotex's December 2, 2021 letter, (D.I. 858), requesting a teleconference for Defendants' motion to strike portions of Plaintiffs' second supplemental infringement contentions and expert reports, (D.I. 824), and Apotex's motion to strike portions of Plaintiffs' supplemental infringement contentions and expert reports, (D.I. 830), respectively. It hereby ORDERS as follows: (1) A teleconference to address these motions is set for December 20, 2021 at 11:00 a.m. before Judge Christopher J. Burke.; (2) By no later than December 16, 2021, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (3) The Court may choose to resolve the motions prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Christopher J. Burke on 12/3/2021. (dlb) |
| Dec 3, 2021 | 865 | Main Document (4) Docket Text: REDACTED VERSION of [854] Letter, by Apotex Inc.. (Attachments: # (1) Exhibit 11, # (2) Exhibit 12)(Phillips, John) |
| Dec 3, 2021 | 865 | Exhibit 11 (3) |
| Dec 3, 2021 | 865 | Exhibit 12 (6) |
| Dec 3, 2021 | 866 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION to Resolve Discovery Disputes re Curia re [829] Oral Order,,,,, - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Dec 2, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The redacted version of D.I. [836] has been deleted per request of filer. A corrected version containing the exhibits will be filed soon. (nmf) |
| Dec 2, 2021 | 857 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Daniel T. Smith on December 3, 2021 filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Dec 2, 2021 | 858 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from John C. Phillips, Jr. regarding request for teleconference - re [830] MOTION to Strike Portions of Plaintiffs' Supplemental Infringement Contentions and Expert Reports. (Phillips, John) |
| Dec 2, 2021 | 859 | Redacted Document (4) Docket Text: REDACTED VERSION of [846] Letter, to The Honorable Christopher J. Burke from Christopher Viceconte regarding in Opposition to Astellas and Gilead's Motion to Modify the Protective Order by Curia Global, Inc., Curia Missouri Inc.. (Viceconte, Christopher) |
| Dec 2, 2021 | 861 | Main Document (4) Docket Text: REDACTED VERSION of [849] Letter to Honorable Christopher J. Burke from Gregory Booker by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7)(Oakes, Robert) |
| Dec 2, 2021 | 861 | Exhibit 6 (9) |
| Dec 2, 2021 | 861 | Exhibit 7 (4) |
| Dec 2, 2021 | 862 | Main Document (4) Docket Text: REDACTED VERSION of [836] Letter, to Honorable Christopher J. Burke from Robert Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Oakes, Robert) |
| Dec 2, 2021 | 862 | Exhibit 1 (75) |
| Dec 2, 2021 | 862 | Exhibit 2 (53) |
| Dec 2, 2021 | 862 | Exhibit 3 (36) |
| Dec 2, 2021 | 862 | Exhibit 4 (3) |
| Dec 2, 2021 | 862 | Exhibit 5 (3) |
| Dec 2, 2021 | 863 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Allen Myerson on December 8, 2021 at 9:00 am Eastern time [Remote] filed by Hospira, Inc..(Gattuso, Dominick) |
| Nov 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (46 in 1:21-cv-00671-CFC) (855 in 1:18-cv-01675-CFC-CJB) MOTION for Pro Hac Vice Appearance of Attorney Vincent Li, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 11/30/2021. Associated Cases: 1:21-cv-00671-CFC, 1:18-cv-01675-CFC-CJB(kmd) |
| Nov 30, 2021 | 855 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Vincent Li - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 30, 2021 | 856 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Sarah J. Fischer as co-counsel.. (Keller, Karen) |
| Nov 29, 2021 | 852 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Natasha L. White - filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Certification of Natasha L. White)(Haney, Megan) |
| Nov 29, 2021 | 852 | Certification of Natasha L. White (1) |
| Nov 29, 2021 | 853 | Main Document (7) Docket Text: REDACTED VERSION of [847] Letter, to Honorable Christopher J. Burke from Gregory Booker by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Booker, Gregory) |
| Nov 29, 2021 | 853 | Exhibit A (8) |
| Nov 29, 2021 | 853 | Exhibit B (8) |
| Nov 29, 2021 | 853 | Exhibit C (6) |
| Nov 29, 2021 | 853 | Exhibit D (2) |
| Nov 29, 2021 | 853 | Exhibit E (117) |
| Nov 29, 2021 | 853 | Exhibit F (4) |
| Nov 29, 2021 | 853 | Exhibit G (15) |
| Nov 29, 2021 | 853 | Exhibit H (13) |
| Nov 29, 2021 | 853 | Exhibit I (2) |
| Nov 24, 2021 | 851 | Notice (Other) (2) Docket Text: NOTICE of Change of Address/Firm for Jason Leonard by Astellas Pharma US, Inc., Astellas US LLC (Oakes, Robert) |
| Nov 23, 2021 | 850 | Redacted Document (4) Docket Text: REDACTED VERSION of [842] Letter, to Magistrate Judge Burke from Defendants IMS, Hospira and DRL regarding in Reply to Plaintiffs' Opposition to Defendants' Motion to Strike by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Nov 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [844] STIPULATION TO EXTEND TIME redaction deadline for D.I. 829 to 12/2/2021 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Christopher J. Burke on 11/19/2021. (dlb) |
| Nov 19, 2021 | 848 | Main Document (5) Docket Text: REDACTED VERSION of [831] Letter,, by Apotex Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibits 7-9, # (8) Exhibit 10)(Phillips, John) |
| Nov 19, 2021 | 848 | Exhibit 1 (136) |
| Nov 19, 2021 | 848 | Exhibit 2 (20) |
| Nov 19, 2021 | 848 | Exhibit 3 (20) |
| Nov 19, 2021 | 848 | Exhibit 4 (176) |
| Nov 19, 2021 | 848 | Exhibit 5 (187) |
| Nov 19, 2021 | 848 | Exhibit 6 (19) |
| Nov 19, 2021 | 848 | Exhibits 7-9 (1) |
| Nov 19, 2021 | 848 | Exhibit 10 (2) |
| Nov 18, 2021 | 844 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME redaction deadline for D.I. 829 to 12/2/2021 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 18, 2021 | 845 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Christopher Viceconte on behalf of Curia Missouri Inc., Curia Global, Inc. (Viceconte, Christopher) |
| Nov 16, 2021 | 841 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Nathan R. Hoeschen regarding Requesting Teleconference - re [824] MOTION to Strike Portions of Plaintiffs' Second Supplemental Infringement Contentions and Expert Reports. (Hoeschen, Nathan) |
| Nov 16, 2021 | 843 | Main Document (7) Docket Text: REDACTED VERSION of [834] Letter,, Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13)(Oakes, Robert) |
| Nov 16, 2021 | 843 | Exhibit 1 (2) |
| Nov 16, 2021 | 843 | Exhibit 2 (78) |
| Nov 16, 2021 | 843 | Exhibit 3 (78) |
| Nov 16, 2021 | 843 | Exhibit 4 (4) |
| Nov 16, 2021 | 843 | Exhibit 5 (20) |
| Nov 16, 2021 | 843 | Exhibit 6 (14) |
| Nov 16, 2021 | 843 | Exhibit 7 (17) |
| Nov 16, 2021 | 843 | Exhibit 8 (15) |
| Nov 16, 2021 | 843 | Exhibit 9 (10) |
| Nov 16, 2021 | 843 | Exhibit 10 (8) |
| Nov 16, 2021 | 843 | Exhibit 11 (3) |
| Nov 16, 2021 | 843 | Exhibit 12 (2) |
| Nov 16, 2021 | 843 | Exhibit 13 (2) |
| Nov 15, 2021 | 837 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of the Supplemental Rebuttal Expert Report of Jonathan Steed, PhD. [HIGHLY CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Nov 15, 2021 | 838 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Second Supplemental Rebuttal Expert Report of Jonathan Steed, Ph.D. filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Nov 15, 2021 | 839 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Supplemental Rebuttal Report of Jeremy Karl Cockcroft, Ph.D. Concerning Non-Infringement on Behalf of Apotex and Supplemental Expert Report of Graham Buckton, Ph.D. Concerning Non-Infringement on Behalf of Apotex filed by Apotex Inc..(Haney, Megan) |
| Nov 15, 2021 | 840 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Patricia Gupta (2) International Medication System's Supplemental Rebuttal Expert Report of Jonathan Steed, Ph.D. filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Nov 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [835] STIPULATION TO EXTEND TIME for Apotex to file the redacted version of Apotex's Letter Brief in Support of Its Motion to Strike (D.I. 831) to November 19, 2021 filed by Apotex Inc.. Ordered by Judge Christopher J. Burke on 11/12/2021. (mlc) |
| Nov 11, 2021 | 835 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Apotex to file the redacted version of Apotex's Letter Brief in Support of Its Motion to Strike (D.I. 831) to November 19, 2021 - filed by Apotex Inc.. (Haney, Megan) |
| Nov 9, 2021 | 833 | Redacted Document (30) Docket Text: REDACTED VERSION of [825] Letter, by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Nov 8, 2021 | N/A | Motions Referred (0) Docket Text: MOTION REFERRED: [830] MOTION to Strike Portions of Plaintiffs' Supplemental Infringement Contentions and Expert Reports Motion referred to Magistrate Judge Christopher J. Burke.(nmf) |
| Nov 8, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having been referred the motion to strike portions of plaintiffs' supplemental infringement contentions and expert reports ("the Motion"), (D.I. 830), hereby ORDERS as follows: (1) By no later than November 19, 2021, an answering brief shall be filed regarding the Motion, not to exceed five (5) single-spaced pages, in no less than 12-point font; and (2) By no later than November 29, 2021, a reply brief shall be filed regarding the motion, not to exceed two (2) single-spaced pages, in no less than 12-point font. Ordered by Judge Christopher J. Burke on 11/8/2021. (dlb) |
| Nov 5, 2021 | 830 | Main Document (2) Docket Text: MOTION to Strike Portions of Plaintiffs' Supplemental Infringement Contentions and Expert Reports - filed by Apotex Inc.. (Attachments: # (1) Text of Proposed Order)(Phillips, John) |
| Nov 5, 2021 | 830 | Text of Proposed Order (1) |
| Nov 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [828] STIPULATION TO EXTEND TIME to file a proposed public version of Defendants' IMS, Hospira, and DRL's Opening Letter Brief in Support of Their Motion to Strike (D.I. 825) to November 9, 2021 filed by International Medication Systems, Limited. Ordered by Judge Christopher J. Burke on 11/3/2021. (dlb) |
| Nov 3, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has reviewed Plaintiffs' November 2, 2021 letter, in which they request the scheduling of a discovery dispute teleconference. (D.I. 743) The Court will allow Curia Missouri, Inc. and Curia Global, Inc. ("Curia") to intervene for purposes of addressing this dispute before the Court. As noted in the Court's June 24, 2021 Oral Order, it will not automatically schedule a teleconference as to this dispute, but will permit full letter briefing and will expect to resolve it on the papers. The Court also ORDERS that the following letter briefing schedule will apply to the instant dispute: (a) By no later than November 11, 2021, Plaintiffs shall file an opening letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues.; (b) By no later than November 18, 2021, any party opposing the application for relief may file a responsive letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining that party(s) reasons for its opposition.; (c) By November 22, 2021, Plaintiffs shall file a reply letter brief, not to exceed two (2) single-spaced pages, in no less than 12-point font.; and (d) The parties should file a "Motion to Resolve Discovery Disputes" for the Court's administrative purposes. Ordered by Judge Christopher J. Burke on 11/3/2021. (dlb) |
| Nov 2, 2021 | 827 | Letter (2) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding Discovery Dispute re Curia. (Oakes, Robert) |
| Nov 2, 2021 | 828 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file a proposed public version of Defendants' IMS, Hospira, and DRL's Opening Letter Brief in Support of Their Motion to Strike (D.I. 825) to November 9, 2021 - filed by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having been referred the motion to strike portions of plaintiffs' supplemental infringement contentions and expert reports ("the Motion"), (D.I. 824), hereby ORDERS as follows: (1) By no later than November 9, 2021, an answering brief shall be filed regarding the Motion, not to exceed five (5) single-spaced pages, in no less than 12-point font; and (2) By no later than November 16, 2021, a reply brief shall be filed regarding the motion, not to exceed two (2) single-spaced pages, in no less than 12-point font. Ordered by Judge Christopher J. Burke on 10/27/2021. (dlb) |
| Oct 26, 2021 | N/A | Motions Referred (0) Docket Text: MOTION REFERRED: [824] MOTION to Strike Portions of Plaintiffs' Second Supplemental Infringement Contentions and Expert Reports Motion referred to Christopher J. Burke.(dlb) |
| Oct 26, 2021 | 823 | SO ORDERED (3) Docket Text: SO ORDERED, re [822] STIPULATION TO EXTEND TIME Supplemental Rebuttal Infringement Reports and Supplemental Reply Infringement Reports to November 12, 2021 and November 26, 2021 respectively filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 10/26/2021. (kmd) |
| Oct 26, 2021 | 824 | Main Document (2) Docket Text: MOTION to Strike Portions of Plaintiffs' Second Supplemental Infringement Contentions and Expert Reports - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc., Hospira, Inc., International Medication Systems, Limited. (Attachments: # (1) Text of Proposed Order)(Hoeschen, Nathan) |
| Oct 26, 2021 | 824 | Text of Proposed Order (1) |
| Oct 25, 2021 | 822 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Supplemental Rebuttal Infringement Reports and Supplemental Reply Infringement Reports to November 12, 2021 and November 26, 2021 respectively - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Oct 15, 2021 | 821 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant International Medication System, Ltd.'s Supplemental Objections and Responses to Plaintiffs' First Set of Supplemental Interrogatories (Nos. 3, 4) filed by International Medication Systems, Limited.(Keller, Karen) |
| Oct 8, 2021 | 819 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hospira, Inc.'s Fourth Amended Rule 26(a)(1) Disclosures [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Oct 8, 2021 | 820 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Final Infringement Contentions directed to Apotex Inc. (Confidential - Outside Counsel Eyes' Only) filed by Astellas Pharma US, Inc., Astellas US LLC.(Oakes, Robert) |
| Oct 6, 2021 | 818 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hospira, Inc.'s Fourth Amended Privilege Log filed by Hospira, Inc..(Gattuso, Dominick) |
| Oct 5, 2021 | 817 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Second Supplemental Final Infringement Contentions directed to DRL; (2) Plaintiffs' Second Supplemental Final Infringement Contentions directed to Hospira; and (3) Plaintiffs' Second Supplemental Final Infringement Contentions directed to IMS filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 1, 2021 | 816 | SO ORDERED (2) Docket Text: SO ORDERED, re [815] STIPULATION TO EXTEND TIME supplemental discovery deadlines between Apotex and Plaintiffs to various filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 10/1/2021. (kmd) |
| Sep 29, 2021 | 815 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME supplemental discovery deadlines between Apotex and Plaintiffs to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Sep 22, 2021 | 814 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Second (9/21/21) Privilege Log filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [810] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Kane and Ryan V. Petty filed by Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 9/16/2021. (kmd) |
| Sep 15, 2021 | N/A | Document Unsealed (0) Docket Text: Document unsealed: D.I. [808] Order. Per D.I. 812 no redactions requested. Ordered by Judge Christopher J. Burke on 9/15/2021. (dlb) |
| Sep 15, 2021 | 809 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Kelly A Del Dotto on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Del Dotto, Kelly) |
| Sep 15, 2021 | 810 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Kane and Ryan V. Petty - filed by Astellas Pharma US, Inc., Astellas US LLC. (Oakes, Robert) |
| Sep 15, 2021 | 811 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Objections and Responses to Plaintiffs' First Set of Supplemental Interrogatories; Dr. Reddy's Objections and Responses to Plaintiffs' First Set of Supplemental Requests for Production of Documents and Things; and Dr. Reddy's Objections and Responses to Plaintiffs' Supplemental Requests for Admission filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 15, 2021 | 812 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Megan C. Haney regarding the parties do not intend to request redactions to the Order issued on September 14, 2021 (D.I. 808). (Haney, Megan) |
| Sep 15, 2021 | 813 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Amanda L. Major, Amy K. Wigmore, Brittany B. Amadi, Charles T. Cox, Jr., and Kevin M. Yurkerwich of Wilmer Cutler Pickering Hale and Dorr LLP as co-counsel. Reason for request: no longer working on case. (Oakes, Robert) |
| Sep 14, 2021 | 808 | Order (3) Docket Text: ORDER re [777] Joint MOTION to Resolve Discovery Disputes filed by Biophore India Pharmaceuticals Pvt. Ltd.. Signed by Judge Christopher J. Burke on 9/14/2021.This order will be emailed to local counsel. (dlb) Document unsealed - Modified on 9/15/2021 (dlb). |
| Sep 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [807] STIPULATION TO EXTEND TIME supplemental discovery deadlines re Plaintiffs and DRL only to various filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 9/13/2021. (nmf) |
| Sep 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [806] MOTION for Pro Hac Vice Appearance of Attorney John M. Farrell, Caitlin M. Dean, Laura E. Powell, and K. Nicole Williams filed by Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 9/10/2021. (fms) |
| Sep 10, 2021 | 807 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME supplemental discovery deadlines re Plaintiffs and DRL only to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Sep 9, 2021 | 802 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Douglas Edward McCann on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (McCann, Douglas) |
| Sep 9, 2021 | 803 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gregory Robert Booker on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Booker, Gregory) |
| Sep 9, 2021 | 804 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by William Chad Shear on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Shear, William) |
| Sep 9, 2021 | 805 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Elizabeth M. Flanagan on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Flanagan, Elizabeth) |
| Sep 9, 2021 | 806 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John M. Farrell, Caitlin M. Dean, Laura E. Powell, and K. Nicole Williams - filed by Astellas Pharma US, Inc., Astellas US LLC. (Oakes, Robert) |
| Sep 8, 2021 | 801 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Supplemental (9/7/2021) Objections and Responses to Plaintiffs' Amended First Set of Common Interrogatories; DRL's Supplemental (9/7/2021) Objections and Responses to Plaintiffs' First Set of Common Requests for Admission; DRL's Supplemental (9/7/2021) Objections and Responses to Plaintiffs' First Set of Individual Requests for Admission; and Dr. Reddy's Supplemental (9/7/2021) Objections and Responses to Plaintiffs' First Set of Individual Interrogatories filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 3, 2021 | 798 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Defendant International Medication System Ltd.'s Objections and Responses to Plaintiffs' First Set of Supplemental Interrogatories 2. Defendant International Medication Systems' Objections and Responses to Plaintiffs' First Set of Supplemental Requests for Admission 3. Defendant International Medication Systems' Objections and Responses to Plaintiffs' First Set of Supplemental Requests for Production of Documents and Things to International Medication Systems, Ltd. filed by International Medication Systems, Limited.(Keller, Karen) |
| Sep 3, 2021 | 799 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) DRL's Supplemental (9/3/2021) Objections and Responses to Plaintiffs' Amended First Set of Common Interrogatories; (2) DRL's Supplemental (9/3/2021) Objections and Responses to Plaintiffs' First Set of Common Requests for Admission; (3) DRL's Supplemental (9/3/2021) Objections and Responses to Plaintiffs' First Set of Individual Requests for Admission; (4) DRL's Supplemental (9/3/2021) Objections and Responses to Plaintiffs' First Set of Individual Interrogatories; and (5) DRL's Supplemental (9/3/2021) Initial Disclosures filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 3, 2021 | 800 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Hospira, Inc.'s Objections and Responses to Plaintiffs' Supplemental Requests for Admission to Hospira [CONFIDENTIAL]; (ii) Defendant Hospira, Inc.'s Responses and Objections to Plaintiffs' Supplemental Requests for Production of Documents to Hospira, Inc. [CONFIDENTIAL]; and, (iii) Defendant Hospira, Inc.'s Responses and Objections to Plaintiffs' Supplemental First Set of Individual Interrogatories [CONFDIENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Aug 30, 2021 | 797 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Supplemental Requests for Production of Documents and Things, First Set of Supplemental Interrogatories and Supplemental Requests for Admission to DEFENDANT IMS filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Aug 27, 2021 | 796 | SO ORDERED (4) Docket Text: SO ORDERED, re [795] STIPULATION and Order to Modify Scheduling Order, ORDER, Setting Scheduling Order Deadlines (Supplemental Fact Discovery completed by 9/24/2021., Supplemental Expert Discovery due by 12/8/2021., Proposed Pretrial Order due by 12/21/2021.) See order for further details. Signed by Judge Colm F. Connolly on 8/27/2021. (nmf) |
| Aug 25, 2021 | 794 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Hospira, Inc.'s Supplemental Objections and Responses to Plaintiffs' First Set of Individual Requests for Admission; (ii) Defendant Hospira, Inc.'s Second Supplemental Responses and Objections to Plaintiffs' First Set of Individual Interrogatories; (iii) Hospira, Inc.'s Third Amended Rule 26(a)(1) Disclosures; (iv) Defendant Hospira's First and Second Supplemental Responses and Objections to Plaintiffs' Third Amended First Set of Common Interrogatories; and, (v) Defendant Hospira, Inc.'s Supplemental Objections and Responses to Plaintiffs' First Set of Common Requests for Admission filed by Hospira, Inc..(Gattuso, Dominick) |
| Aug 25, 2021 | 795 | Stipulation (4) Docket Text: STIPULATION and Proposed Order to Modify Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Gupta Fiorella, Nitika) |
| Aug 24, 2021 | 793 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Defendant International Medication System, Ltd.'s First Supplemental Objections and Responses to Plaintiffs' First Individual Interrogatory (2) Defendant International Medication Systems' First Supplemental Objections and Responses to Plaintiffs' First Set of Common Requests for Admission Nos. 23 and 24 (3) Defendant International Medication Systems' First Supplemental Objections and Responses to Plaintiffs' First Set of Individual Requests for Admission No. 8 (4) Defendant International Medication Systems' Second Supplemental Objections and Responses to Plaintiffs' Common Interrogatories (Nos. 1, 5, 7-9) (5) International Medication Systems, Ltd.'s Second Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by International Medication Systems, Limited.(Keller, Karen) |
| Aug 23, 2021 | 792 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Amended Supplemental Privilege Log (8/16/21) filed by Apotex Inc..(Haney, Megan) |
| Aug 20, 2021 | 791 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Greg J. Winter as co-counsel. Reason for request: Left Firm. (Gattuso, Dominick) |
| Aug 19, 2021 | 789 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Mark McBriar as co-counsel. Reason for request: no longer working on case. (Oakes, Robert) |
| Aug 19, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' joint motion to resolve a discovery dispute ("Motion"), (D.I. [749]), and the briefing related thereto, (D.I. 750; D.I. 753; D.I. 755), hereby ORDERS that the Motion--involving Plaintiffs' request that Defendant Apotex be compelled to complete the production of certain XRPD documents in the possession of third-party entities Biophore and Teena Biolabs ("Teena") and to produce custodial documents from Biophore employee Manik Pullagurla--is DENIED. The success of the Motion is premised on Plaintiffs being able to show that Apotex has "control" over documents in the possession of Biophore and Teena, pursuant to Federal Rule of Civil Procedure 34. (D.I. 750 at 1-2) The parties agree that to show that Apotex has control over the documents in Biophore's and Teena's possession, Plaintiffs must show that Apotex has the "legal right to obtain the documents required on demand" from those third parties. (D.I. 753 at 1; see also D.I. 750 at 2; D.I. 755 at 2); see also Princeton Digital Image Corp. v. Konami Digit. Ent. Inc., 316 F.R.D. 89, 90 (D. Del. 2016). Plaintiffs have not come close to making such a showing. This is not a case like some referenced in Plaintiffs' briefing (i.e., Princeton Digital, In re Benicar, Sanofi-Aventis, Afros or In re Mushroom Direct Purchaser Antitrust Litig.), where the party from whom discovery is sought and the third party/parties are corporate affiliates. In such cases, before any other factual analysis of "control" begins, it can already be said that there is some type of close (corporate) connection between the entities. And the United States Court of Appeals for the Third Circuit has set out particular tests that courts should use to analyze "control" in those "corporate affiliate" scenarios--tests that examine whether the respective entities are alter egos or have otherwise acted "as one" with regard to the transaction at issue. See Princeton Digital, 316 F.R.D. at 91 (citing Gerling Int'l Ins. Co. v. Comm'r of Internal Revenue, 839 F.2d 131, 141 (3d Cir. 1988)). Here, in contrast, Apotex is not a corporate affiliate of Biophore or Teena. (D.I. 753 at 3) Nor is this a scenario like in some of the other cases cited in Plaintiffs' briefing (i.e., Moretti, LG.Philips) where the party from whom discovery was sought had a contractual right to obtain the documents at issue from a third party. See also Integra LifeScis. Corp. v. HyperBranch Med. Tech., Inc., Civil Action No. 15-819-LPS-CJB, 2016 WL 675553, at *1 (D. Del. Feb. 12, 2016). Here there is no evidence that Apotex possesses such a contractual right. (D.I. 753 at 3) And otherwise, Plaintiffs have not demonstrated that Apotex has some other form of "legal right" (or its equivalent) to obtain the documents at issue from Biophore or Teena. See Gerling, 839 F.2d at 140. To the extent that Plaintiffs believe that they can make a case that some form of "selective production" of documents regarding a certain subject matter by Apotex or Biophore should result in the exclusion of certain evidence in the case, (D.I. 755 at 1), that request would seem better made in the form of a motion to strike or a motion in limine, not a motion to compel premised on Rule 34 "control" grounds. Lastly, in light of the Court's decision above, Apotex's motion for leave to file a sur-reply brief, (D.I. [761]), is DENIED as MOOT. Ordered by Judge Christopher J. Burke on 8/19/2021. (mlc) |
| Aug 18, 2021 | 788 | SO ORDERED (2) Docket Text: SO ORDERED, re [783] Stipulation of Dismissal filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Party Accord Healthcare, Inc. terminated. Signed by Judge Colm F. Connolly on 8/17/2021. (fms) |
| Aug 17, 2021 | 784 | Main Document (6) Docket Text: REDACTED VERSION of [780] Answering Brief in Opposition, Opposition to Biophore's Motion for Protective Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Oakes, Robert) |
| Aug 17, 2021 | 784 | Exhibit A (1) |
| Aug 17, 2021 | 784 | Exhibit B (27) |
| Aug 17, 2021 | 784 | Exhibit C (3) |
| Aug 17, 2021 | 785 | Main Document (6) Docket Text: REDACTED VERSION of [779] Letter, to Judge Burke by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - E)(Oakes, Robert) |
| Aug 17, 2021 | 785 | Exhibit A (17) |
| Aug 17, 2021 | 785 | Exhibit B (27) |
| Aug 17, 2021 | 785 | Exhibit C - E (1) |
| Aug 17, 2021 | 786 | Main Document (5) Docket Text: REDACTED VERSION of [778] Letter, by Biophore India Pharmaceuticals Pvt. Ltd.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9)(Haney, Megan) |
| Aug 17, 2021 | 786 | Exhibit 1 (1) |
| Aug 17, 2021 | 786 | Exhibit 2 (15) |
| Aug 17, 2021 | 786 | Exhibit 3 (8) |
| Aug 17, 2021 | 786 | Exhibit 4 (21) |
| Aug 17, 2021 | 786 | Exhibit 5 (17) |
| Aug 17, 2021 | 786 | Exhibit 6 (9) |
| Aug 17, 2021 | 786 | Exhibit 7 (15) |
| Aug 17, 2021 | 786 | Exhibit 8 (7) |
| Aug 17, 2021 | 786 | Exhibit 9 (12) |
| Aug 17, 2021 | 787 | Main Document (5) Docket Text: REDACTED VERSION of [781] Letter, by Biophore India Pharmaceuticals Pvt. Ltd.. (Attachments: # (1) Text of Proposed Order)(Haney, Megan) |
| Aug 17, 2021 | 787 | Text of Proposed Order (1) |
| Aug 16, 2021 | 783 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Accord Healthcare, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [782] STIPULATION TO EXTEND TIME for the parties to file redacted versions of the opening letter briefs regarding the Biophore discovery disputes (D.I. 778) and (D.I. 779) to August 17, 2021 filed by Biophore India Pharmaceuticals Pvt. Ltd. Ordered by Judge Christopher J. Burke on 8/13/2021. (dlb) |
| Aug 13, 2021 | 782 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to file redacted versions of the opening letter briefs regarding the Biophore discovery disputes (D.I. 778) and (D.I. 779) to August 17, 2021 - filed by Biophore India Pharmaceuticals Pvt. Ltd.. (Haney, Megan) |
| Aug 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [776] Proposed Order Regarding Expedited Briefing on Biophore Dispute re 775 Oral Order filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Christopher J. Burke on 8/4/2021. (dlb) |
| Aug 4, 2021 | 777 | Motion for Miscellaneous Relief (1) Docket Text: Joint MOTION to Resolve Discovery Disputes - filed by Biophore India Pharmaceuticals Pvt. Ltd.. Motions referred to Christopher J. Burke.(Phillips, John) |
| Aug 3, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs and non-party Biophore's July 30, 2021 letter, in which they, inter alia, request an expediting briefing schedule regarding their discovery disputes, (D.I. 772), hereby ORDERS that by no later than August 3, 2021, Plaintiffs and Biophore should file a jointly proposed order setting out their proposed expedited briefing schedule. These parties should also (1) consult Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website; and (2) file a "Motion to Resolve Discovery Disputes" for the Court's administrative purposes. Ordered by Judge Christopher J. Burke on 8/3/2021. (dlb) |
| Aug 3, 2021 | 776 | Proposed Order (2) Docket Text: PROPOSED ORDER Regarding Expedited Briefing on Biophore Dispute re [775] Oral Order,,, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 2, 2021 | 773 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Surapanini Sridevi on August 4, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 2, 2021 | 774 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Martin Ehlert on August 12, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 30, 2021 | 772 | Letter (2) Docket Text: Joint Letter to The Honorable Christopher J. Burke from John C. Phillips, Jr. regarding non-party Biophores request for resolution of discovery dispute. (Phillips, John) |
| Jul 28, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [770] MOTION for Pro Hac Vice Appearance of Attorney Robert J. Gunther, Jr. filed by Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 7/28/2021. (fms) |
| Jul 27, 2021 | 770 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert J. Gunther, Jr. - filed by Astellas Pharma US, Inc., Astellas US LLC. (Oakes, Robert) |
| Jul 27, 2021 | 771 | Redacted Document (6) Docket Text: REDACTED VERSION of [766] Reply Brief by Apotex Inc.. (Haney, Megan) |
| Jul 26, 2021 | 769 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Supplemental (7/23/21) Objections and Responses to Plaintiffs' First Set of Supplemental Interrogatories and Apotex's Amended (7/23/21) Objections and Responses to Plaintiffs' First Set of Supplemental Requests for Production of Documents and Things filed by Apotex Inc..(Haney, Megan) |
| Jul 22, 2021 | 768 | Main Document (5) Docket Text: REDACTED VERSION of [764] Response to Motion, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A)(Oakes, Robert) |
| Jul 22, 2021 | 768 | Exhibit A (3) |
| Jul 20, 2021 | 767 | Main Document (4) Docket Text: REDACTED VERSION of [761] MOTION for Leave to File a Sur-Reply in Opposition to Plaintiffs' Motion to Compel by Apotex Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Proposed Order)(Phillips, John) |
| Jul 20, 2021 | 767 | Exhibit A (6) |
| Jul 20, 2021 | 767 | Exhibit B (38) |
| Jul 20, 2021 | 767 | Proposed Order (1) |
| Jul 19, 2021 | 765 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Supplemental Privilege Log (7/16/21) filed by Apotex Inc..(Haney, Megan) |
| Jul 16, 2021 | 762 | Redacted Document (5) Docket Text: REDACTED VERSION of [755] Letter, to Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 16, 2021 | 763 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Accord's Supplemental Privilege Log filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Jul 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [760] STIPULATION TO EXTEND TIME for production of a Biophore litigation sample to Plaintiffs to July 23, 2021 filed by Apotex Inc. Ordered by Judge Christopher J. Burke on 7/15/2021. (dlb) |
| Jul 14, 2021 | 760 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for production of a Biophore litigation sample to Plaintiffs to July 23, 2021 - filed by Apotex Inc.. (Haney, Megan) |
| Jul 13, 2021 | 758 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to Plaintiffs' June 21, 2021 Supplemental 30(b)(6) Deposition Topics filed by Apotex Inc..(Haney, Megan) |
| Jul 13, 2021 | 759 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Accord's Objections and Responses to Plaintiffs' Supplemental 30(b)(6) Deposition Notice filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Jul 12, 2021 | 756 | SO ORDERED (2) Docket Text: SO ORDERED, re [754] Stipulation of Dismissal filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Party Glenmark Pharmaceuticals Limited terminated. Signed by Judge Colm F. Connolly on 7/12/2021. (fms) |
| Jul 12, 2021 | 757 | Redacted Document (5) Docket Text: REDACTED VERSION of [753] Answering Brief in Opposition, by Apotex Inc.. (Phillips, John) |
| Jul 9, 2021 | 754 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 6, 2021 | 752 | Main Document (6) Docket Text: REDACTED VERSION of [750] Letter,, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R, # (20) Exhibit S, # (21) Exhibit T, # (22) Exhibit U)(Oakes, Robert) |
| Jul 6, 2021 | 752 | Text of Proposed Order (2) |
| Jul 6, 2021 | 752 | Exhibit A (4) |
| Jul 6, 2021 | 752 | Exhibit B (6) |
| Jul 6, 2021 | 752 | Exhibit C (3) |
| Jul 6, 2021 | 752 | Exhibit D (1) |
| Jul 6, 2021 | 752 | Exhibit E (1) |
| Jul 6, 2021 | 752 | Exhibit F (3) |
| Jul 6, 2021 | 752 | Exhibit G (5) |
| Jul 6, 2021 | 752 | Exhibit H (10) |
| Jul 6, 2021 | 752 | Exhibit I (8) |
| Jul 6, 2021 | 752 | Exhibit J (1) |
| Jul 6, 2021 | 752 | Exhibit K (1) |
| Jul 6, 2021 | 752 | Exhibit L (1) |
| Jul 6, 2021 | 752 | Exhibit M (1) |
| Jul 6, 2021 | 752 | Exhibit N (1) |
| Jul 6, 2021 | 752 | Exhibit O (1) |
| Jul 6, 2021 | 752 | Exhibit P (4) |
| Jul 6, 2021 | 752 | Exhibit Q (5) |
| Jul 6, 2021 | 752 | Exhibit R (3) |
| Jul 6, 2021 | 752 | Exhibit S (3) |
| Jul 6, 2021 | 752 | Exhibit T (24) |
| Jul 6, 2021 | 752 | Exhibit U (2) |
| Jul 2, 2021 | 751 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Alison Burton as co-counsel.. (Oakes, Robert) |
| Jun 29, 2021 | 749 | Motion for Miscellaneous Relief (3) Docket Text: Joint MOTION to Resolve Discovery Disputes - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Jun 28, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [748] STIPULATION TO EXTEND TIME to produce litigation sample to July 16, 2021 filed by Apotex Inc. Ordered by Judge Christopher J. Burke on 6/28/2021. (mlc) |
| Jun 25, 2021 | 748 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to produce litigation sample to July 16, 2021 - filed by Apotex Inc.. (Phillips, John) |
| Jun 24, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has reviewed Plaintiffs and Defendant Apotex Inc.'s June 17, 2021 letter, in which they request the scheduling of a discovery dispute teleconference. (D.I. 743) In light of the very large number of discovery dispute teleconferences requested in this case (by the Court's count, this is the 13th such request), and in order to balance the need to promptly resolve discovery disputes with the promotion of judicial efficiency, the Court hereby ORDERS that, going forward, it will no longer automatically schedule discovery dispute teleconferences in this matter unless, after reviewing the briefing, it deems such a teleconference necessary. Instead, it will permit full letter briefing (that is, the filing of opening, answering and reply letter briefs) as to such disputes and will expect to resolve those disputes on the papers. The Court also ORDERS that the following letter briefing schedule will apply to the instant disputes: (a) By no later than June 29, 2021, any party seeking relief shall file an opening letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues.; (b) By no later than July 6, 2021, any party opposing the application for relief may file a responsive letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining that party(s) reasons for its opposition.; (c) By July 9, 2021, any party seeking relief shall file a reply letter brief, not to exceed two (2) single-spaced pages, in no less than 12-point font. (d) The parties should also consult Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; and (e) The parties should file a "Motion to Resolve Discovery Disputes" for the Court's administrative purposes. Ordered by Judge Christopher J. Burke on 6/24/2021. (dlb) |
| Jun 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [745] MOTION for Pro Hac Vice Appearance of Attorney Jason Leonard filed by Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 6/21/2021. (nmf) |
| Jun 21, 2021 | 746 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) Directed to Apotex, Inc. and Plaintiffs' Supplemental Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) Directed to Accord, Inc. filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 17, 2021 | 743 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding request for scheduling conference re discovery dispute with Apotex. (Oakes, Robert) |
| Jun 17, 2021 | 744 | Stipulation (2) Docket Text: STIPULATION Regarding Apotex's Supplemental Document Production by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 17, 2021 | 745 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jason Leonard - filed by Astellas Pharma US, Inc., Astellas US LLC. (Oakes, Robert) |
| Jun 16, 2021 | 742 | Redacted Document (3) Docket Text: REDACTED VERSION of [740] Stipulation of Dismissal by Sandoz Inc.. (Haney, Megan) |
| Jun 14, 2021 | 739 | Subpoena Returned Executed (2) Docket Text: SUBPOENA Returned Executed as to Biphore Pharma Inc. (for Production and Testimony) on June 8, 2021 (Oakes, Robert) |
| Jun 8, 2021 | 737 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accord's Objections and Responses to Plaintiffs' First Set of Supplemental Interrogatories to Apotex and Accord; (2) Accord's Objections and Responses to Plaintiffs' First Set of Supplemental Requests for Admission to Apotex and Accord; (3) Accord's Objections and Responses to Plaintiffs' First Set of Supplemental Requests for Production to Apotex and Accord and; (4) Accord's Objections and Responses to Plaintiffs' Second Set of Requests for Admission to Authenticate Documents to Accord filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Jun 8, 2021 | 738 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Objections and Responses to Plaintiffs' First Set of Supplemental Interrogatories; (2) Apotex's Objections and Responses to Plaintiffs' First Set of Supplemental Requests for the Production of Documents and Things; (3) Apotex's Objections and Responses to Plaintiffs' Supplemental Requests for Admission; and (4) Apotex's Objections and Responses to Plaintiffs' Second Set of Requests for Admission to Authenticate Documents filed by Apotex Inc..(Haney, Megan) |
| Jun 7, 2021 | 736 | Scheduling Order (3) Docket Text: SCHEDULING ORDER: Proposed Pretrial Order due by 11/24/2021. A Final Pretrial Conference is set for 12/15/2021 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 1/24/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/7/2021. (nmf) |
| May 27, 2021 | 734 | Proposed Order (3) Docket Text: PROPOSED ORDER regarding Pre-trial and Trial Dates by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| May 27, 2021 | 735 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Co-Counsel Robert M. Galvin by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Oakes, Robert) |
| May 26, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. A Telephone Conference is set for 5/26/2021 at 02:00 PM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 5/26/2021. (nmf) |
| May 26, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 5/26/2021. (Court Reporter V. Gunning.) (nmf) |
| May 26, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before June 2, 2021, counsel shall file a revised proposed scheduling order including the dates discussed during today's telephone conference. Ordered by Judge Colm F. Connolly on 5/26/2021. (nmf) |
| May 26, 2021 | 733 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of TO APOTEX and ACCORD: 1st Supplemental Interrogatories, Requests for Production, Requests for Admission and Requests for Admission to Authenticate; TO ACCORD: Second Set of Requests for Admission to Authenticate Documents; TO APOTEX: Second Set of Requests for Admission to Authenticate Documents filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| May 17, 2021 | 732 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. § 282 filed by Hospira, Inc..(Gattuso, Dominick) |
| May 14, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has read Mr. Phillips' letter (D.I. [730]), Ms. Marshall's May 13, 2021 email to chambers, and Mr. Oakes' letter (D.I. [731]). The Court agrees with Mr. Oakes that it is premature to set a date for what will be a single trial to adjudicate the infringement claims alleged against the non-Sun defendants. Ordered by Judge Colm F. Connolly on 5/14/2021. (nmf) |
| May 12, 2021 | 730 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding trial date for the Apotex and Accord infringement cases. (Attachments: # (1) Exhibit A)(Phillips, John) |
| May 12, 2021 | 730 | Exhibit A (58) |
| May 12, 2021 | 731 | Letter (3) Docket Text: Letter to Honorable Colm F. Connolly from Robert M. Oakes regarding response to Apotex/Accord request for bifurcated trial - re [730] Letter. (Oakes, Robert) |
| May 11, 2021 | 727 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Apotex's Supplemental (5/10/21) Objections and Responses to First Set of Individual Requests for Admission; (2) Apotex's Supplemental (5/10/21) Objections and Responses to Plaintiffs' Amended First Set of Common Interrogatories; (3) Apotex's Supplemental (5/10/21) Objections and Responses to First Set of Common Requests for Admission; (4) Apotex's Supplemental Objections and Responses (5/10/21) to Plaintiffs' First Set of Common Requests for Production of Documents and Things; (5) Apotex's Supplemental (5/10/21) Objections and Responses to Plaintiffs' Second Set of Common Interrogatories; and (6) Apotex's Supplemental (5/10/21) Initial Disclosures filed by Apotex Inc..(Haney, Megan) |
| May 11, 2021 | 728 | Order (3) Docket Text: ORDER REGARDING DISCOVERY FROM EUTICALS. Signed by Judge Christopher J. Burke on 5/11/2021. (dlb) |
| May 11, 2021 | 729 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accord Healthcare, Inc.'s Second Supplemental Responses to Plaintiffs' Amended First Set of Common Interrogatories (Nos. 1-11) and; (2) Accord Healthcare, Inc.'s First Supplemental Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-15) filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| May 10, 2021 | 726 | Proposed Order (3) Docket Text: PROPOSED ORDER regarding Discovery from Euticals re [725] Oral Order,, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| May 7, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The pretrial conference will be conducted by telephone. Plaintiffs shall make the necessary telephone arrangements and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 5/7/2021. (nmf) |
| May 7, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' May 4, 2021 letter and proposed order, (D.I. 721), and for the reasons set out by Defendants DRL, IMS, and Hospira ("Defendants"), agrees with Defendants' proposal. Defendants should have the ability to review the search results for relevance and exclude obviously irrelevant information. The parties should jointly submit a revised proposed order no later than May 10, 2021. Ordered by Judge Christopher J. Burke on 5/7/2021. (dlb) |
| May 6, 2021 | 723 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding pretrial conference. (Phillips, John) |
| May 6, 2021 | 724 | Main Document (3) Docket Text: Letter to Honorble Christopher J. Burke from Robert M. Oakes regarding Joint Status Letter Submitted in Accordance with April 26, 2021 Oral Order. (Attachments: # (1) Exhibit 1)(Oakes, Robert) |
| May 6, 2021 | 724 | Exhibit 1 (9) |
| May 5, 2021 | 722 | Main Document (4) Docket Text: REDACTED VERSION of [715] Letter, to Honorable Christopher J. Burke from Robert M. Oakes regarding Joint Letter in Accordance with D.I. 709 by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit 1)(Oakes, Robert) |
| May 5, 2021 | 722 | Exhibit A (3) |
| May 5, 2021 | 722 | Exhibit B (2) |
| May 5, 2021 | 722 | Exhibit C (16) |
| May 5, 2021 | 722 | Exhibit 1 (3) |
| May 4, 2021 | 720 | Scheduling Order (3) Docket Text: SUPPLEMENTAL SCHEDULING ORDER: Supplemental Fact Discovery completed by 8/13/2021. Supplemental Expert Discovery due by 11/23/2021. Please see Order for further details and deadlines. Signed by Judge Christopher J. Burke on 5/4/2021. (dlb) |
| May 4, 2021 | 721 | Main Document (2) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding Joint Status Letter submitted in accordance with D.I. 711 and 718. (Attachments: # (1) Text of Proposed Order)(Oakes, Robert) |
| May 4, 2021 | 721 | Text of Proposed Order (3) |
| May 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [718] Stipulation to extend time for submitting joint status letter re 711 Oral Order filed by International Medication Systems, Limited. Ordered by Judge Christopher J. Burke on 5/3/2021. (dlb) |
| May 3, 2021 | 719 | Proposed Order (3) Docket Text: PROPOSED ORDER Proposed Supplemental Scheduling Order between Plaintiffs, Apotex and Accord re [717] Oral Order,,,,, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Apr 30, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs and Apotex/Accord's April 28, 2021 joint letter, (D.I. [715]), hereby ORDERS as follows with regard to the content of a supplemental discovery schedule: (1) The Court adopts Plaintiffs' proposed schedule (with one exception, listed below), for the reasons that Plaintiffs set out in the joint letter. (Id. at 1, para. 1); (2) Added to that schedule can be Apotex/Accord's proposal of an entry related to production of a Biophore litigation sample. The parties' dispute as to representativeness of that sample is not something for the Court to address now.; (3) As to the scope of supplemental discovery, while the Court agrees that it should not be expansive, it seems likely that Plaintiffs will need to serve some supplemental discovery requests. The Court does not understand, in light of the nature of this supplemental discovery and the reason for it, why "such requests [should] be reciprocal." (Id. at 2 n.4; see also id. at 1, para. 2).; and (4) Plaintiffs, on behalf of all relevant parties, shall submit a final proposed scheduling order that takes into account the Court's decisions by no later than May 3, 2021. Ordered by Judge Christopher J. Burke on 4/30/2021. (mlc) |
| Apr 30, 2021 | 718 | Stipulation (2) Docket Text: STIPULATION (and proposed order) to extend time for submitting joint status letter re [711] Oral Order,,,,,,,,, by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Apr 29, 2021 | 716 | Notice of Change of Address (1) Docket Text: NOTICE of Change of Address by James S. Green, Jr (Green, James) |
| Apr 27, 2021 | 714 | Main Document (3) Docket Text: REDACTED VERSION of [708] Status Report by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A)(Oakes, Robert) |
| Apr 27, 2021 | 714 | Exhibit A (67) |
| Apr 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [712] STIPULATION TO EXTEND TIME for the parties to submit (1) the proposed schedule and letter required by the Court's Oral Order (D.I. 709); and (2) the redacted version of the parties' joint status report (D.I. 708) to April 28, 2021 filed by Apotex Inc. Ordered by Judge Christopher J. Burke on 4/26/2021. (dlb) |
| Apr 26, 2021 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. BurkeDiscovery Teleconference held on 4/26/2021. After hearing the parties regarding the dispute, (D.I.688), the Court resolved the dispute on the record. The transcript shall serve as the substance of the Court's Order. (Clerk, Sforza) APPEARANCES: R. Oakes, B. Amadi, A. Wigmore and A. Tiglio for Astellas; M. Velez for Gilead; A. Poff, S. Benson, K. Beis and D. Knapp for Sun; J. Phillips, Jr. and J. Jaros for Apotex; C. Galligan for DRL; C. Hitch and B. Mahon for Accord; D. Gattuso and A. King for Hospira; K. Keller and N. Daughtrey for IMS. (Court Reporter: Gail Verbano) (dlb) |
| Apr 26, 2021 | 713 | Redacted Document (30) Docket Text: REDACTED VERSION of [710] Letter, by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,. (Vrana, Robert) |
| Apr 23, 2021 | 712 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit (1) the proposed schedule and letter required by the Court's Oral Order (D.I. 709); and (2) the redacted version of the parties' joint status report (D.I. 708) to April 28, 2021 - filed by Apotex Inc.. (Haney, Megan) |
| Apr 20, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' April 5, 2021 joint status letter, (D.I. 689), hereby ORDERS as follows: (1) The Court agrees with Plaintiffs that Dr. Grisenti is likely to have e-mails that are relevant to the subject matter of the Hancock Declaration, (see, e.g., D.I. 689, ex. 3), and it appears undisputed that Dr. Grisenti spent a substantial portion of the relevant time period in Italy, (D.I. 689 at 1). While it seems correct that some of those relevant e-mails may also have been sent to Euticals' employees in the United States (and might be found in the sources that Euticals is already going to search), (id. at 3), it certainly seems likely that some relevant e-mails would be found only on Euticals' Italian servers/archived e-mails. And although Defendants DRL, IMS and Hospira ("Defendants") suggest that it would be unduly burdensome for Euticals to collect those Italian-based e-mails, (id. at 3), absolutely no showing has been made about the nature of that burden.; (2) With regard to the dispute about search terms, the Court disagrees with Defendants that the term "sampl*" must be in every search in order to locate relevant material. And Plaintiffs proposed terms 1, 2 and 4 all seem focused on the subject matter of the Hancock Declaration (term 3 seems less so and overly broad). (D.I. 689, ex. VV); (3) So if Euticals were a party to this suit, the Court would be ordering it to conduct a search of the Italian servers/archived e-mails using Plaintiffs' search terms 1, 2 and 4. But Euticals is not a party, and there has been no finding that Euticals' documents are in Defendants' "control" pursuant to Fed. R. Civ. P. 26. So, the Court will not order Euticals to do anything.; and (4) That said, if Euticals refuses to conduct this search, and Plaintiffs believe that, in light of that, they can make a case that Defendants' defense premised on the Hancock Declaration should be stricken, Plaintiffs are free to petition the Court for such relief. The parties shall further meet and confer on that issue, and submit a joint status report of no more than two single-spaced pages by no later than April 30, 2021. Ordered by Judge Christopher J. Burke on 4/20/2021. (dlb) |
| Apr 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [705] STIPULATION TO EXTEND TIME Date of Deposition of Bernhardt Trout to April 19, 2021 filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 4/19/2021. (nmf) |
| Apr 19, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs/Apotex Inc.'s ("Apotex") April 16, 2021 joint status letter, (D.I. 708), is inclined to set a further supplemental fact discovery schedule now regarding Apotex and infringement/non-infringement issues. In crafting a schedule, the parties and the Court can take into account the fact of the June 2021 trial (including whether certain discovery-related periods should be extended beyond what might otherwise be called for, in light of that trial). (D.I. 708 at 2) The Court hereby ORDERS that by no later than April 26, 2021, Plaintiffs/Apotex shall provide the Court with a proposed Scheduling Order regarding those issues, along with a letter, not to exceed two single-spaced pages, setting out any disputes as to that schedule and the parties' respective positions. Ordered by Judge Christopher J. Burke on 4/19/2021. (dlb) |
| Apr 16, 2021 | 704 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Bernhardt Trout on April 19, 2021 filed by Hospira, Inc..(Gattuso, Dominick) |
| Apr 16, 2021 | 705 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Date of Deposition of Bernhardt Trout to April 19, 2021 - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Apr 16, 2021 | 706 | SO ORDERED (5) Docket Text: SO ORDERED, re [702] STIPULATION regarding Pretrial exchange schedule filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC, ORDER, Re-Setting Scheduling Order Deadlines: The Final Pretrial Conference is rescheduled for 6/8/2021 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly. See order for further details and deadlines. Signed by Judge Colm F. Connolly on 4/16/2021. (nmf) |
| Apr 16, 2021 | 707 | Main Document (5) Docket Text: REDACTED VERSION of [698] Letter, by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Proposed Order, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15)(Phillips, John) |
| Apr 16, 2021 | 707 | Proposed Order (1) |
| Apr 16, 2021 | 707 | Exhibit 1 (7) |
| Apr 16, 2021 | 707 | Exhibit 2 (7) |
| Apr 16, 2021 | 707 | Exhibit 3 (8) |
| Apr 16, 2021 | 707 | Exhibit 4 (8) |
| Apr 16, 2021 | 707 | Exhibit 5 (8) |
| Apr 16, 2021 | 707 | Exhibit 6 (20) |
| Apr 16, 2021 | 707 | Exhibit 7 (9) |
| Apr 16, 2021 | 707 | Exhibit 8 (3) |
| Apr 16, 2021 | 707 | Exhibit 9 (9) |
| Apr 16, 2021 | 707 | Exhibit 10 (3) |
| Apr 16, 2021 | 707 | Exhibit 11 (7) |
| Apr 16, 2021 | 707 | Exhibit 12 (24) |
| Apr 16, 2021 | 707 | Exhibit 13 (3) |
| Apr 16, 2021 | 707 | Exhibit 14 (15) |
| Apr 16, 2021 | 707 | Exhibit 15 (1) |
| Apr 14, 2021 | N/A | Document Unsealed (0) Docket Text: Document Unsealed - [696] Memorandum and Order per Letter at D.I. 701. (dlb) |
| Apr 14, 2021 | 702 | Stipulation (5) Docket Text: STIPULATION regarding Pretrial exchange schedule by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Apr 14, 2021 | 703 | Status Report (6) Docket Text: Joint STATUS REPORT by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Apr 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [697] STIPULATION TO EXTEND TIME joint status letter with Apotex to April 16, 2021 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Christopher J. Burke on 4/13/2021. (dlb) |
| Apr 13, 2021 | 700 | Redacted Document (2) Docket Text: REDACTED VERSION of [692] Proposed Order, by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Apr 13, 2021 | 701 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from John C. Phillips, Jr. regarding Plaintiffs and DRL Defendants do not request any redactions to the memorandum order issued on April 8, 2021 (D.I. 696). (Phillips, John) |
| Apr 12, 2021 | 699 | Main Document (5) Docket Text: REDACTED VERSION of [689] Letter, to Judge Burke from Robert Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Plaintiffs' Exhibits 1-4, # (2) Plaintiffs' Proposed Order, # (3) Defendants' Exhibits VV-ZZ, # (4) Defendants' Exhibit ZZ)(Oakes, Robert) |
| Apr 12, 2021 | 699 | Plaintiffs' Exhibits 1-4 (26) |
| Apr 12, 2021 | 699 | Plaintiffs' Proposed Order (2) |
| Apr 12, 2021 | 699 | Defendants' Exhibits VV-ZZ (34) |
| Apr 12, 2021 | 699 | Defendants' Exhibit ZZ (1) |
| Apr 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [693] STIPULATION TO EXTEND TIME regarding Sun Depositions to Dr. Myerson on April 9 and Dr. Claybourn on April 13 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 4/9/2021. (fms) |
| Apr 9, 2021 | 697 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME joint status letter with Apotex to April 16, 2021 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Apr 8, 2021 | 695 | Redacted Document (4) Docket Text: REDACTED VERSION of [685] Letter by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Apr 8, 2021 | 696 | Memorandum and Order (9) Docket Text: MEMORANDUM ORDER regarding D.I. [525] Joint MOTION for Discovery MOTION Joint Motion for Teleconference to Resolve Discovery Dispute filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Christopher J. Burke on 4/8/2021.This order has been emailed to local counsel. (mlc) Modified on 4/14/2021 document unsealed.(dlb) |
| Apr 7, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 4/7/2021. (Court Reporter V. Gunning.) (nmf) |
| Apr 7, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Trial shall begin at 8:30 a.m. on June 14, 2021. The Court will first try the Defendants' claims of invalidity. Each side shall have 10.5 hours, not including time for closing arguments. The Court will determine at trial whether it will entertain closing arguments. After the invalidity claims are tried, the Court will try the Plaintiffs' infringement case against Sun. Each side shall have five hours. The parties shall submit no later than April 14, 2021 a joint status report to update the Court about trial logistics. Ordered by Judge Colm F. Connolly on 4/7/2021. (nmf) |
| Apr 7, 2021 | 693 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME regarding Sun Depositions to Dr. Myerson on April 9 and Dr. Claybourn on April 13 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Apr 7, 2021 | 694 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Dr. Allan Myerson on April 9, 2021 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Apr 6, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Apotex Inc. removed as filing party for D.I. [691] per request of counsel. (sam) |
| Apr 6, 2021 | 690 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of International Medication Systems' Supplemental Expert Report of Jonathan Steed, Ph.D. filed by International Medication Systems, Limited.(Keller, Karen) |
| Apr 6, 2021 | 691 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Allan Myerson on April 7, 2021 filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc., Hospira, Inc., International Medication Systems, Limited.(Haney, Megan) Modified on 4/6/2021 (sam). |
| Apr 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [686] STIPULATION TO EXTEND TIME (and proposed order) to submit joint status report to April 5, 2021 filed by International Medication Systems, Limited. Ordered by Judge Christopher J. Burke on 4/5/2021. (dlb) |
| Apr 5, 2021 | 687 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Supplemental Expert Report of Jonathan Steed, Ph.D. filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Apr 5, 2021 | 688 | Motion for Hearing (2) Docket Text: Joint MOTION for Hearing [Teleconference] to Resolve Discovery Dispute - filed by Apotex Inc.. Motions referred to Christopher J. Burke.(Phillips, John) |
| Apr 1, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [681] Letter, [674] Letter, ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. A Telephone Conference is set for 4/7/2021 at 10:00 AM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 4/1/2021. (nmf) |
| Apr 1, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Resetting Teleconference: The discovery dispute teleconference scheduled for April 12, 2021 with Judge Burke, (D.I. 669), has been rescheduled to April 26, 2021 at 1:00 PM. The briefing schedule for the dispute is hereby modified as follows: (1) By no later than April 9, 2021, Defendants Apotex Inc., Accord Healthcare, Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc., Hospira, Inc. and International Medication Systems, Ltd. ("Moving Defendants") shall collectively file with the Court their opening letter brief.; (2) By no later than April 19, 2021, Plaintiffs and Defendants Sun Pharma Global FZE and Sun Pharmaceuticals Industries, Ltd.'s shall collectively file with the Court their answering letter brief.; (3) By no later than April 22, 2021, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (4) The parties shall abide by the remaining portions of the Courts March 26, 2021 Oral Order, (D.I. 669). Ordered by Judge Christopher J. Burke on 4/1/2021. (dlb) |
| Apr 1, 2021 | 686 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit joint status report to April 5, 2021 - filed by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Mar 31, 2021 | 682 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Allan Myerson on April 7, 2021 filed by Hospira, Inc..(Gattuso, Dominick) |
| Mar 31, 2021 | 683 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gautam Desiraju on April 7, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Mar 30, 2021 | 675 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Graham Buckton on April 2, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Mar 30, 2021 | 676 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jeremy Cockcroft on April 6, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Mar 30, 2021 | 677 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Ivan Hofmann on March 31, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 30, 2021 | 678 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Michael Claybourn on April 6, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Mar 30, 2021 | 679 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Piotr Karpinski on April 8, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Mar 30, 2021 | 680 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Michael E. Tate on April 2, 2021 filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Mar 30, 2021 | 681 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding Response to Plaintiffs' March 29, 2021 letter. (Phillips, John) |
| Mar 29, 2021 | 670 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Allan S. Myerson on March 31, 2021 filed by Apotex Inc..(Haney, Megan) |
| Mar 29, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs' discovery dispute motion ("Motion"), (D.I. 645), and the briefing related thereto, (D.I. 640; D.I. 648; D.I. 652; D.I. 657; D.I. 658), and having heard argument on March 15, 2021, hereby ORDERS as follows: (1) With the Motion, Plaintiffs ask the Court to strike Defendants' Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Hospira, Inc. and International Medication Systems, Ltd.'s (collectively, "Defendants") proffered declaration of Stephen Hancock ("Hancock Declaration" or "declaration"), (D.I. 640, ex. A), and certain portions of Defendants' expert reports ("expert reports") that rely on testimony in the Hancock Declaration, (id., ex. Z; id., ex. AA; id., ex. BB). (Id. at 1 & n.1) Plaintiffs also request, in the alternative, for Defendants to produce certain samples, certain documents, and a witness for deposition. (Id. at 1); (2) The Court DENIES Plaintiffs' Motion, to the extent it seeks to strike the declaration/expert reports at issue. It does so because it is not convinced that, under the circumstances here, Defendants' service of the declaration/expert reports amounts to a clear discovery violation. The declaration/expert reports are meant to be responsive to Plaintiffs' theory that Euticals' crude and Form F regadenoson infringe the patents-in-suit. (D.I. 657 at 1) But from what the Court can tell, Plaintiffs did not formally and clearly assert this theory as a contention that applied to all Defendants until after fact discovery closedi.e., as of either October 16, 2020 (the date of submission of Plaintiffs' Final Infringement Contentions, in which Plaintiffs first listed the theory as an infringement contention) or as of November 12, 2020 (the date of submission of Plaintiffs' supplemental Final Infringement Contentions, in which Plaintiffs provided more detailed and specific arguments about how and why this theory was viable, and in which Plaintiffs first cited to Mr. Hancock's deposition testimony in doing so). (D.I. 648 at 2-3; D.I. 657 at 1-2 (citing the relevant contentions); Tr. at 28-29, 34-36) The Court is not saying that this late disclosure is necessarily Plaintiffs' fault, (see Tr. at 38), but the point is that this was a very late-developing theory, to which a late-developing response would have to have been expected. And while Defendants could well have added the substance of Dr. Hancock's response-at-issue to their non-infringement contentions sometime between at least November 12, 2020 and January 29, 2021 (the date of the submission of the declaration/expert reports), (id. at 15-17), this delay was not outsized, especially in light of the fact that for most of that time, the parties were in the midst of expert discovery, (id. at 27). Moreover, Defendants did at least take some action in that November-to-January timeframe, as they amended their initial disclosures to add Mr. Hancock as a witness with relevant knowledge of this general subject matter in mid-to-late November 2020. (D.I. 648 at 1 & n.3); and (3) Although the Court has not found a discovery violation here, it agrees with Plaintiffs that if Defendants want to rely on Euticals' employee Mr. Hancock's testimony/declaration for their response to this infringement theory, then Defendants have to demonstrate that they have been sufficiently rigorous in working with Euticals to identify, gather and turn over relevant discovery as to that theory (i.e., relevant samples if they exist, and relevant documents if they exist) and making a witness (presumably Mr. Hancock) available for another deposition. (D.I. 657 at 2) The Court is not yet in a position to determine if the particular requests that Plaintiffs make regarding sample or document discovery (e.g., the particular search methodology Plaintiffs are requesting) are fair and reasonable, (id.); in that regard, by no later than April 1, 2021, the parties shall meet and confer about those requests (including as to the existence and relevance of certain documents cited by Plaintiffs), (id. at 2 & n.2; Tr. at 32), and submit to the Court a joint status letter, of no more than three (3) single-spaced pages, explaining whether they have come to an agreement on the scope of that discovery (and if not, what their positions are as to any relevant disputes). Ordered by Judge Christopher J. Burke on 3/29/2021. (dlb) |
| Mar 29, 2021 | 672 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jonathan Steed on April 9, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Mar 29, 2021 | 673 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gabriela Gurau on April 2, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Mar 29, 2021 | 674 | Letter (1) Docket Text: Letter to Honorable Colm F. Connolly from Robert M. Oakes regarding trial time. (Oakes, Robert) |
| Mar 26, 2021 | 668 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Trevor Laird on March 30, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 26, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' March 25, 2021 letter requesting a discovery teleconference. (D.I. 667) The Court hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order will be modified as follows with regard to the dispute: (1) A discovery dispute teleconference is set for April 12, 2021 at 12:00 p.m. before Judge Christopher J. Burke.; (2) By no later than April 2, 2021, Defendants Apotex Inc., Accord Healthcare, Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc., Hospira, Inc. and International Medication Systems, Ltd. ("Moving Defendants") shall collectively file with the Court one letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues they are raising and their position on those issues.; (3) In light of Defendants Sun Pharma Global FZE and Sun Pharmaceuticals Industries, Ltd.'s ("Sun") objection that the first issue in dispute is not ripe ("objection"), (id. at 2 n.3), the Court ORDERS that Moving Defendants and Sun and Plaintiffs further meet and confer at least once more prior to the submission of the opening letter brief in an attempt to resolve that issue.; (4) By no later than April 8, 2021, Plaintiffs/Sun may collectively file one answering letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to the opening letter brief.; (5) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (6) By no later than April 8, 2021, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; (7) The parties should also consult Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; and (8) It is possible that the Court may choose to resolve the disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 3/26/2021. (dlb) |
| Mar 25, 2021 | 667 | Letter (2) Docket Text: Letter to The Honorable Christopher J. Burke from John C. Phillips, Jr. regarding Discovery Dispute. (Phillips, John) |
| Mar 24, 2021 | 664 | Redacted Document (5) Docket Text: REDACTED VERSION of [658] Letter, by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Mar 24, 2021 | 665 | Main Document (5) Docket Text: REDACTED VERSION of [657] Letter, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit GG, # (2) Exhibit HH, # (3) Exhibit II, # (4) Exhibit JJ, # (5) Exhibit KK, # (6) Exhibit LL, # (7) Exhibit MM, # (8) Exhibit NN, # (9) Exhibit OO, # (10) Exhibit PP, # (11) Exhibit QQ, # (12) Exhibit RR, # (13) Exhibit SS, # (14) Exhibit TT, # (15) Exhibit UU)(Oakes, Robert) |
| Mar 24, 2021 | 665 | Exhibit GG (4) |
| Mar 24, 2021 | 665 | Exhibit HH (4) |
| Mar 24, 2021 | 665 | Exhibit II (21) |
| Mar 24, 2021 | 665 | Exhibit JJ (15) |
| Mar 24, 2021 | 665 | Exhibit KK (10) |
| Mar 24, 2021 | 665 | Exhibit LL (18) |
| Mar 24, 2021 | 665 | Exhibit MM (1) |
| Mar 24, 2021 | 665 | Exhibit NN (1) |
| Mar 24, 2021 | 665 | Exhibit OO (1) |
| Mar 24, 2021 | 665 | Exhibit PP (2) |
| Mar 24, 2021 | 665 | Exhibit QQ (1) |
| Mar 24, 2021 | 665 | Exhibit RR (1) |
| Mar 24, 2021 | 665 | Exhibit SS (1) |
| Mar 24, 2021 | 665 | Exhibit TT (1) |
| Mar 24, 2021 | 665 | Exhibit UU (1) |
| Mar 24, 2021 | 666 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Dr. Bernhardt Trout on March 26, 2021 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Mar 23, 2021 | 661 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Peter Stephens on March 26, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 23, 2021 | 662 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Supplemental Expert Report of Professor Bernhardt L. Trout (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 23, 2021 | 663 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Bernhardt Trout on March 25, 2021 filed by Hospira, Inc..(Gattuso, Dominick) |
| Mar 19, 2021 | 660 | Main Document (3) Docket Text: REDACTED VERSION of [652] Letter by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit CC, # (2) Exhibit DD, # (3) Exhibit EE, # (4) Exhibit FF)(Oakes, Robert) |
| Mar 19, 2021 | 660 | Exhibit CC (13) |
| Mar 19, 2021 | 660 | Exhibit DD (24) |
| Mar 19, 2021 | 660 | Exhibit EE (8) |
| Mar 19, 2021 | 660 | Exhibit FF (17) |
| Mar 18, 2021 | 659 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Dr. Pamela Smith on March 22, 2021 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Mar 17, 2021 | 655 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Pamela A. Smith on March 19, 2021 filed by Apotex Inc..(Haney, Megan) |
| Mar 17, 2021 | 656 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of John Galla on March 18, 2021 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 15, 2021 | N/A | Discovery Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke Discovery Dispute Teleconference held on March 15, 2021. After hearing the parties regarding the dispute, the Court took the matter under advisement. (Clerk, Sforza) APPEARANCES: R. Oakes, A. Wigmore, B. Amadi, N. Xu and A. Tiglio for Astellas; L. Ferri and T. Amirgholizadeh for Gilead; K. Keller, N. Daughtrey and J. Bennett for IMS; J. Phillips, J. Jaros and C. Galligan for DRL; D. Gattuso, C. Klein and A. Heydorn for Hospira. (Court Reporter Valerie Gunning) (dlb) |
| Mar 15, 2021 | 653 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Daniel T. Smith on March 17, 2021 filed by Accord Healthcare, Inc., Apotex Inc..(Haney, Megan) |
| Mar 15, 2021 | 654 | Redacted Document (30) Docket Text: REDACTED VERSION of [648] Letter by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Mar 10, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jeffrey A. Marx for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Mar 10, 2021 | 651 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Peter Stephens, Ph.D. and Reply Expert Report of Gautam Desiraju, Ph.D. filed by Apotex Inc..(Haney, Megan) |
| Mar 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [649] MOTION for Pro Hac Vice Appearance of Attorney Jeffrey A. Marx filed by Apotex Inc. Signed by Judge Colm F. Connolly on 3/9/2021. (fms) |
| Mar 9, 2021 | 649 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey A. Marx - filed by Apotex Inc.. (Attachments: # (1) Marx Pro Hac Certification)(Haney, Megan) |
| Mar 9, 2021 | 649 | Marx Pro Hac Certification (1) |
| Mar 9, 2021 | 650 | Main Document (6) Docket Text: REDACTED VERSION of [640] Letter,,, to Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Ex. C, # (4) Ex. D, # (5) Ex. E, # (6) Ex. F, # (7) Ex. G, # (8) Ex. H, # (9) Ex. I, # (10) Ex. J, # (11) Ex. K, # (12) Ex. L, # (13) Ex. M, # (14) Ex. N, # (15) Ex. O, # (16) Ex. P, # (17) Ex. Q, # (18) Ex. R, # (19) Ex. S, # (20) Ex. T, # (21) Ex. U, # (22) Ex. V, # (23) Ex. W, # (24) Ex. X, # (25) Ex. Y, # (26) Ex. Z, # (27) Ex. AA, # (28) Ex. BB)(Oakes, Robert) |
| Mar 9, 2021 | 650 | Ex. A (1) |
| Mar 9, 2021 | 650 | Ex. B (1) |
| Mar 9, 2021 | 650 | Ex. C (17) |
| Mar 9, 2021 | 650 | Ex. D (3) |
| Mar 9, 2021 | 650 | Ex. E (4) |
| Mar 9, 2021 | 650 | Ex. F (21) |
| Mar 9, 2021 | 650 | Ex. G (4) |
| Mar 9, 2021 | 650 | Ex. H (5) |
| Mar 9, 2021 | 650 | Ex. I (1) |
| Mar 9, 2021 | 650 | Ex. J (10) |
| Mar 9, 2021 | 650 | Ex. K (10) |
| Mar 9, 2021 | 650 | Ex. L (5) |
| Mar 9, 2021 | 650 | Ex. M (18) |
| Mar 9, 2021 | 650 | Ex. N (13) |
| Mar 9, 2021 | 650 | Ex. O (17) |
| Mar 9, 2021 | 650 | Ex. P (1) |
| Mar 9, 2021 | 650 | Ex. Q (1) |
| Mar 9, 2021 | 650 | Ex. R (1) |
| Mar 9, 2021 | 650 | Ex. S (2) |
| Mar 9, 2021 | 650 | Ex. T (1) |
| Mar 9, 2021 | 650 | Ex. U (1) |
| Mar 9, 2021 | 650 | Ex. V (1) |
| Mar 9, 2021 | 650 | Ex. W (12) |
| Mar 9, 2021 | 650 | Ex. X (10) |
| Mar 9, 2021 | 650 | Ex. Y (1) |
| Mar 9, 2021 | 650 | Ex. Z (1) |
| Mar 9, 2021 | 650 | Ex. AA (1) |
| Mar 9, 2021 | 650 | Ex. BB (1) |
| Mar 8, 2021 | 642 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Hospira, Inc., Apotex Inc., Dr. Reddy's Laboratories Ltd., International Medical Systems, Ltd., Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited Reply Expert Report of Trevor Laird, Ph.D. [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Mar 8, 2021 | 643 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] Reply Expert Report of Jeremy Karl Cockcroft, Ph.D. filed by Apotex Inc..(Haney, Megan) |
| Mar 8, 2021 | 644 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Reply Invalidity Expert Report of Piotr Karpinski, Ph.D., to the Rebuttal Expert Report of Bernhardt L. Trout, Ph.D. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Mar 8, 2021 | 645 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION for Discovery Teleconference - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Mar 8, 2021 | 646 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Allan Myerson (Apotex); Reply Expert Report of Pamela Smith (Apotex); Reply Expert Report of Allan Myerson (DRL); Reply Expert Report of Allan Myerson (Hospira); Reply Expert Report of Allan Myerson (IMS); Reply Expert Report of Allan Myerson (Sun); Reply Expert Report of Allan Myerson (Accord); Reply Expert Report of Pamela Smith (Sun) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 8, 2021 | 647 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Ivan T. Hofmann filed by International Medication Systems, Limited.(Keller, Karen) |
| Mar 5, 2021 | 641 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Hospira, Inc., Apotex Inc., Dr. Reddys Laboratories Ltd., International Medical Systems, Ltd., Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Reply Expert Report of John M. Galla, M.D. [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Mar 3, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: PDF's at D.I. 640 Ex. AA, Y, X, and W have been replaced at the request of the filer. (dlb) |
| Feb 25, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' February 24, 2021 letter requesting a discovery teleconference. (D.I. 637) The Court hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order will be modified as follows with regard to the dispute: (1) A discovery dispute teleconference is set for March 15, 2021 at 2:00 p.m. before Judge Christopher J. Burke.; (2) By no later than March 2, 2021, the parties seeking relief shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issue they are raising and their position on that issue.; (3) By no later than March 8, 2021, the opposing parties may file an answering letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to the opening letter brief.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than March 8, 2021, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) It is possible that the Court may choose to resolve the dispute prior to the telephone conference. Ordered by Judge Christopher J. Burke on 2/25/2021. (dlb) |
| Feb 24, 2021 | 637 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding discovery dispute with Defendants DRL, Hospira and IMS. (Oakes, Robert) |
| Feb 24, 2021 | 638 | Main Document (4) Docket Text: REDACTED VERSION of [634] MOTION to Seal and Redact Order (Unopposed) by Apotex Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Phillips, John) |
| Feb 24, 2021 | 638 | Exhibit 1 (6) |
| Feb 24, 2021 | 638 | Exhibit 2 (6) |
| Feb 19, 2021 | 635 | Order (2) Docket Text: ORDER GRANTING D.I. [634] MOTION to Seal and Redact Order (Unopposed) filed by Apotex Inc. Signed by Judge Christopher J. Burke on 2/19/2021. (mlc) |
| Feb 19, 2021 | 636 | Redacted Document (5) Docket Text: REDACTED VERSION of D.I. [633] Memorandum Order. (mlc) |
| Feb 11, 2021 | 629 | Main Document (5) Docket Text: REDACTED VERSION of [624] Letter by Apotex Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9)(Phillips, John) |
| Feb 11, 2021 | 629 | Exhibit 6 (1) |
| Feb 11, 2021 | 629 | Exhibit 7 (2) |
| Feb 11, 2021 | 629 | Exhibit 8 (7) |
| Feb 11, 2021 | 629 | Exhibit 9 (5) |
| Feb 11, 2021 | 630 | Redacted Document (3) Docket Text: REDACTED VERSION of [622] Letter to Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 11, 2021 | 631 | Main Document (6) Docket Text: REDACTED VERSION of [623] Letter, Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Ex. C, # (4) Ex. D, # (5) Ex. E, # (6) Ex. F, # (7) Ex. G, # (8) Ex. H, # (9) Ex. I, # (10) Ex. J, # (11) Ex. K, # (12) Ex. L, # (13) Ex. M)(Oakes, Robert) |
| Feb 11, 2021 | 631 | Ex. A (29) |
| Feb 11, 2021 | 631 | Ex. B (39) |
| Feb 11, 2021 | 631 | Ex. C (16) |
| Feb 11, 2021 | 631 | Ex. D (18) |
| Feb 11, 2021 | 631 | Ex. E (1) |
| Feb 11, 2021 | 631 | Ex. F (1) |
| Feb 11, 2021 | 631 | Ex. G (1) |
| Feb 11, 2021 | 631 | Ex. H (1) |
| Feb 11, 2021 | 631 | Ex. I (1) |
| Feb 11, 2021 | 631 | Ex. J (1) |
| Feb 11, 2021 | 631 | Ex. K (1) |
| Feb 11, 2021 | 631 | Ex. L (5) |
| Feb 11, 2021 | 631 | Ex. M (1) |
| Feb 11, 2021 | 632 | Redacted Document (3) Docket Text: REDACTED VERSION of [625] Exhibit to a Document Exhibit N by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jenny Zhang for International Medication Systems, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Feb 8, 2021 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Dispute Teleconference held on 2/8/2021. After hearing the parties regarding the dispute, the Court took the matter under advisement. (Clerk, Sforza) APPEARANCES: R. Oakes, A. Wigmore, A. Burton, A. Tiglio and N. Xu for Astellas; M. Velez for Gilead; J. Phillips, Jr., J. Jaros and C. Sun for Apotex, C. Hitch, A. Barkoff and B. Mahon for Accord. (Court Reporter, Valerie Gunning) (dlb) |
| Feb 5, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Defendant Apotex Inc.'s January 29, 2021 status report, (D.I. 610), and Plaintiffs February 4, 2021 response, (D.I. 622), notes that for now, with regard to this issue, it will simply wait for the filing of the further status report described on pages 25 and 26 of the January 4, 2021 hearing transcript. In the interval, if any party feels as if it needs to move for more urgent relief regarding this issue, they can alert the Court to that by way of the filing of a one-page letter. Lastly, the Court does not feel that it needs to take any action at this time with regard to the filing of Dr. Pullagurla's declaration, (D.I. 622 at 1). Ordered by Judge Christopher J. Burke on 2/5/2020. (dlb) |
| Feb 5, 2021 | 628 | Main Document (3) Docket Text: REDACTED VERSION of [610] Letter by Apotex Inc.. (Attachments: # (1) Exhibit 1)(Phillips, John) |
| Feb 5, 2021 | 628 | Exhibit 1 (1) |
| Feb 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [618] MOTION for Pro Hac Vice Appearance of Attorney Jenny J. Zhang filed by International Medication Systems, Limited. Signed by Judge Colm F. Connolly on 2/2/2021. (fms) |
| Feb 2, 2021 | 618 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jenny J. Zhang - filed by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Feb 2, 2021 | 619 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Peter W. Stephens, Ph.D. (2) International Medication Systems' Rebuttal Expert Report of Jonathan Steed, Ph.D. filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Feb 2, 2021 | 620 | Main Document (6) Docket Text: REDACTED VERSION of [609] Letter, by Apotex Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5)(Haney, Megan) |
| Feb 2, 2021 | 620 | Text of Proposed Order (1) |
| Feb 2, 2021 | 620 | Exhibit 1 (27) |
| Feb 2, 2021 | 620 | Exhibit 2 (5) |
| Feb 2, 2021 | 620 | Exhibit 3 (4) |
| Feb 2, 2021 | 620 | Exhibit 4 (1) |
| Feb 2, 2021 | 620 | Exhibit 5 (4) |
| Feb 2, 2021 | 621 | Main Document (6) Docket Text: REDACTED VERSION of [608] Letter, Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Ex. C, # (4) Ex. D, # (5) Ex. E, # (6) Ex. F, # (7) Ex. G, # (8) Ex. H, # (9) Ex. I)(Oakes, Robert) |
| Feb 2, 2021 | 621 | Ex. A (29) |
| Feb 2, 2021 | 621 | Ex. B (34) |
| Feb 2, 2021 | 621 | Ex. C (1) |
| Feb 2, 2021 | 621 | Ex. D (3) |
| Feb 2, 2021 | 621 | Ex. E (2) |
| Feb 2, 2021 | 621 | Ex. F (6) |
| Feb 2, 2021 | 621 | Ex. G (1) |
| Feb 2, 2021 | 621 | Ex. H (6) |
| Feb 2, 2021 | 621 | Ex. I (39) |
| Feb 1, 2021 | 611 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rebuttal Expert Report of Jeremy Karl Cockcroft, Ph.D. and Rebuttal Expert Report of Grapham Buckton, Ph.D. filed by Apotex Inc..(Haney, Megan) |
| Feb 1, 2021 | 612 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Rebuttal Expert Report of Jonathan Steed, Ph.D. filed by Dr. Reddy's Laboratories Ltd..(Haney, Megan) |
| Feb 1, 2021 | 613 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Expert Report of Gabriela Gurau, Ph.D. filed by Hospira, Inc..(Gattuso, Dominick) |
| Feb 1, 2021 | 614 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accord's Rebuttal Expert Report of Graham Buckton concerning non-infringement; and (2) Accord's Rebuttal Expert Report of Jeremy Karl Cockcroft concerning non-infringement filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Feb 1, 2021 | 615 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Supplemental Opening Invalidity Expert Report of Piotr Karpinski, Ph.D. and 2) Responsive Infringement Expert Report of Michael Claybourn, Ph.D. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Feb 1, 2021 | 616 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Michael E. Tate; (2) Rebuttal Expert Report of Jeffrey A. Leppo, MD Relating To Lexiscan and U.S. Patent Nos. 8,106,183; RE 47,301; and 8,524,883; (3) Rebuttal Expert Report of Bernhardt L. Trout, Ph.D., Concerning Validity of U.S. Patent Nos. 8,106,183; 8,524,883; and RE 47,301; (4) Rebuttal Expert Report of Bernhardt L. Trout, Ph.D. To the Opening Expert Report of Piotr Karpinski, Ph.D. Concerning Validity of U.S. Patent Nos. 8,106,183; 8,524,883; and RE 47,301 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Feb 1, 2021 | 617 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Hospira, Inc.'s Expert Report of Jonathan Steed, Ph.D. filed by Hospira, Inc..(Gattuso, Dominick) |
| Jan 22, 2021 | 607 | Redacted Document (2) Docket Text: REDACTED VERSION of [603] Letter by Apotex Inc.. (Phillips, John) |
| Jan 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [606] STIPULATION TO EXTEND TIME to Amend Scheduling Order to Various Dates filed by Apotex Inc.. Ordered by Judge Colm F. Connolly on 1/21/2021. (fms) |
| Jan 20, 2021 | 606 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Amend Scheduling Order to Various Dates - filed by Apotex Inc.. (Phillips, John) |
| Jan 19, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' January 15, 2021 letter requesting a discovery teleconference. (D.I. 603) The Court hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order will be modified as follows with regard to the dispute: (1) A discovery dispute teleconference is set for February 8, 2021 at 12:00 p.m. before Judge Christopher J. Burke.; (2) By no later than January 26, 2021, the moving parties shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues they are raising and their position on those issues; (3) By no later than February 4, 2021, the responding parties may file an answering letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to the opening letter brief.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than February 4, 2021, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) It is possible that the Court may choose to resolve the disputes prior to the telephone conference. The Court also notes that certain of Defendants' requests for relief appear to relate to deadlines occurring before the date of the teleconference. Defendants should be prepared that even if their motion is ultimately successful, they will receive no relief prior to February 8. Relatedly, Defendants are on notice that they should do whatever they feel they need to do in the interim to ensure that, if they ultimately do not prevail on their motion, they have not forfeited any rights due to their failure to take certain actions. Ordered by Judge Christopher J. Burke on 1/19/2021. (dlb) |
| Jan 19, 2021 | 605 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Apotex Inc.. Motions referred to Christopher J. Burke.(Phillips, John) |
| Jan 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [602] STIPULATION TO EXTEND TIME Responsive Expert Reports and Reply Expert Reports to January 22, 2021 and February 26, 2021 respectively filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 1/12/2021. (fms) |
| Jan 11, 2021 | 602 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Responsive Expert Reports and Reply Expert Reports to January 22, 2021 and February 26, 2021 respectively - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Jan 7, 2021 | N/A | Document Unsealed (0) Docket Text: Minute Entry for teleconference held on 1/4/2021 has been amended. (dlb) |
| Jan 7, 2021 | 601 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove George J. Barry III and Timothy H. Kratz as co-counsel.. (Dorsney, Kenneth) |
| Jan 6, 2021 | 600 | Main Document (6) Docket Text: REDACTED VERSION of [599] Letter, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H)(Oakes, Robert) |
| Jan 6, 2021 | 600 | Exhibit A (42) |
| Jan 6, 2021 | 600 | Exhibit B (1) |
| Jan 6, 2021 | 600 | Exhibit C (5) |
| Jan 6, 2021 | 600 | Exhibit D (3) |
| Jan 6, 2021 | 600 | Exhibit E (1) |
| Jan 6, 2021 | 600 | Exhibit F (3) |
| Jan 6, 2021 | 600 | Exhibit G (11) |
| Jan 6, 2021 | 600 | Exhibit H (5) |
| Jan 5, 2021 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Dispute Teleconference held on 1/4/2021. After hearing the parties regarding the dispute, the Court denied the Motion as premature. The Court ordered Apotex to provide it with a status report of no more than three (3) single-spaced pages by Jan. 29, 2021. APPEARANCES: R. Oakes, A. Major, A. Wigmore, B. Amadi, A. Burton and M. Velez for Plaintiffs; J. Phillips, J. Jaros and C. Sun for Defendants. (Court Reporter Jennifer Guy, Hawkins Reporting) (dlb) Modified on 1/7/2021 (dlb). |
| Dec 29, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of D.I. 596, Sealed Exhibit 7 has been replaced with a corrected version per request of filer as the slip sheet was incorrectly labeled. (nmg) |
| Dec 29, 2020 | 598 | Main Document (5) Docket Text: REDACTED VERSION of [596] Letter, by Apotex Inc.. (Attachments: # (1) Exhibits 1-6, # (2) Exhibit 7, # (3) Proposed Order)(Phillips, John) |
| Dec 29, 2020 | 598 | Exhibits 1-6 (1) |
| Dec 29, 2020 | 598 | Exhibit 7 (3) |
| Dec 29, 2020 | 598 | Proposed Order (2) |
| Dec 28, 2020 | 597 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Gary M. Fox as co-counsel. Reason for request: no longer with Wilmer Hale law firm. (Oakes, Robert) |
| Dec 17, 2020 | 594 | Redacted Document (2) Docket Text: REDACTED VERSION of [592] Letter by Apotex Inc.. (Phillips, John) |
| Dec 17, 2020 | 595 | Motion for Miscellaneous Relief (1) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Apotex Inc.. Motions referred to Christopher J. Burke.(Phillips, John) |
| Dec 15, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the December 14, 2020 letter from Defendant Apotex Inc. ("Apotex") requesting a discovery teleconference. (D.I. 592) The Court sees from the letter that Plaintiffs thinks the issue is not ripe, but it also appears from the letter that the parties have met and conferred about it on two occasions. As a result, the Court will schedule a hearing now, and Plaintiffs can address any lack-of-ripeness issue in their letter brief. Therefore, the Court hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order will be modified as follows with regard to the dispute: (1) A discovery dispute teleconference is set for January 4, 2021 at 12:00 p.m. before Judge Christopher J. Burke.; (2) By no later than December 22, 2020, Apotex shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issue it is raising and its position on that issue; (3) By no later than December 30, 2020, Plaintiffs may file an answering letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to Apotex's opening letter brief.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than December 30, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) It is possible that the Court may choose to resolve the dispute prior to the telephone conference.. Ordered by Judge Christopher J. Burke on 12/15/2020. (dlb) |
| Dec 10, 2020 | 591 | Redacted Document (2) Docket Text: REDACTED VERSION of [590] STIPULATION TO EXTEND TIME Plaintiffs' opening expert reports re Apotex and Accord to December 15, 2020 by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Dec 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [590] STIPULATION TO EXTEND TIME Plaintiffs' opening expert reports re Apotex and Accord to December 15, 2020 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 12/9/2020. (fms) |
| Dec 3, 2020 | 589 | Redacted Document (11) Docket Text: REDACTED VERSION of D.I. [588] [SEALED] ANSWER to [556] Answer to Amended Complaint, Counterclaim (Apotex) by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc(Oakes, Robert) Modified on 12/3/2020 (fms). |
| Dec 1, 2020 | N/A | Remark (0) Docket Text: D.I. [588] ANSWER has been placed under seal per request of counsel. (nmf) |
| Nov 30, 2020 | 587 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Martin Ehlert on December 2, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Nov 25, 2020 | 583 | Redacted Document (3) Docket Text: REDACTED VERSION of [572] Stipulation by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 25, 2020 | 584 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Hospira, Inc.'s Second Amended Rule 26(a)(1) Disclosures filed by Hospira, Inc..(Gattuso, Dominick) |
| Nov 25, 2020 | 585 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) International Medication Systems, Ltd.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Nov 25, 2020 | 586 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Supplemental (11/25/2020) Initial Disclosures filed by Apotex Inc..(Haney, Megan) |
| Nov 24, 2020 | 581 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding Hospira discovery dispute resolution - re [575] Joint MOTION for Hearing re [529] Order Setting Teleconference,,,,, Teleconference to Resolve Discovery Dispute. (Oakes, Robert) |
| Nov 24, 2020 | 582 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Opening Expert Reports of Dr. Allan Myerson regarding Infringement directed to (1) Dr. Reddy's (2) IMS (3) Hospira, and (4) Sun; Opening Expert Report of Dr. Pamela Smith Regarding Infringement directed to Sun filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Nov 23, 2020 | 576 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Trevor Laird, Ph.D. filed by Hospira, Inc..(Gattuso, Dominick) |
| Nov 23, 2020 | 577 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Invalidity Expert Report of Piotr Karpinski, Ph.D. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Nov 23, 2020 | 578 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Graham Buckton, Ph.D. filed by Apotex Inc..(Haney, Megan) |
| Nov 23, 2020 | 579 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Reports of Robin D. Rogers, Ph.D. and Gautam R. Desiraju, Ph.D. filed by Apotex Inc..(Haney, Megan) |
| Nov 23, 2020 | 580 | Main Document (5) Docket Text: REDACTED VERSION of [569] Letter, Letter to The Honorable Christopher J. Burke from Dominick T. Gattuso, Esquire regarding Hospira Inc.'s Responsive Letter Brief Regarding Plaintiffs' Motion to Compel Production of Certain Privileged Documents and Further Testimony of Dr. Knill by Hospira, Inc.. (Attachments: # (1) Exhibit A-H, # (2) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Nov 23, 2020 | 580 | Exhibit A-H (14) |
| Nov 23, 2020 | 580 | Exhibit Certificate of Service (1) |
| Nov 20, 2020 | 575 | Motion for Hearing (1) Docket Text: Joint MOTION for Hearing re [529] Order Setting Teleconference,,,,, Teleconference to Resolve Discovery Dispute - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Nov 19, 2020 | 571 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendant Hospira, Inc.s Third Amended Privilege Log [CONFIDENTIAL]; and, (ii) Hospira, Inc.s Production Letter (including bates labeled documents HOS00666960 - HOS00668073 and HOS00666944 - HOS00666959) filed by Hospira, Inc..(Gattuso, Dominick) |
| Nov 19, 2020 | 573 | Redacted Document (1) Docket Text: REDACTED VERSION of [567] Status Report by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 19, 2020 | 574 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of CONFIDENTIAL Notice of Deposition filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Nov 18, 2020 | 570 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Supplemental (11/18/20) Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Nov 16, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ben J. Mahon and Aaron F. Barkoff for Accord Healthcare, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Nov 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [568] MOTION for Pro Hac Vice Appearance of Attorney Stephen P. Benson filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Signed by Judge Colm F. Connolly on 11/16/2020. (fms) |
| Nov 16, 2020 | 568 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stephen P. Benson - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,. (Vrana, Robert) |
| Nov 13, 2020 | 565 | Letter (2) Docket Text: Letter to The Honorable Christopher J. Burke from Dominick T. Gattuso, Esquire regarding third issue referenced in the parties joint discovery dispute letter (D.I. 526) - re [526] Letter. (Gattuso, Dominick) |
| Nov 13, 2020 | 566 | SO ORDERED (2) Docket Text: SO ORDERED, re [563] Stipulation of Dismissal filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Party USV Private Limited terminated. Signed by Judge Colm F. Connolly on 11/13/2020. (fms) |
| Nov 12, 2020 | N/A | Document Unsealed (0) Docket Text: Document Unsealed. [550] Memorandum Order unsealed. (dlb) |
| Nov 12, 2020 | 563 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Defendant USV Private Limited (C.A. No. 20-793) by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 12, 2020 | 564 | Redacted Document (30) Docket Text: REDACTED VERSION of [556] Answer to Amended Complaint, Counterclaim by Apotex Inc.. (Haney, Megan) |
| Nov 11, 2020 | 562 | Main Document (6) Docket Text: REDACTED VERSION of [553] Letter, to Honorable Christopher J. Burke from Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B to L)(Oakes, Robert) |
| Nov 11, 2020 | 562 | Exhibit A (2) |
| Nov 11, 2020 | 562 | Exhibit B to L (1) |
| Nov 10, 2020 | 561 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.'s Second Amended Privilege Log filed by Hospira, Inc..(Gattuso, Dominick) |
| Nov 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [559] MOTION for Pro Hac Vice Appearance of Attorney Aaron F. Barkoff and Attorney Ben J. Mahon filed by Accord Healthcare, Inc. Signed by Judge Colm F. Connolly on 11/9/2020. (fms) |
| Nov 9, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Teleconference held on 11/9/2020. After hearing the parties regarding the dispute, the Court resolved the dispute on the record. The transcript shall serve as the substance of the Court's Order. (Clerk, Benyo) APPEARANCES: R. Oakes, A. Major,, A. Wigmore, K. Yurkerwich and J. Bor-Zle, M. Velez for Plaintiffs; C. Hitch, A. Barkoff,G. Barry for Defendants. (Court Reporter Valerie Gunning) (dlb) |
| Nov 9, 2020 | 560 | Letter (1) Docket Text: Letter to The Honorable Christoper J. Burke from John C. Phillips, Jr. regarding no redactions to Memorandum Order - re [550] Memorandum and Order. (Phillips, John) |
| Nov 6, 2020 | 557 | Redacted Document (5) Docket Text: REDACTED VERSION of [544] STIPULATION TO EXTEND TIME Apotex and Accord deadlines to various by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 6, 2020 | 558 | Redacted Document (2) Docket Text: REDACTED VERSION of [545] Letter to The Honorable Christopher J. Burke regarding Accord's Supplemental Response in Opposition to Plaintiffs' Motion to Compel by Accord Healthcare, Inc.. (Dorsney, Kenneth) |
| Nov 6, 2020 | 559 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aaron F. Barkoff and Attorney Ben J. Mahon - filed by Accord Healthcare, Inc.. (Dorsney, Kenneth) |
| Nov 5, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: PDF for Ex. A has been replace at D.I 553 per request of filer. (dlb) |
| Nov 5, 2020 | 554 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Supplemental (11/4/2020) Objections and Reponses to First Set of Common Requests for Admission; and (2) Apotex's Supplemental (11/4/2020) Objections and Responses to First Set of Individual Requests for Admission filed by Apotex Inc..(Haney, Megan) |
| Nov 5, 2020 | 555 | Motion for Hearing (1) Docket Text: Joint MOTION for Hearing to Resolve Discovery Dispute re Accord - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Nov 4, 2020 | 550 | Memorandum and Order (3) Docket Text: MEMORANDUM ORDER re [517] Joint MOTION for Teleconference to Resolve Discovery Dispute filed by Apotex Inc.. Signed by Judge Christopher J. Burke on 11/4/2020.This order will be emailed to local counsel. (dlb)UNSEALED on 11/12/2020 (dlb). |
| Nov 4, 2020 | 551 | Redacted Document (4) Docket Text: REDACTED VERSION of [535] Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney regarding Accord's Responsive Discovery Dispute Letter by Accord Healthcare, Inc.. (Dorsney, Kenneth) |
| Nov 4, 2020 | 552 | Redacted Document (15) Docket Text: REDACTED VERSION of [536] Declaration, of George J. Barry III by Accord Healthcare, Inc.. (Dorsney, Kenneth) |
| Nov 3, 2020 | 548 | Main Document (4) Docket Text: REDACTED VERSION of [537] Letter by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Exhibit 30, # (2) Exhibit 31, # (3) Exhibit 32)(Phillips, John) |
| Nov 3, 2020 | 548 | Exhibit 30 (28) |
| Nov 3, 2020 | 548 | Exhibit 31 (36) |
| Nov 3, 2020 | 548 | Exhibit 32 (67) |
| Nov 3, 2020 | 549 | Main Document (4) Docket Text: REDACTED VERSION of [538] Letter to Honorable Christopher J. Burke by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A)(Oakes, Robert) |
| Nov 3, 2020 | 549 | Exhibit A (8) |
| Nov 2, 2020 | 547 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Stephen Hancock on November 5, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [544] STIPULATION TO EXTEND TIME Apotex and Accord deadlines to various filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 10/30/2020. (nmf) |
| Oct 30, 2020 | 546 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of CONFIDENTIAL Supplemental Plaintifs' Final Infringement Contentions [DRL] filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 29, 2020 | 541 | Main Document (2) Docket Text: REDACTED VERSION of [516] MOTION for Leave to File Unopposed Second Amended Complaint re Apotex by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A Redacted Second Amended Complaint re Apotex, # (2) Exhibit B - Redline)(Oakes, Robert) |
| Oct 29, 2020 | 541 | Exhibit A Redacted Second Amended Complaint re Apotex (97) |
| Oct 29, 2020 | 541 | Exhibit B - Redline (16) |
| Oct 29, 2020 | 542 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Supplemental (10/29/2020) Objections and Responses to Plaintiffs' Amended First Set of Common Interrogatories filed by Apotex Inc..(Haney, Megan) |
| Oct 29, 2020 | 543 | Main Document (6) Docket Text: REDACTED VERSION of [519] Letter, to Honorable Christopher J. Burke by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A-Q, # (2) Exhibit R, # (3) Exhibit S)(Oakes, Robert) |
| Oct 29, 2020 | 543 | Exhibit A-Q (1) |
| Oct 29, 2020 | 543 | Exhibit R (21) |
| Oct 29, 2020 | 543 | Exhibit S (6) |
| Oct 28, 2020 | 539 | Main Document (5) Docket Text: REDACTED VERSION of [518] Letter by Apotex Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Phillips, John) |
| Oct 28, 2020 | 539 | Exhibit 1 (1) |
| Oct 28, 2020 | 539 | Exhibit 2 (1) |
| Oct 26, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request from filer, PDFS at D.I. 507 Ex. 5 and Ex. 13 have been replaced. (dlb) |
| Oct 26, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Hearing held on 10/26/2020. The Court heard the parties' arguments regarding Defendants' Motion for Teleconference to Resolve Discovery Dispute. (D.I. 517) The Court took the matters under advisement. (Clerk, Sforza) APPEARANCES: J. Phillips, Jr., J. Jaros, L. lesko, C. Galligan for Apotex; N. Hoeschen, K. Keller, J. Bennett for IMS; D. Gattuso, J. Wong for Hospira; R. Oakes, K. Yurkerwich, A. Major, B. Amadi for Astellas; M. Velez for Gilead (Court Reporter Valerie Gunning) (dlb) |
| Oct 26, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Hearing held on 10/26/2020. The Court heard the parties' arguments regarding Plaintiffs' Motion for Teleconference to Resolve Discovery Dispute. (D.I. 525) The Court took the matters under advisement. (Clerk, Sforza) APPEARANCES: J. Phillips, Jr., J. Jaros, C. Galligan for Dr. Reddys Laboratories; R. Oakes, A. Wigmore, B. Amadi, A. Burton for Astellas; M. Velez, T. Amirgholizadeh for Gilead (Court Reporter, Valerie Gunning) (dlb) Modified on 10/26/2020 (dlb). |
| Oct 26, 2020 | 534 | Main Document (5) Docket Text: REDACTED VERSION of [512] Letter, to Honorable Christopher J. Burke by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) 1, # (2) 2, # (3) 3, # (4) 4, # (5) 5, # (6) 6, # (7) 7)(Oakes, Robert) |
| Oct 26, 2020 | 534 | 1 (18) |
| Oct 26, 2020 | 534 | 2 (44) |
| Oct 26, 2020 | 534 | 3 (15) |
| Oct 26, 2020 | 534 | 4 (2) |
| Oct 26, 2020 | 534 | 5 (4) |
| Oct 26, 2020 | 534 | 6 (4) |
| Oct 26, 2020 | 534 | 7 (2) |
| Oct 23, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the October 22, 2020 letter from Plaintiffs and Defendant Hospira, Inc. requesting a discovery teleconference. (D.I. 526) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order, (D.I. 45), will be modified as follows with regard to these disputes: (1) A discovery dispute teleconference is set for November 30, 2020 at 2:00 p.m. before Judge Christopher J. Burke.; (2) By no later than November 4, 2020, the moving parties shall file with the Court a letter, not to exceed three single-spaced pages, in no less than 12-point font, outlining the issues they are raising and their position on those issues; (3) By no later than November 16, 2020, the responding parties may file an answering letter brief, not to exceed three single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to Plaintiffs' opening letter brief.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than November 23, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via email to use for the call.; and (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 10/23/2020. (dlb) Modified on 10/28/2020 (dlb). |
| Oct 23, 2020 | 530 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kamlesh Sawant on November 2, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 23, 2020 | 531 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Harish Mondkar on November 5, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 23, 2020 | 532 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Rahul Gupta on November 12, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 23, 2020 | 533 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Chetan Doshi on November 9, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 22, 2020 | 525 | Motion for Discovery (3) Docket Text: Joint MOTION for Discovery , MOTION Joint Motion for Teleconference to Resolve Discovery Dispute - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Oct 22, 2020 | 526 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding request for discovery dispute teleconference with Hospira. (Oakes, Robert) |
| Oct 22, 2020 | 527 | Redacted Document (3) Docket Text: REDACTED VERSION of [515] Stipulation by Apotex Inc.. (Haney, Megan) |
| Oct 22, 2020 | 528 | ANDA Form (1) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 16, 2020. Date of Expiration of Patent: February 2, 2027.Thirty Month Stay Deadline: 3/16/2023. (Oakes, Robert) |
| Oct 21, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of Exhibit K to D.I. [508] has been replaced with a corrected version per request of filer. (nmf) |
| Oct 21, 2020 | 520 | Main Document (6) Docket Text: REDACTED VERSION of [508] Letter,, to Judge Burke from Robert Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exs. A-O)(Oakes, Robert) |
| Oct 21, 2020 | 520 | Exs. A-O (33) |
| Oct 21, 2020 | 521 | Main Document (5) Docket Text: REDACTED VERSION of [507] Letter,, by Apotex Inc., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29)(Haney, Megan) |
| Oct 21, 2020 | 521 | Exhibit 1 (4) |
| Oct 21, 2020 | 521 | Exhibit 2 (21) |
| Oct 21, 2020 | 521 | Exhibit 3 (6) |
| Oct 21, 2020 | 521 | Exhibit 4 (19) |
| Oct 21, 2020 | 521 | Exhibit 5 (1) |
| Oct 21, 2020 | 521 | Exhibit 6 (25) |
| Oct 21, 2020 | 521 | Exhibit 7 (1) |
| Oct 21, 2020 | 521 | Exhibit 8 (1) |
| Oct 21, 2020 | 521 | Exhibit 9 (1) |
| Oct 21, 2020 | 521 | Exhibit 10 (1) |
| Oct 21, 2020 | 521 | Exhibit 11 (1) |
| Oct 21, 2020 | 521 | Exhibit 12 (1) |
| Oct 21, 2020 | 521 | Exhibit 13 (1) |
| Oct 21, 2020 | 521 | Exhibit 14 (15) |
| Oct 21, 2020 | 521 | Exhibit 15 (2) |
| Oct 21, 2020 | 521 | Exhibit 16 (1) |
| Oct 21, 2020 | 521 | Exhibit 17 (1) |
| Oct 21, 2020 | 521 | Exhibit 18 (1) |
| Oct 21, 2020 | 521 | Exhibit 19 (1) |
| Oct 21, 2020 | 521 | Exhibit 20 (1) |
| Oct 21, 2020 | 521 | Exhibit 21 (24) |
| Oct 21, 2020 | 521 | Exhibit 22 (20) |
| Oct 21, 2020 | 521 | Exhibit 23 (15) |
| Oct 21, 2020 | 521 | Exhibit 24 (7) |
| Oct 21, 2020 | 521 | Exhibit 25 (22) |
| Oct 21, 2020 | 521 | Exhibit 26 (10) |
| Oct 21, 2020 | 521 | Exhibit 27 (5) |
| Oct 21, 2020 | 521 | Exhibit 28 (5) |
| Oct 21, 2020 | 521 | Exhibit 29 (15) |
| Oct 20, 2020 | 514 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to Plaintiffs' Amended 30(b)(6) Deposition Topics and Apotex's Supplemental (10/15/2020) Initial Disclosures filed by Apotex Inc..(Haney, Megan) |
| Oct 20, 2020 | 517 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Apotex Inc.. Motions referred to Christopher J. Burke.(Haney, Megan) |
| Oct 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [510] STIPULATION TO EXTEND TIME deadline for Accord to depose Dr. Pathak and supplement infringement contentions to October 30, 2020 and within one week filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 10/19/2020. (fms) |
| Oct 16, 2020 | 511 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hospira, Inc.s [Confidential] Amended and Supplemental Responses and Objections to Plaintiffs Common Interrogatory No. 12 filed by Hospira, Inc..(Gattuso, Dominick) |
| Oct 16, 2020 | 513 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Final Invalidity Contentions Regarding U.S. Patent Nos. 8,106,183 B2, 8,524,883 B2 and RE 47,301 E filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Oct 15, 2020 | 509 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to USV Private Limited's First Set of Individual Interrogatories (Nos. 1-9) and (2) Plaintiffs' Objections and Responses to USV Private Limited's First Set of Individual Requests for Production of Documents and Things to Plaintiffs (Nos. 1-13) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 15, 2020 | 510 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME deadline for Accord to depose Dr. Pathak and supplement infringement contentions to October 30, 2020 and within one week - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 14, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [504] Stipulation filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 10/14/2020. (fms) |
| Oct 14, 2020 | 505 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) USV's Response to Plaintiffs' First Set of Individual Interrogatories (Nos. 1-2); (2) USV's Response to Plaintiffs' Fourth Amended First Set of Common Interrogatories (Nos. 1-11); (3) USV's Response to Plaintiffs' Second Amended Second Set of Common Interrogatories (Nos. 12-15); (4) USV's Responses to Plaintiffs' First Set of Individual Requests for Admission (Nos. 1-19); (5) USV's Response to Plaintiffs' First Set of Requests for Admission to Authenticate Documents (Nos. 1-34); (6) USV's Response to Plaintiffs' First Amended First Set of Common Requests for Admission (Nos. 1-24); (7) USV's Response to Plaintiffs' Fourth Amended First Set of Common Requests for Production (Nos.1-30); and (8) USV's Responses to Plaintiffs' Third Amended Second Set of Common Requests for Production (No. 31) filed by USV Private Limited.(Dorsney, Kenneth) |
| Oct 14, 2020 | 506 | Letter (2) Docket Text: Joint Letter to The Honorable Christopher J. Burke from Robert M. Oakes, John C. Phillips, Jr., Nathan R. Hoeschen, and Dominick T. Gattuso regarding Resolution of Extension for Euticals Deposition - re [489] Letter. (Oakes, Robert) |
| Oct 13, 2020 | 503 | Stipulation (3) Docket Text: STIPULATION regarding Discovery by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 13, 2020 | 504 | Stipulation (2) Docket Text: STIPULATION to Extend Deadlines regarding Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 12, 2020 | 501 | Letter (2) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding partial resolution of issues in D.I. 488 - re [488] Letter,. (Oakes, Robert) |
| Oct 12, 2020 | 502 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Confidential Notice of Deposition Pursuant to 30(b)(6) to USV filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 9, 2020 | 500 | Redacted Document (2) Docket Text: REDACTED VERSION of [489] Letter by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Phillips, John) |
| Oct 8, 2020 | 499 | Stipulation (2) Docket Text: STIPULATION regarding Dr. Reddy's deposition by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 7, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORDER Setting Teleconference: The Court has reviewed the October 2, 2020 letter from Plaintiffs and Defendant Accord Healthcare, Inc. ("Accord") requesting a discovery teleconference. (D.I. 487) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order, (D.I. 45), will be modified as follows with regard to these disputes: (1) A discovery dispute teleconference is set for November 9, 2020 at 2:00 p.m. before Judge Christopher J. Burke.; (2) By no later than October 16, 2020, Plaintiffs shall file with the Court a letter, not to exceed three single-spaced pages, in no less than 12-point font, outlining the issues they are raising and their position on those issues; (3) By no later than October 27, 2020, Accord may file an answering letter brief, not to exceed three single-spaced pages, in no less than 12-point font, outlining its reasons for its opposition to Plaintiffs' opening letter brief.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than November 4, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via email to use for the call.; and (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 10/7/2020. (dlb) |
| Oct 7, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORDER Setting Teleconference: The Court has reviewed the October 2, 2020 letter from Plaintiffs and Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc. ("DRL") requesting a discovery teleconference. (D.I. 488) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order, (D.I. 45), will be modified as follows with regard to these disputes: (1) A discovery dispute teleconference is set for October 26, 2020 at 2:00 p.m. before Judge Christopher J. Burke.; (2) By no later than October 14, 2020, Plaintiffs shall file with the Court a letter, not to exceed three single-spaced pages, in no less than 12-point font, outlining the issues they are raising and their position on those issues; (3) By no later than October 21, 2020, DRL may file an answering letter brief, not to exceed three single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to Plaintiffs' opening letter brief.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than October 22, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via email to use for the call.; and (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 10/7/2020. (dlb) |
| Oct 7, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORDER Setting Teleconference: The Court has reviewed the October 2, 2020 letter from Plaintiffs and Defendants Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc., Apotex, Inc., International Medication Systems, Ltd. and Hospira Inc. ("Defendants") requesting a discovery teleconference. (D.I. 489) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order, (D.I. 45), will be modified as follows with regard to these disputes: (1) A discovery dispute teleconference is set for October 26, 2020 at 12:00 p.m. before Judge Christopher J. Burke.; (2) By no later than October 14, 2020, the moving parties shall file with the Court a letter, not to exceed three single-spaced pages, in no less than 12-point font, outlining the issues they are raising and their position on those issues; (3) By no later than October 21, 2020, the responding parties may file an answering letter brief, not to exceed three single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to the moving parties' opening letter brief.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than October 22, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via email to use for the call.; and (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 10/7/2020. (dlb) |
| Oct 7, 2020 | 495 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Supplemental Objections and Responses to Dr. Reddy's Second Set of Interrogatories and (2) Plaintiffs' Supplemental Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 7, 2020 | 496 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Objections and Responses to Defendant Hospira, Inc.'s First Set of Individual Interrogatories (Nos. 1-9) and (2) Plaintiffs' Supplemental Disclosures Pursuant to Paragraph 3 and 4(a) of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 7, 2020 | 497 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Objections and Responses to International Medication Systems' First Set of Interrogatories and (2) Plaintiffs' Supplemental Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 7, 2020 | 498 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories (Nos. 1-11), (2) Plaintiffs' Fed. R. Civ. P. 26(a)(1) Amended Initial Disclosures, and (3) Plaintiffs' Supplemental Privilege Log filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 5, 2020 | 490 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendant International Medication Systems' First Supplemental Objections and Responses to Plaintiffs' Second Amended First Set of Common Interrogatories (Nos. 1-11) and Plaintiffs' Second Set of Common Interrogatories (Nos. 12-15) filed by International Medication Systems, Limited.(Keller, Karen) |
| Oct 5, 2020 | 491 | Redacted Document (3) Docket Text: REDACTED VERSION of [477] Stipulation by Apotex Inc.. (Haney, Megan) |
| Oct 2, 2020 | 484 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accord's Supplemental Rule 26(a) Initial Disclosures; (2) Accord's first supplemental response to Plaintiffs' First Set of Individual Interrogatories; and (3) Accord's first supplemental response to Plaintiffs' Amended First Set of Common Interrogatories filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Oct 2, 2020 | 485 | Main Document (5) Docket Text: REDACTED VERSION of [474] Letter, by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Phillips, John) |
| Oct 2, 2020 | 485 | Exhibit 1 (1) |
| Oct 2, 2020 | 485 | Exhibit 2 (1) |
| Oct 2, 2020 | 485 | Exhibit 3 (1) |
| Oct 2, 2020 | 485 | Exhibit 4 (1) |
| Oct 2, 2020 | 485 | Exhibit 5 (1) |
| Oct 2, 2020 | 485 | Exhibit 6 (1) |
| Oct 2, 2020 | 485 | Exhibit 7 (1) |
| Oct 2, 2020 | 485 | Exhibit 8 (1) |
| Oct 2, 2020 | 486 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.'s Responses and Objections to Plaintiff Second Set of Individual Interrogatories filed by Hospira, Inc..(Gattuso, Dominick) |
| Oct 2, 2020 | 487 | Letter (2) Docket Text: Letter to The Honorable Christopher J. Burke from Robert M. Oakes regarding Request to Schedule Discovery Teleconference. (Oakes, Robert) |
| Oct 2, 2020 | 488 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Robert M. Oakes regarding Plaintiffs and Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.'s Request to Schedule a Discovery Teleconference. (Oakes, Robert) |
| Oct 1, 2020 | 483 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's First Supplemental Response to Plaintiffs' First Individual Interrogatory and 2) Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's First Supplemental Response to Plaintiffs' Second Set of Common Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Sep 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [481] STIPULATION TO EXTEND TIME for DRL to file the redacted version of its answering discovery dispute letter (D.I. 474) to October 2, 2020 filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd. Ordered by Judge Christopher J. Burke on 9/30/2020. (dlb) |
| Sep 30, 2020 | 481 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for DRL to file the redacted version of its answering discovery dispute letter (D.I. 474) to October 2, 2020 - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Haney, Megan) |
| Sep 29, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs' discovery dispute motion ("Motion"), (D.I. 472), in which they seek to compel an additional Rule 30(b)(6) deposition with regard to Topics 4, 8, 9, 12, 13 and 38, and the briefing related thereto, (D.I. 467; D.I. 474), and having heard argument on September 28, 2020, hereby ORDERS that the MOTION is GRANTED-IN-PART for the reasons that follow: (1) With the Motion, Plaintiffs argue that Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s ("Defendants") Rule 30(b)(6) designee, Dr. Sumitra Ashok Pillai, was unprepared to discuss these topics as they relate to XRPD testing of Defendants' API and communications between Defendants and Euticals Inc. regarding the same ("the Subject Matter at Issue").; (2) The Court agrees with Plaintiffs, in light of the issues at play in this case, that the Subject Matter at Issue is important and relevant testimony that Plaintiffs would have been expected to seek pursuant to these topics. (See, e.g., United States Patent No. RE47,301) Defendants should have expected that Dr. Pillai would be asked about the Subject Matter at Issue during her deposition.; (3) The Court also agrees with Plaintiffs that with respect to the Subject Matter at Issue, Dr. Pillai was not prepared to provide substantive answers. Indeed, at almost any point at which Dr. Pillai was asked to provide a substantive response regarding XRPD testing, the witness was unable to do so. (See, e.g., D.I. 474, ex. 2 at 156-160, 168-69, 171, 175, 187-88, 210-11, 216, 225) Additionally, when asked whether she spoke to others who had such answers, Dr. Pillai often said she did not or that she did not speak to them in any great detail. (D.I. 467 at 2); (4) To the extent Defendants argued that some of Plaintiffs' questions during the deposition regarding the Subject Matter at Issue unfairly called for expert testimony, (D.I. 474 at 2), the Court disagrees. Questions that seek Defendants' viewpoint or understanding of what certain testing results mean are not out of bounds for a Rule 30(b)(6) deposition; if Defendants do not have any such viewpoint or understanding as corporate entities, then their Rule 30(b)(6) witness can always just say so. Further, the Court disagrees with Defendants that the wording of Topic 13 did not fairly call for Defendants to provide their viewpoint or understanding of such documents.; and (5) Therefore, Plaintiffs are entitled to a further Rule 30(b)(6) deposition on the relevant topics, which shall be further limited to the Subject Matter at Issue. Ordered by Judge Christopher J. Burke on 9/29/2020. (dlb) |
| Sep 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [477] SEALED Stipulation filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 9/28/2020. (fms) |
| Sep 28, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Hearing held on 9/28/20. The Court heard the parties' arguments Plaintiffs' Motion for Teleconference to Resolve Discovery Dispute with DRL. (D.I. 472) The Court took the matters under advisement. (Clerk, Sforza) APPEARANCES: B. Amadi, R. Oakes, A. Burton and A. Wigmore for Astellas US LLC; M. Velez for Gilead Sciences, Inc.; and J. Jaros, C. Galligan, J. Phillips, Jr. and J. Martins for Apotex, Inc. (Court Reporter, V. Gunning) (dlb) |
| Sep 28, 2020 | 478 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Hospira Inc.'s First Amended Privilege Log filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 28, 2020 | 479 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of First Amended Objections and Responses to Plaintiffs' First Set of Common Requests for Admission filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 25, 2020 | 475 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Apotex's Supplemental (9/24/2020) Objections and Responses to First Set of Individual Requests for Admission; (2) Apotex's Supplemental (9/24/2020) Objections and Responses to First Set of Requests for Admission to Authenticate Documents; (3) Apotex's Supplemental (9/24/2020) Initial Disclosures; (4) Apotex's Supplemental (9/24/2020) Objections and Responses to Plaintiffs' Individual Interrogatory; (5) Apotex's Supplemental (9/24/2020) Objections and Responses to Plaintiffs' Second Set of Common Interrogatories; (6) Apotex's Supplemental (9/24/2020) Objections and Responses to Plaintiffs' Amended First Set of Common Interrogatories; and (7) Apotex's Supplemental (9/24/2020) Objections and Responses to First Set of Common Requests for Admission filed by Apotex Inc..(Haney, Megan) |
| Sep 25, 2020 | 476 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Individual Interrogatories to Hospira, Inc. (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 23, 2020 | 472 | Motion for Miscellaneous Relief (3) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute with DRL - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Sep 23, 2020 | 473 | Main Document (6) Docket Text: REDACTED VERSION of [467] Letter, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Oakes, Robert) |
| Sep 23, 2020 | 473 | Exhibit A (25) |
| Sep 23, 2020 | 473 | Exhibit B (1) |
| Sep 23, 2020 | 473 | Exhibit C (14) |
| Sep 23, 2020 | 473 | Exhibit D (1) |
| Sep 23, 2020 | 473 | Exhibit E (1) |
| Sep 23, 2020 | 473 | Exhibit F (1) |
| Sep 23, 2020 | 473 | Exhibit G (1) |
| Sep 23, 2020 | 473 | Exhibit H (1) |
| Sep 23, 2020 | 473 | Exhibit I (1) |
| Sep 23, 2020 | 473 | Exhibit J (1) |
| Sep 23, 2020 | 473 | Exhibit K (1) |
| Sep 23, 2020 | 473 | Exhibit L (6) |
| Sep 22, 2020 | 471 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.s Supplemental Responses and Objections to Plaintiffs First Set of Individual Interrogatories [CONFIDENTIAL], and (ii) Defendant Hospira, Inc.s Amended and Supplemental Responses and Objections to Plaintiffs Common Interrogatories Nos. 7-11 [CONFIDENTIAL] were served filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [469] STIPULATION TO EXTEND TIME of Various Scheduling Order Deadlines to See Stipulation filed by Apotex Inc. Signed by Judge Colm F. Connolly on 9/21/2020. (fms) |
| Sep 21, 2020 | 469 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME of Various Scheduling Order Deadlines to See Stipulation - filed by Apotex Inc.. (Phillips, John) |
| Sep 21, 2020 | 470 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Amended (9/18/2020) Objections and Responses to 30(b)(6) Deposition Topics filed by Apotex Inc..(Haney, Megan) |
| Sep 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [468] MOTION for Pro Hac Vice Appearance of Attorney Michaela P. Sewall and Mark McBriar filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 9/18/2020. (fms) |
| Sep 18, 2020 | 468 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michaela P. Sewall and Mark McBriar - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Sep 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-00793-CFC) STIPULATION AND ORDER to Consolidate Action with 18-1675 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. The discovery limits and Scheduling Order entered in 18-1675-CFC shall apply with modifications as outlined in the stipulation. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1675-CFC ONLY. Signed by Judge Colm F. Connolly on 9/16/2020. Associated Cases: 1:20-cv-00793-CFC, 1:18-cv-01675-CFC-CJB(nmf) |
| Sep 16, 2020 | 466 | Answer to Counterclaim (11) Docket Text: ANSWER to [429] Answer to Complaint, Counterclaim Plaintiffs' Answer to Defendant's Amended Counterclaims by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 10, 2020 | 462 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of John DeMay on September 18, 2020 filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 10, 2020 | 465 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Balaji Panneerselvam on September 16, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 9, 2020 | 460 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Andrew Knill on September 29, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 9, 2020 | 461 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of [Second Amended] Elfatih Elzein on September 11, 2020 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Sep 8, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER: The Court has reviewed the parties' September 4, 2020 letter requesting a discovery teleconference regarding Plaintiffs' disputes. (D.I. 453) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order, (D.I. 45), will be modified as follows with regard to these disputes: (1) A discovery dispute teleconference is set for September 28, 2020 at 4:00 PM before Judge Christopher J. Burke.; (2) By no later than September 16, 2020, Plaintiffs shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues as to the disputes they are raising.; (3) By no later than September 23, 2020, the side opposing relief may file an answering letter brief, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition to the opening letter brief of the other side.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than September 23, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via email to use for the call.; and (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 9/4/2020. (dlb) |
| Sep 8, 2020 | 455 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Shaik Riyaz Ahmed (DRL) on September 10, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 8, 2020 | 456 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.s First Privilege Log [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 8, 2020 | 457 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Accord's response to Plaintiffs' First Set of Individual Interrogatories filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Sep 4, 2020 | 446 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Confidential to Apotex: Plaintiffs' Objections and Responses to: First Set of Individual Requests for Production (Nos. 1-13); First Set of Requests for Admission; and First Set of Interrogatories (Nos 1-10) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 4, 2020 | 447 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Confidential to Hospira: Plaintiffs' Objections and Responses to: Second Set of Individual Requests for Production (Nos. 4-13); First set of Individual Interrogatories (Nos 1-9) and First set of Individual Requests for Admission (Nos 1-20) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 4, 2020 | 448 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Confidential to IMS: Plaintiffs' Objections and Responses to: First Set of Requests for Production (Nos 4-20); First Set of Requests for Admission; and First Set of Interrogatories (Nos 1-7) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 4, 2020 | 449 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Confidential to DRL: Plaintiffs' Objections and Responses to: First Set of Requests for Admission (No 1-20); Second Set of Interrogatories (Nos 5-10); and Third Set of Requests for Production (Nos. 9-25) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 4, 2020 | 450 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Confidential to Accord: Plaintiffs' Objections and Responses to First Set of Individual Interrogatories (Nos 1-9); Plaintiffs' Objections and Responses to First Set of Individual Requests for Production (Nos. 1-13) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 4, 2020 | 451 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 4, 2020 | 452 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.s First Amended Rule 26(a)(1) Disclosures [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 4, 2020 | 453 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding DRL and Plaintiffs request for discovery teleconference. (Oakes, Robert) |
| Sep 3, 2020 | 445 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendant Hospira, Inc.s Objections and Responses to Plaintiffs First Set of Individual Requests for Admission [CONFIDENTIAL]; and, (ii) Defendant Hospira, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Admission to Authenticate Documents [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [436] STIPULATION TO EXTEND TIME Fact and Expert Discovery, Daubert Motions, Final Contentions to various filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 9/2/2020. (fms) |
| Sep 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [437] Stipulation of Dismissal filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Party Gland Pharma Limited. Ordered by Judge Colm F. Connolly on 9/2/2020. (fms) |
| Sep 2, 2020 | 444 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.s Responses and Objections to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Sep 1, 2020 | 440 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendant International Medication System, Ltd.'s Objections and Responses to Plaintiffs' First Individual Interrogatory filed by International Medication Systems, Limited.(Keller, Karen) |
| Sep 1, 2020 | 441 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to Plaintiffs' Individual Interrogatory filed by Apotex Inc..(Haney, Megan) |
| Sep 1, 2020 | 442 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Objections and Responses to First Set of Individual Interrogatories filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 1, 2020 | 443 | Main Document (2) Docket Text: REDACTED VERSION of [428] MOTION for Leave to File [Unopposed Motion for Leave to File Amended Answer, Defenses and Counterclaims] by Apotex Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Proposed Order)(Haney, Megan) |
| Sep 1, 2020 | 443 | Exhibit A (29) |
| Sep 1, 2020 | 443 | Exhibit B (30) |
| Sep 1, 2020 | 443 | Proposed Order (1) |
| Aug 31, 2020 | 434 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Supplemental and Revised Privilege Log filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Aug 31, 2020 | 435 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Response to Plaintiffs' First Individual Interrogatory filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Aug 31, 2020 | 436 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME Fact and Expert Discovery, Daubert Motions, Final Contentions to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 31, 2020 | 437 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Gland Pharma Limited (C.A. No. 20-347) by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 31, 2020 | 438 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.s Responses and Objections to Plaintiffs First Set of Individual Interrogatories [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Aug 31, 2020 | 439 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) the Responses and Objections to Plaintiffs Confidential Notice of Subpoena for Documents [CONFIDENTIAL], and (ii) the Responses and Objections to Plaintiffs Confidential Notice of Subpoena for Testimony [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Aug 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [430] MOTION for Pro Hac Vice Appearance of Attorney Gary M. Fox filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC, [431] MOTION for Pro Hac Vice Appearance of Attorney Joel L. Broussard filed by International Medication Systems, Limited. Signed by Judge Colm F. Connolly on 8/28/2020. (nmf) |
| Aug 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joel L. Broussard for International Medication Systems, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 28, 2020 | 433 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of (AMENDED) Elfatih Elzein on September 2, 2020, beginning at 10:00 a.m. CT filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Aug 26, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [428] MOTION for Leave to File [Unopposed Motion for Leave to File Amended Answer, Defenses and Counterclaims] filed by Apotex Inc.. Ordered by Judge Colm F. Connolly on 8/26/2020. (fms) |
| Aug 26, 2020 | 430 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gary M. Fox - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 26, 2020 | 431 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joel L. Broussard - filed by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Aug 26, 2020 | 432 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Jeff Zablocki on August 31, 2020 filed by Accord Healthcare, Inc., Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc., Gland Pharma Limited, Hospira, Inc., International Medication Systems, Limited, Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Haney, Megan) |
| Aug 25, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [427] MOTION for Pro Hac Vice Appearance of Attorney James Bor-Zale filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 8/25/2020. (nmf) |
| Aug 25, 2020 | 426 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sabita Nair (Accord) on August 27, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 25, 2020 | 427 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James Bor-Zale - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [419] STIPULATION TO EXTEND TIME Substantial Completion of Document Production and Exchange of Privilege Logs to August 28, 2020 and September 4, 2020 respectively filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 8/24/2020. (fms) |
| Aug 24, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The text of D.I. [424] has been corrected per request of filer to reflect that the Notice of Service of Objections and Responses is in response to Defendant International Medication Systems, Limited's First Set of Request for Production. (nmf) |
| Aug 24, 2020 | 423 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendant International Medication Systems' Responses to Plaintiffs' First Set of Common Requests for Admission (2) Defendant International Medication Systems' Responses to Plaintiffs' First Set of Individual Requests for Admission filed by International Medication Systems, Limited.(Keller, Karen) |
| Aug 24, 2020 | 424 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant International Medication Systems, Limited's First Set of Requests for Production (Nos. 1-3) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.(Oakes, Robert) Modified on 8/24/2020 (nmf). |
| Aug 24, 2020 | 425 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Objections and Responses to Defendant Hospira, Inc.s First Set of Requests for Production filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 21, 2020 | 418 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants' Notice of Deposition to Robert Seemayer filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Aug 21, 2020 | 419 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME Substantial Completion of Document Production and Exchange of Privilege Logs to August 28, 2020 and September 4, 2020 respectively - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Aug 21, 2020 | 420 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Response to Plaintiffs' First Set of Requests for Admission; 2) Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Objections and Responses to Plaintiffs' First Set of Common Requests for Admission; and 3) Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Objections and Responses to Plaintiffs' First Set of Individual Requests for Admission to Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Aug 21, 2020 | 421 | Notice (Other) (4) Docket Text: NOTICE of Defendants' Notice of Deposition to Travis Lemons by Hospira, Inc. (Gattuso, Dominick) |
| Aug 21, 2020 | 422 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses To Dr. Reddy's Second Set Of Requests For Production (Nos. 5-8) and Plaintiffs' Objections and Responses to Apotex's First Set of Requests for Production (Nos. 1-8) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [416] STIPULATION and ORDER to extend discovery deadlines filed by Gland Pharma Limited. Signed by Judge Colm F. Connolly on 8/20/2020. (nmf) |
| Aug 19, 2020 | 417 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Rule 30(b)(6) Notice and Plaintiffs' Designated Witnesses to Defendants' Rule 30(b)(6) Notice filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 18, 2020 | 411 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Objections and Responses to First Set of Common Requests for Admission; (2) Apotex's Objections and Responses to First Set of Individual Requests for Admission; and (3) Apotex's Objections and Responses to First Set of Requests for Admission to Authenticate Documents filed by Apotex Inc..(Haney, Megan) |
| Aug 18, 2020 | 412 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) DRL's Objections and Responses to First Set of Common Requests for Admission; (2) DRL's Objections and Responses to First Set of Individual Requests for Admission; and (3) DRL's Objections and Responses to First Set of Requests for Admission to Authenticate Documents filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Aug 18, 2020 | 413 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Accord's First Amended Responses and Objections to Plaintiffs' Notice of 30(b)(6) Deposition filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Aug 18, 2020 | 414 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Objections and Supplemental Responses to Second Set of Common Interrogatories filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Aug 18, 2020 | 415 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendant International Medication Systems' Responses to Plaintiffs' First Set of Requests for Admission to Authenticate Documents filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Aug 18, 2020 | 416 | Stipulation (2) Docket Text: STIPULATION (and proposed order) to extend discovery deadlines by Gland Pharma Limited. (Fry, David) |
| Aug 17, 2020 | 406 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accord's response to Plaintiffs' First Set of Individual Requests for Admission; (2) Accord's response to Plaintiffs' First Set of Common Requests for Admission; (3) Accord's responses to Plaintiffs' First Set of Requests for Admission to Authenticate Documents filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Aug 17, 2020 | 407 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Confidential Notice of Subpoena for Documents and Confidential Notice of Subpoena for Testimony filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 17, 2020 | 408 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Alpesh Pathak on August 20, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 17, 2020 | 409 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sumitra Ashok Pillai on August 20, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 17, 2020 | 410 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendant Hospira, Inc.s Objections And Responses to Plaintiffs First Set of Common Requests for Admission [CONFIDENTIAL]; (ii) Defendant Hospira, Inc.s Responses and Objections to Plaintiffs Third Amended First Set Of Common Interrogatories [CONFIDENTIAL]; (iii) Defendant Hospira, Inc.s Responses and Objections to Plaintiffs First Amended Second Set of Common Interrogatories [CONFIDENTIAL]; (iv) Defendant Hospira, Inc.s Responses and Objections to Plaintiffs Second Amended Second Set of Common Requests for Production of Documents and Things [CONFIDENTIAL]; and, (v) Defendant Hospira, Inc.s Responses and Objections to Plaintiffs Third Amended First Set Of Common Requests For Production of Documents and Things [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Aug 14, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Lauren M. Lesko for Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 14, 2020 | 404 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Accord's response to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-15) filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Aug 14, 2020 | 405 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.s Initial Invalidity Contentions filed by Hospira, Inc..(Gattuso, Dominick) |
| Aug 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [402] MOTION for Pro Hac Vice Appearance of Attorney Beth Ashbridge filed by International Medication Systems, Limited. Signed by Judge Colm F. Connolly on 8/13/2020. (fms) |
| Aug 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [403] MOTION for Pro Hac Vice Appearance of Attorney Lauren M. Lesko filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc. Signed by Judge Colm F. Connolly on 8/13/2020. (fms) |
| Aug 13, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Beth Ashbridge for International Medication Systems, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 13, 2020 | 402 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Beth Ashbridge - filed by International Medication Systems, Limited. (Hoeschen, Nathan) |
| Aug 13, 2020 | 403 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lauren M. Lesko - filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Lesko Pro Hac Certification)(Haney, Megan) |
| Aug 13, 2020 | 403 | Lesko Pro Hac Certification (1) |
| Aug 11, 2020 | 396 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant International Medication System, Ltd.s Objections and Responses to Plaintiffs Second Set of Common Interrogatories (Nos. 12-15) filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Aug 11, 2020 | 397 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Eden Ramaizel on September 15, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 11, 2020 | 398 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Balaji Paneerselvan on September 8, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 11, 2020 | 399 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Eric Blumenthal on September 2, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 11, 2020 | 400 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Emily Fearnow on September 11, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 11, 2020 | 401 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of 30(B)(6) Deposition to Hospira, Inc. (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 10, 2020 | 392 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DRL's Second Amended Response to Notice of Rule 30(b)(6) Deposition filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Aug 10, 2020 | 393 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Response to Plaintiffs' Second Set of Common Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Aug 10, 2020 | 394 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories filed by Apotex Inc..(Haney, Megan) |
| Aug 10, 2020 | 395 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Objections and Responses to Second Set of Common Interrogatories filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Aug 7, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Claire A. Fundakowski for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 7, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [389] STIPULATION TO EXTEND TIME to extend certain dates in the Scheduling Order to (See attached Stipulation for various dates) filed by Hospira, Inc. Ordered by Judge Colm F. Connolly on 8/7/2020. (fms) |
| Aug 7, 2020 | 391 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding pending motion to compel and show cause. (Oakes, Robert) |
| Aug 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [388] STIPULATION TO EXTEND TIME deadline for parties to submit a joint letter to court proposing a remaining briefing schedule to August 7, 2020 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Christopher J. Burke on 8/6/2020. (mlc) |
| Aug 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [387] Stipulation filed by Gland Pharma Limited. Ordered by Judge Colm F. Connolly on 8/6/2020. (fms) |
| Aug 6, 2020 | 389 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to extend certain dates in the Scheduling Order to (See attached Stipulation for various dates) - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Aug 6, 2020 | 390 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Elfatih Elzein on August 21, 2020 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Aug 5, 2020 | 386 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO HOSPIRA - Plaintiffs' First Set of Individual Requests for Admission and First Set of Requests for Admission to Authenticate Documents filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 5, 2020 | 387 | Stipulation (2) Docket Text: STIPULATION to Extend Various Discovery Deadlines by Gland Pharma Limited. (Fry, David) |
| Aug 5, 2020 | 388 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME deadline for parties to submit a joint letter to court proposing a remaining briefing schedule to August 7, 2020 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 4, 2020 | 380 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants First Set of Requests for Admission filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Aug 4, 2020 | 381 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accord's First Set of Individual Interrogatories to Plaintiffs (Nos. 1-9); and (2) Accord's First Set of Individual Requests for Production to Plaintiffs (Nos. 1-13) filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Aug 4, 2020 | 382 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Apotex's First Set of Requests for Admission; (2) Apotex's First Set of Interrogatories; and (3) Apotex's Second Set of Requests for Production filed by Apotex Inc..(Haney, Megan) |
| Aug 4, 2020 | 383 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Dr. Reddy's First Set of Requests for Admission; (2) Dr. Reddy's Second Set of Interrogatories; and (3) Dr. Reddy's Third Set of Requests for Production filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Aug 4, 2020 | 384 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Hospira, Inc.s First Set of Individual Interrogatories (Nos. 1-9) [CONFIDENTIAL-SUBJECT TO THE PROTECTIVE ORDER]; (ii) Hospira, Inc.s Second Set of Individual Requests for Production (Nos. 4-13) [CONFIDENTIAL-SUBJECT TO THE PROTECTIVE ORDER]; and, (iii) Hospira, Inc.s First Set of Individual Requests for Admission (Nos. 1-20) [CONFIDENTIAL-SUBJECT TO THE PROTECTIVE ORDER] filed by Hospira, Inc..(Gattuso, Dominick) |
| Aug 4, 2020 | 385 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. International Medication Systems First Set of Requests for Admission 2. International Medication Systems Second Set of Requests for Production 3. International Medication Systems First Set of Interrogatories filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Aug 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [370] MOTION for Pro Hac Vice Appearance of Attorney Tara M. Raghavan filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd., [369] MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino, William A. Rakoczy, Joseph T. Jaros and Chris P. Galligan filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 8/3/2020. (fms) |
| Aug 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (18 in 1:20-cv-00516-CFC) SEALED Stipulation filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 8/3/2020. Associated Cases: 1:20-cv-00516-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Aug 3, 2020 | 378 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DRL's First Amended Response to Notice of Rule 30(b)(6) Depositions filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Aug 3, 2020 | 379 | Main Document (6) Docket Text: REDACTED VERSION of [363] MOTION to Strike [355] MOTION to Compel Compliance with The Court's Discovery Orders and to Show Cause (DRL) by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Text of Proposed Order)(Haney, Megan) |
| Aug 3, 2020 | 379 | Text of Proposed Order (1) |
| Jul 31, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs' motion to compel and to show cause, (D.I. [355]; D.I. [356]), and the Dr. Reddy's Defendants' motion to strike, (D.I. [363]), notes that these are motions that have been referred for resolution to the Court by the District Court, as they relate to discovery disputes between the parties. Therefore, and in light of the content of the motions, the Court ORDERS as follows: (1) The parties should further meet and confer about the subject matter of the motions; and (2) if by no later than August 5, 2020 the parties have not resolved their disagreements, they should submit a joint letter to the Court proposing a remaining briefing schedule regarding the disputes (one that makes use of the briefs already filed) and including a suggested time frame in which the Court should schedule telephonic argument on the motion(s). Ordered by Judge Christopher J. Burke on 7/31/2020. (mlc) |
| Jul 31, 2020 | 369 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino, William A. Rakoczy, Joseph T. Jaros and Chris P. Galligan - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Molino Pro Hac Certification, # (2) Rakoczy Pro Hac Certification, # (3) Jaros Pro Hac Certification, # (4) Galligan Pro Hac Certification)(Haney, Megan) |
| Jul 31, 2020 | 369 | Molino Pro Hac Certification (1) |
| Jul 31, 2020 | 369 | Rakoczy Pro Hac Certification (1) |
| Jul 31, 2020 | 369 | Jaros Pro Hac Certification (1) |
| Jul 31, 2020 | 369 | Galligan Pro Hac Certification (1) |
| Jul 31, 2020 | 370 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tara M. Raghavan - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Raghavan Pro Hac Certification)(Haney, Megan) |
| Jul 31, 2020 | 370 | Raghavan Pro Hac Certification (1) |
| Jul 31, 2020 | 371 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO IMS: Plaintiffs First Individual Interrogatory No. 1 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 31, 2020 | 372 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO ACCORD: Plaintiffs First Set of Individual Interrogatory Nos. 1-2 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 31, 2020 | 373 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO DRL: Plaintiffs First Set of Individual Interrogatory Nos. 1-2 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 31, 2020 | 374 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO HOSPIRA: Plaintiffs First Set of Individual Interrogatory Nos. 1-2 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 31, 2020 | 375 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO GLAND: Plaintiffs First Individual Interrogatory No. 1 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 31, 2020 | 376 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO SUN: Plaintiffs First Set of Individual Interrogatory No. 1 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 31, 2020 | 377 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO APOTEX: Plaintiffs First Individual Interrogatory No. 1 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 30, 2020 | 367 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Mark Schwitzenberg on August 14, 2020 filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Jul 29, 2020 | 364 | Main Document (5) Docket Text: REDACTED VERSION of [355] MOTION to Compel Compliance with The Court's Discovery Orders and to Show Cause (DRL) by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Text of Proposed Order)(Oakes, Robert) |
| Jul 29, 2020 | 364 | Text of Proposed Order (2) |
| Jul 29, 2020 | 365 | Redacted Document (30) Docket Text: REDACTED VERSION of [356] Opening Brief in Support, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 29, 2020 | 366 | Main Document (6) Docket Text: REDACTED VERSION of [357] Declaration of Alison Burton by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A-G, # (2) Exhibit H-O, # (3) Exhibit P-U)(Oakes, Robert) |
| Jul 29, 2020 | 366 | Exhibit A-G (98) |
| Jul 29, 2020 | 366 | Exhibit H-O (19) |
| Jul 29, 2020 | 366 | Exhibit P-U (35) |
| Jul 28, 2020 | N/A | Motions Referred (0) Docket Text: MOTION REFERRED: [363] MOTION to Strike [355] MOTION to Compel Compliance with The Court's Discovery Orders and to Show Cause (DRL) Motion referred to Magistrate Judge Christopher J. Burke.(nmf) |
| Jul 27, 2020 | 362 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Accord's privilege log filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Jul 24, 2020 | 360 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) International Medication Systems' First Set of Requests for Production filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Jul 24, 2020 | 361 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions to Hospira (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 23, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alison M. Heydorn for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jul 23, 2020 | 358 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) to Plaintiffs filed by International Medication Systems, Limited.(Keller, Karen) |
| Jul 23, 2020 | 359 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.s First Set of Requests for Production (Nos. 1-3) filed by Hospira, Inc..(Gattuso, Dominick) |
| Jul 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [351] STIPULATION (and proposed order) to extend time - Gland's Responses to First Set of Interrogatories and Requests for Production to August 7, 2020 and Gland's Substantial Completion of Document Production to August 21, 2020. Signed by Judge Colm F. Connolly on 7/22/2020. (nmf) |
| Jul 22, 2020 | 351 | Stipulation (2) Docket Text: STIPULATION (and proposed order) to extend time - Gland's Responses to First Set of Interrogatories and Requests for Production to August 7, 2020 and Gland's Substantial Completion of Document Production to August 21, 2020 by Gland Pharma Limited. (Fry, David) |
| Jul 22, 2020 | 352 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of TO HOSPIRA: (1) Plaintiffs Objections and Responses to Defendants First Set of Common Requests for Production of Document and Things (Confidential): (2) Plaintiffs Objections and Responses to Defendants First Set of Common Interrogatories; and (3) Plaintiffs Supplemental Objections and Responses to Defendants First Set of Common Interrogatories Nos. 1-11 (Confidential) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 22, 2020 | 353 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's First Set of Requests for Production filed by Apotex Inc..(Haney, Megan) |
| Jul 22, 2020 | 354 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Second Set of Requests for Production filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Jul 20, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The text of D.I. [334] has been modified per request of filer to reflect that it is Plaintiff's Answer to Defendant Hospira's Inc.'s counterclaims as the answer was filed in the member case and therefore the filing could not be linked. (nmf) |
| Jul 20, 2020 | 335 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Privilege Log (7/17/20) filed by Apotex Inc..(Haney, Megan) |
| Jul 20, 2020 | 336 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's First (7/17/20) Privilege Log filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Jul 20, 2020 | 337 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Privilege Log filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Jul 20, 2020 | 338 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) International Medication Systems, Ltd.'s Privilege Log filed by International Medication Systems, Limited.(Keller, Karen) |
| Jul 20, 2020 | 339 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Supplemental (7/20/20) Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Jul 20, 2020 | 340 | Redacted Document (3) Docket Text: REDACTED VERSION of [322] Notice of Service by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 20, 2020 | 341 | Redacted Document (3) Docket Text: REDACTED VERSION of [323] Notice of Service by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 20, 2020 | 342 | Redacted Document (3) Docket Text: REDACTED VERSION of [324] Notice of Service by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 20, 2020 | 343 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of To Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. First set of Individual Requests for Admission and First Request for Admission to Authenticate Documents filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 20, 2020 | 344 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO International Medication Systems, Ltd First set of Individual Requests for Admission and First Request for Admission to Authenticate Documents filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 20, 2020 | 345 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. First set of Individual Requests for Admission and First Request for Admission to Authenticate Documents filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 20, 2020 | 346 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO Apotex Inc. First set of Individual Requests for Admission and First Request for Admission to Authenticate Documents filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 20, 2020 | 347 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO Accord Healthcare, Inc. First set of Individual Requests for Admission and First Request for Admission to Authenticate Documents filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 20, 2020 | 348 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO Hospira Plaintiffs Initial Disclosures and Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 20, 2020 | 349 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of TO Gland Plaintiffs' Preliminary Infringement Contentions filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 20, 2020 | 350 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of TO ALL DEFENDANTS: (1) Plaintiffs First Set of Common Requests for Admission (Nos. 1-24); (2) Plaintiffs Third Amended First Set of Common Requests for Production of Documents and Things (Nos. 1-30); (3) Plaintiffs Second Amended Second Set of Common Requests for Production of Documents and Things (Nos. 31); (4) Plaintiffs Third Amended First Set of Common Interrogatories (Nos. 1-11); (5) Plaintiffs First Amended Second Set of Common Interrogatories (Nos. 12-15); (6) Astellas US LLC and Astellas Pharma US, LLC First Privilege Log; and (7) Gilead Sciences, Inc.s First Privilege Log filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 17, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [330] MOTION for Pro Hac Vice Appearance of Attorney Alison M. Heydorn filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 7/17/2020. (nmf) |
| Jul 17, 2020 | 333 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of copies of (i) Hospira, Inc.s Rule 26(a)(1) Disclosures [CONFIDENTIAL]; and, (ii) Hospira Inc.s Disclosures Pursuant to Paragraph 3 of the Default Standard [CONFIDENTIAL] filed by Hospira, Inc..(Gattuso, Dominick) |
| Jul 17, 2020 | 334 | Amended Answer to Complaint (7) Docket Text: PLAINTIFFS' ANSWER to DEFENDANT Hospira, Inc.'s COUNTERCLAIM filed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc. (Oakes, Robert) Modified on 7/20/2020 (nmf). |
| Jul 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Greg L. Goldblatt for Apotex Inc., for Dr. Reddy's Laboratories Ltd.,for Dr. Reddy's Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (11 in 1:20-cv-00893-CFC) Stipulation to Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 20-893-CFC and C.A. No. 18-1675-CFC are consolidated forall purposes;All filings shall be made in C.A. No. 18-1675-CFC. Ordered by Judge Colm F. Connolly on 7/15/2020. Associated Cases: 1:20-cv-00893-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Jul 15, 2020 | 330 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alison M. Heydorn - filed by Hospira, Inc.. (Gattuso, Dominick) |
| Jul 14, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [327] MOTION for Pro Hac Vice Appearance of Attorney Greg L. Goldblatt filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc. Signed by Judge Colm F. Connolly on 7/14/2020. (nmf) |
| Jul 13, 2020 | 327 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Greg L. Goldblatt - filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Goldblatt Pro Hac Certification)(Haney, Megan) |
| Jul 13, 2020 | 327 | Goldblatt Pro Hac Certification (1) |
| Jul 13, 2020 | 328 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants First Set of Common Interrogatories Nos. 1-11 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 13, 2020 | 329 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First set of Common Interrogatories (Confidential); and (2) Plaintiffs' Objections and Responses to Defendants' First set of Common Request for Production of Documents and Things (Confidential) (to Gland) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 10, 2020 | 325 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Common Interrogatories filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 10, 2020 | 326 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Objections and Responses (7/10/20) to Plaintiffs' First Set of Common Requests for Production of Documents and Things; and (2) Apotex's Supplemental (7/10/20) Initial Disclosures filed by Apotex Inc..(Haney, Megan) |
| Jul 8, 2020 | 320 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Tony Marrs (IMS) on August 25, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 8, 2020 | 321 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Bhaskar Ganguly (DRL) on August 21, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 7, 2020 | 319 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of subpoena filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 2, 2020 | 318 | Redacted Document (9) Docket Text: REDACTED VERSION of [311] Letter to Judge Burke from Robert M. Vrana Regarding D.I. 272 by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,. (Vrana, Robert) |
| Jun 29, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties letter, (D.I. 311), HEREBY ORDERS that the teleconference scheduled for Monday, June 29, 2020, is CANCELLED.. Ordered by Judge Christopher J. Burke on 6/29/2020. (dlb) |
| Jun 29, 2020 | 315 | Main Document (4) Docket Text: REDACTED VERSION of [276] Letter to Judge Burke from Robert Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Ex. C, # (4) Ex. D, # (5) Ex. E, # (6) Ex. F, # (7) Ex. G)(Oakes, Robert) |
| Jun 29, 2020 | 315 | Ex. A (2) |
| Jun 29, 2020 | 315 | Ex. B (2) |
| Jun 29, 2020 | 315 | Ex. C (4) |
| Jun 29, 2020 | 315 | Ex. D (4) |
| Jun 29, 2020 | 315 | Ex. E (4) |
| Jun 29, 2020 | 315 | Ex. F (2) |
| Jun 29, 2020 | 315 | Ex. G (4) |
| Jun 26, 2020 | 312 | Letter (2) Docket Text: Letter to Honorable Christopher J. Burke from Robert Oakes and Adam Poff regarding resolution of discovery dispute - re [310] Joint MOTION for Discovery Teleconference to Resolve Discovery Dispute with Sun Defendants. (Oakes, Robert) |
| Jun 26, 2020 | 313 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Defendant Gland Pharma Limiteds Initial Disclosures Under Rule 26(a)(1) 2. Defendant Gland Pharma Limiteds ESI Disclosures Under the District of Delawares Default Standard for Discovery filed by Gland Pharma Limited.(Fry, David) |
| Jun 25, 2020 | 310 | Motion for Discovery (2) Docket Text: Joint MOTION for Discovery Teleconference to Resolve Discovery Dispute with Sun Defendants - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Jun 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [278] STIPULATION TO EXTEND TIME (and proposed order) to extend document production deadline to June 26, 2020 filed by International Medication Systems, Limited. Signed by Judge Colm F. Connolly on 6/24/2020. (fms) |
| Jun 24, 2020 | 308 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Amended First Set of Common Interrogatories (To Gland Defendants) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 24, 2020 | 309 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' FRCP 26(a)(1) Initial Disclosures and Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery (To Gland Defendants) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 277 | Transcript (104) Docket Text: Official Transcript of Markman hearing held on March 5, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/14/2020. Redacted Transcript Deadline set for 7/24/2020. Release of Transcript Restriction set for 9/21/2020. (vjg) |
| Jun 23, 2020 | 278 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to extend document production deadline to June 26, 2020 - filed by International Medication Systems, Limited. (Keller, Karen) |
| Jun 23, 2020 | 279 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Mukesh Bothra on August 13, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 280 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Alex George (Accord) on September 1, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 281 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sabita Nair (Accord) on August 27, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 282 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Alpesh Pathak (Accord) on August 20, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 283 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kiran Krishnan (Apotex) on August 11, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 284 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Surapanini Sridevi (Apotex) on August 18, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 285 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Subramanian Venkatesan (Apotex) on August 25, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 286 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jacob Liawatidewi (IMS) on August 21, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 287 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Fonda Su (IMS) on August 14, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 288 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Wenbo Yu (IMS) on August 5, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 289 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Shaik Riyaz Ahmmad (DRL) on August 12, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 290 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jaya Lakshmi Ayyagari (DRL) on July 30, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 291 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Mahendra Reddy Dontireddy (DRL) on August 19, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 292 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sumitra Ashok Pillai on August 4, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 293 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Satheesh B (DRL) on August 26, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 294 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Arvind Tekumal (DRL) on August 7, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 295 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Arunkumar Yadav (Sun) on August 17, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 296 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Craig Kuchii (Sun) on August 28, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 297 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jasmin Davda (Sun) on July 23, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 298 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Debjani Banerjee (Sun) on July 27, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 299 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Anil Gite (Sun) on August 6, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 300 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kanhoba Walavalkar (Sun) on August 24, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 301 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Bharati Nadkarni on July 30, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 302 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Nayna Daptardar (Sun) on September 1, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 303 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of P. Rita. Santhakumar (Sun) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 304 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Pritesh Dasare (Sun) on September 3, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 305 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Rajeev S. Mathur (Sun) on August 3, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 306 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Samir Shah (Sun) on August 13, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 23, 2020 | 307 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sudeep Agrawal (Sun) on August 20, 2020 filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 22, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed certain parties' joint motion to resolve a discovery dispute, (D.I. 268), and the briefing related thereto, (D.I. 270; D.I. 273), hereby ADOPTS Plaintiffs' proposal (which was joined at least in part by Defendants DRL, IMS and Sun) to modify the remaining case schedule while keeping the current pre-trial conference and trial dates unchanged, (see D.I. 273 at 2). Defendants Apotex and Accord argue that it is "unrealistic" that fact discovery can be completed by September 3, 2020 (the fact discovery cut-off set out in Plaintiffs' proposal), (id. at 1); while that might turn out to be so, it is not currently clear to the Court that such a deadline is unrealistic. If events transpire such that this new schedule becomes unworkable, then any party may later move for the schedule to be altered. In the interval, the current trial date should stand. Today's 3:00 p.m. teleconference is hereby CANCELLED. Ordered by Judge Christopher J. Burke on 6/22/2020. (dlb) |
| Jun 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-00347-CFC) Stipulation to Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 20-347-CFC and C.A. No. 18-1675-CFC are consolidated for all purposes; All filings shall be made in C.A. No. 18-1675-CFC; Ordered by Judge Colm F. Connolly on 6/18/2020. Associated Cases: 1:20-cv-00347-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Jun 18, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' June 16, 2020 letter requesting a discovery teleconference regarding a discovery dispute between Plaintiffs and the Sun Defendants. (D.I. 272) It hereby ORDERS as follows with regard to this dispute: (1) A discovery dispute teleconference is set for June 29, 2020, at 2:00 p.m. before Judge Christopher J. Burke.; (2) By no later than June 22, 2020, Plaintiffs shall file an opening letter brief, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining their views as to the issue.; (3) By no later than June 25, 2020, Sun Defendants may file an answering letter brief, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining their views as the issue.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than June 25, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) It is possible that the Court may choose to resolve the dispute prior to the telephone conference. Ordered by Judge Christopher J. Burke on 6/18/2020. (dlb) |
| Jun 16, 2020 | 271 | Redacted Document (5) Docket Text: REDACTED VERSION of [270] Letter to Honorable Christoper J. Burke by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 16, 2020 | 272 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding request for discovery teleconference re Sun Defendants. (Oakes, Robert) |
| Jun 16, 2020 | 273 | Letter (3) Docket Text: Letter to The Honorable Christopher J. Burke from John C. Phillips, Jr. regarding Defendants Apotex and Accord's response to Plaintiffs' letter dated June 9, 2020 - re [270] Letter. (Phillips, John) |
| Jun 5, 2020 | 268 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. Motions referred to Christopher J. Burke.(Phillips, John) |
| Jun 5, 2020 | 269 | Memorandum and Order (3) Docket Text: MEMORANDUM ORDER OVERRULING [244] Objections, filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 6/5/2020. (nmf) |
| Jun 2, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' June 1, 2020 letter requesting a discovery teleconference regarding each side's respective discovery dispute. (D.I. 266) It hereby ORDERS as follows with regard to these disputes: (1) A discovery dispute teleconference is set for June 22, 2020, at 03:00 p.m. before Judge Christopher J. Burke.; (2) By no later than June 9, 2020, Plaintiffs and Defendants DRI, IMS and Sun shall file an opening letter brief, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining their views as to their proposed amended case schedule.; (3) By no later than June 16, 2020, Defendants Accord and Apotex may file an answering letter brief, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining their views as to their proposed amended case schedule.; (4) The parties shall jointly file a Motion For Teleconference To Resolve Discovery Dispute.; (5) By no later than June 16, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 6/2/2020. (dlb) |
| Jun 1, 2020 | 266 | Letter (3) Docket Text: Letter to The Honorable Christopher J. Burke from John C. Phillips, Jr. regarding requesting a discovery dispuite teleconference. (Phillips, John) |
| May 28, 2020 | 265 | Redacted Document (18) Docket Text: REDACTED VERSION of [230] Transcript by Dr. Reddy's Inc. and Dr. Reddy's Ltd. (Phillips, John) Modified on 6/4/2020 (dlb). |
| May 21, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having considered certain parties' Joint Motion to Seal and Redact Public Filings, (D.I. 239), (the "Motion"), and in light of the rationale set out in the Court's prior April 24, 2020 Order, (D.I. 241), hereby GRANTS-IN-PART the Motion as it relates to the transcript of the April 6, 2020 discovery hearing, (D.I. 230), for the reasons that follow. (See D.I. 239 at 2-3, id. exs. 1-2). As for the proposed redacted material relating to the purportedly non-public content of Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.'s (DRL) ANDA/ANDA product, or information related thereto, (7:12-18, 7:22-23, 8:11-13, 8:20-22, 10:10-12, 12:8-17, 12:23-13:8, 24:22-25:8, 26:14-28:21, 36:2-23, 37:2-3, 39:17-19, 40:5-41:23, 54:14), the Court will GRANT the Motion. As to all other proposed redactions, the Court will DENY the Motion for the reasons that follow: (a) As to certain actions taken by Plaintiffs (8:25-9:5, 9:10-20, 46:15-19), the Court does not see (and Plaintiffs do not adequately explain) why disclosure of that material would harm Plaintiffs.; (b) With regard to agreements between parties, (14:21-25, 35:7), no good reason for redaction has been provided.; (c) As for the proposed redacted content solely relating to information about DRL's API supplier and the locations where the API and finished dosage form are manufactured, (21:16-25, 22:5-7, 22:9-10, 22:21-23:9, 24:8-9, 24:14, 28:22-29:21, 30:2-6, 30:12-13, 30:20-23, 31:6-7, 31:14-15, 31:17-18, 31:23, 32:15, 32:20-24, 33:21, 37:7-12, 38:20-21, 39:1, 42:1-16, 43:3-6, 44:10-11, 45:15-16, 46:5-14), for reasons set out in the April 24 Order, DRL has not adequately explained why the material would cause serious harm to it if disclosed. The parties are FURTHER ORDERED to submit to the Court a version of the transcript with the redactions that the Court will allow by May 28, 2020.. Ordered by Judge Christopher J. Burke on 5/21/2020. (dlb) |
| May 21, 2020 | 264 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses (5/21/20) to Plaintiffs' Amended First Set of Common Interrogatories filed by Apotex Inc..(Haney, Megan) |
| May 20, 2020 | 257 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Accord's Objections and Responses to Plaintiffs' 30(b)(6) Deposition Notice filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| May 20, 2020 | 258 | Main Document (18) Docket Text: REDACTED VERSION of [254] Response to Objections, by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Ex. A, # (2) Ex. C, # (3) Ex. D, # (4) Ex. E, # (5) Ex. F, # (6) Ex. G, # (7) Ex. S, # (8) Ex. T, # (9) Ex. U, # (10) Ex. V, # (11) Ex. W, # (12) Ex. X)(Oakes, Robert) |
| May 20, 2020 | 258 | Ex. A (17) |
| May 20, 2020 | 258 | Ex. C (43) |
| May 20, 2020 | 258 | Ex. D (15) |
| May 20, 2020 | 258 | Ex. E (2) |
| May 20, 2020 | 258 | Ex. F (2) |
| May 20, 2020 | 258 | Ex. G (2) |
| May 20, 2020 | 258 | Ex. S (7) |
| May 20, 2020 | 258 | Ex. T (32) |
| May 20, 2020 | 258 | Ex. U (80) |
| May 20, 2020 | 258 | Ex. V (2) |
| May 20, 2020 | 258 | Ex. W (2) |
| May 20, 2020 | 258 | Ex. X (22) |
| May 20, 2020 | 259 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharmaceutical Industries Ltd. and Sun Pharma Global FZE's Responses and Objections to Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| May 20, 2020 | 260 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of IMS's Objections and Responses to Plaintiffs' Notice of the Deposition of International Medication Systems, Ltd. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| May 20, 2020 | 261 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to 30(b)(6) Deposition Topics filed by Apotex Inc..(Haney, Megan) |
| May 20, 2020 | 262 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DRL's Response to Notice of Rule 30(b)(6) Deposition filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| May 18, 2020 | 256 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant IMS's Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,106,183 B2, 8,524,883 B2, and RE 47,301 E filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| May 14, 2020 | 255 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Defendant International Medication Systems Objections and Responses to Plaintiffs Second Amended First Set of Common Interrogatories(Nos. 1-11) and 2. Defendant International Medication Systems Objections and Responses to Plaintiffs Second Amended First Set and Amended Second Set of Common Requests for Production of Documents and Things filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| May 7, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [253] STIPULATION TO EXTEND TIME for IMS to serve its initial invalidity contentions and related production of invalidity references to May 15, 2020 filed by International Medication Systems, Limited, [252] STIPULATION Regarding 30(b)(6) Responses by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. Signed by Judge Colm F. Connolly on 5/7/2020. (nmf) |
| May 7, 2020 | 253 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for IMS to serve its initial invalidity contentions and related production of invalidity references to May 15, 2020 - filed by International Medication Systems, Limited. (Hoeschen, Nathan) |
| May 6, 2020 | 252 | Stipulation (4) Docket Text: STIPULATION Regarding 30(b)(6) Responses by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Haney, Megan) |
| May 5, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Defendant Apotex Inc.'s discovery dispute-related motion, (D.I. 249), and noting it does not comply with the Court's procedures regarding the resolution of discovery disputes, (see D.I. 188), hereby ORDERS that the motion be STRICKEN. The parties shall follow the Court's procedures as to this dispute going forward. Ordered by Judge Christopher J. Burke on 5/5/2020. (dlb) |
| May 4, 2020 | N/A | Motions Referred (0) Docket Text: MOTION REFERRED: [249] MOTION for Extension of Time to for Apotex Inc. to substantially complete document production to June 12, 2020 Motion referred to Magistrate Judge Christopher J. Burke per the referral order in this case.(nmf) |
| May 4, 2020 | 248 | Main Document (19) Docket Text: REDACTED VERSION of [244] Objections, by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Proposed Order, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 4, # (5) Exhibit 6, # (6) Exhibit 10, # (7) Exhibit 11, # (8) Exhibit 12, # (9) Exhibit 13, # (10) Exhibit 14, # (11) Exhibit 15, # (12) Exhibit 17, # (13) Exhibit 18)(Haney, Megan) |
| May 4, 2020 | 248 | Proposed Order (2) |
| May 4, 2020 | 248 | Exhibit 1 (1) |
| May 4, 2020 | 248 | Exhibit 2 (10) |
| May 4, 2020 | 248 | Exhibit 4 (7) |
| May 4, 2020 | 248 | Exhibit 6 (5) |
| May 4, 2020 | 248 | Exhibit 10 (1) |
| May 4, 2020 | 248 | Exhibit 11 (1) |
| May 4, 2020 | 248 | Exhibit 12 (1) |
| May 4, 2020 | 248 | Exhibit 13 (6) |
| May 4, 2020 | 248 | Exhibit 14 (1) |
| May 4, 2020 | 248 | Exhibit 15 (1) |
| May 4, 2020 | 248 | Exhibit 17 (10) |
| May 4, 2020 | 248 | Exhibit 18 (8) |
| May 4, 2020 | 249 | Main Document (3) Docket Text: MOTION for Extension of Time to for Apotex Inc. to substantially complete document production to June 12, 2020 - filed by Apotex Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Certificate of Compliance, # (3) Rule 7.1.1 Statement)(Haney, Megan) |
| May 4, 2020 | 249 | Text of Proposed Order (1) |
| May 4, 2020 | 249 | Certificate of Compliance (2) |
| May 4, 2020 | 249 | Rule 7.1.1 Statement (2) |
| May 4, 2020 | 250 | Notice (Other) (2) Docket Text: NOTICE of Joinder to Apotex Inc.'s Motion to Extend Time by Accord Healthcare, Inc. re [249] MOTION for Extension of Time to for Apotex Inc. to substantially complete document production to June 12, 2020 (Dorsney, Kenneth) |
| Apr 30, 2020 | 245 | Proposed Order (5) Docket Text: PROPOSED ORDER re [241] Oral Order,,,,,,, by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Phillips, John) |
| Apr 30, 2020 | 246 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Megan C. Haney regarding courtesy copies. (Haney, Megan) |
| Apr 30, 2020 | 247 | Redacted Document (5) Docket Text: REDACTED VERSION of D.I. [236] [SEALED] Memorandum Order on Motion for Discovery. (dlb) |
| Apr 29, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Plaintiffs shall have 14 days from this date to file a response to Defendant Dr. Reddy's Laboratories' objections to the Magistrate Judge's Order (D.I. [244]). Ordered by Judge Colm F. Connolly on 4/29/2020. (nmf) |
| Apr 24, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having considered certain parties' Joint Motion to Seal and Redact Public Filings, (D.I. 239), (the "Motion"), hereby GRANTS-IN-PART the Motion as it relates to Court's Memorandum Order of April 13, 2020, (D.I. 236), for the reasons that follow. (See D.I. 239 at 3, id. exs. 3-4). As for the proposed redacted material relating to the contents of Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddys Laboratories Inc.'s ("DRL") ANDA product, found on page 2 (lines 4 and 5) of the Memorandum Order, the Court will GRANT the Motion to redact only as to the two words after "contains." Even that material will not likely be redacted in dispositive filings, but for now, as it relates to the content of the product itself, which the Court understands is not publicly known, the Court will allow the redactions. The proposed redaction in line 16 on page 2 is DENIED, as it is to a Bates number. As for the remaining proposed redacted content on page 2 (lines 18-22) and the content on page 3 (lines 1-3), which relates to information about DRL's API supplier and the locations where the API and finished dosage form are manufactured, while DRL asserts that this material, if disclosed, "could be used by DRL's competitors to injure DRL's competitive standing in the marketplace[,]" (D.I. 239 at 3), DRL does not explain why this is so. And absent such an explanation, the Court does not see why this is so. Thus, the Motion is DENIED as to this material. The parties are FURTHER ORDERED to submit to the Court a version of Memorandum Order with the redactions that the Court will allow by April 30, 2020. The Court will resolve the portion of the Motion concerning the transcript of an April 6 teleconference, (D.I. 230), in a subsequent Order.Ordered by Judge Christopher J. Burke on 4/23/2020. (dlb) |
| Apr 24, 2020 | 242 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Subpoena for Production of Documents and Things to Euticals, Inc. (IMS) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 24, 2020 | 243 | Main Document (4) Docket Text: REDACTED VERSION of [239] Joint MOTION to Seal and Redact Public Filings by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Proposed Order)(Phillips, John) |
| Apr 24, 2020 | 243 | Exhibit 1 (1) |
| Apr 24, 2020 | 243 | Exhibit 2 (19) |
| Apr 24, 2020 | 243 | Exhibit 3 (1) |
| Apr 24, 2020 | 243 | Exhibit 4 (6) |
| Apr 24, 2020 | 243 | Proposed Order (2) |
| Apr 20, 2020 | 240 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Confidential Plaintiffs' Objections and Responses to Defendants First Set of Common Request for Production and Interrogatories served on IMS filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 17, 2020 | 237 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Supplemental Objections and Responses to Dr. Reddys First Set of Requests for Production filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 17, 2020 | 238 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Dr. Reddy's Objections and Responses to Plaintiffs' Second Set of Individual Requests for Production of Documents and Things; and (2) Dr. Reddy's Objections and Responses (4/17/20) to Plaintiffs' First Individual Requests for Production of Documents and Things filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Apr 10, 2020 | 231 | Main Document (3) Docket Text: REDACTED VERSION of [218] Letter, by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Text of Proposed Order)(Phillips, John) |
| Apr 10, 2020 | 231 | Exhibit 1 (1) |
| Apr 10, 2020 | 231 | Exhibit 2 (10) |
| Apr 10, 2020 | 231 | Exhibit 3 (22) |
| Apr 10, 2020 | 231 | Exhibit 4 (7) |
| Apr 10, 2020 | 231 | Exhibit 5 (8) |
| Apr 10, 2020 | 231 | Exhibit 6 (5) |
| Apr 10, 2020 | 231 | Exhibit 7 (6) |
| Apr 10, 2020 | 231 | Exhibit 8 (11) |
| Apr 10, 2020 | 231 | Exhibit 9 (5) |
| Apr 10, 2020 | 231 | Text of Proposed Order (1) |
| Apr 10, 2020 | 232 | Main Document (4) Docket Text: REDACTED VERSION of [223] Letter, by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16)(Phillips, John) |
| Apr 10, 2020 | 232 | Exhibit 10 (1) |
| Apr 10, 2020 | 232 | Exhibit 11 (1) |
| Apr 10, 2020 | 232 | Exhibit 12 (1) |
| Apr 10, 2020 | 232 | Exhibit 13 (6) |
| Apr 10, 2020 | 232 | Exhibit 14 (1) |
| Apr 10, 2020 | 232 | Exhibit 15 (1) |
| Apr 10, 2020 | 232 | Exhibit 16 (5) |
| Apr 10, 2020 | 233 | Main Document (6) Docket Text: REDACTED VERSION of [219] Letter, to Judge Burke fr Oakes re DRL discovery dispute by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-O)(Oakes, Robert) |
| Apr 10, 2020 | 233 | Text of Proposed Order (1) |
| Apr 10, 2020 | 233 | Exhibit A-O (201) |
| Apr 10, 2020 | 234 | Main Document (5) Docket Text: REDACTED VERSION of [224] Letter to Judge Burke from Oakes responsive DRL discovery letter by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit P, # (2) Exhibit Q, # (3) Exhibit R, # (4) Exhibit S, # (5) Exhibit T)(Oakes, Robert) |
| Apr 10, 2020 | 234 | Exhibit P (18) |
| Apr 10, 2020 | 234 | Exhibit Q (2) |
| Apr 10, 2020 | 234 | Exhibit R (2) |
| Apr 10, 2020 | 234 | Exhibit S (7) |
| Apr 10, 2020 | 234 | Exhibit T (32) |
| Apr 10, 2020 | 235 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of CONFIDENTIAL Plaintiffs Preliminary Infringement Contentions Directed to IMS filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Oakes, Robert) |
| Apr 7, 2020 | 229 | Main Document (2) Docket Text: NOTICE of of Lodging by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. (Attachments: # (1) Plaintiffs' Slides, # (2) Apotex and DRL's Slides)(Haney, Megan) |
| Apr 7, 2020 | 229 | Plaintiffs' Slides (69) |
| Apr 7, 2020 | 229 | Apotex and DRL's Slides (88) |
| Apr 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [222] STIPULATION TO EXTEND TIME to file redacted copies of the March 27, 2020 letters and exhibits filed under seal to April 10, 2020 filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd.. Signed by Judge Christopher J. Burke on 4/6/2020. (dlb) |
| Apr 6, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Hearing held on April 6, 2020. The Court heard the parties' arguments regarding the parties respective discovery disputes, (D.I. 217). The Court took matters under advisement. (Clerk: Schwerin) APPEARANCES: R. Oakes, A. Major, and B. Amadi for Plaintiffs; J. Phillips, J. Jaros, C. Galligan for Defendant Dr. Reddys Labs. Court Reporter Val Gunning. (dlb) |
| Apr 6, 2020 | 225 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) CONFIDENTIAL Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) Directed to Defendant Apotex, Inc.; (2) CONFIDENTIAL Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) Directed to Defendant Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.; (3) Plaintiffs' Notice of Deposition to Kiran Krishnan (Apotex); (4) Plaintiffs' Notice of Deposition to Jaya Lakshmi Ayyagari (DRL); (5) Plaintiffs' Notice of Deposition to Sumitra Ashok Pillai (DRL) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 6, 2020 | 226 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) CONFIDENTIAL Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) Directed to Defendant Accord Healthcare, Inc.; (2) Plaintiffs Notice of Deposition to Alpesh Pathak (Accord); (3) Plaintiffs Notice of Deposition to Sabita Nair (Accord) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 6, 2020 | 227 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of CONFIDENTIAL Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) Directed to Defendant International Medication Systems, Ltd. filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 6, 2020 | 228 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of CONFIDENTIAL Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) Directed to Defendant Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 2, 2020 | 222 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file redacted copies of the March 27, 2020 letters and exhibits filed under seal to April 10, 2020 - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Haney, Megan) |
| Apr 1, 2020 | 221 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Second Set of Common Requests for Production of Documents and Things (No. 31); Plaintiffs' Second Amended First Set of Common Requests for Production of Documents and Things (Nos. 1-30); Plaintiffs Second Amended First Set Of Common Interrogatories (Nos. 1-11) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 31, 2020 | 220 | Redacted Document (3) Docket Text: REDACTED VERSION of [211] Stipulation regarding Dr. Reddy's Product Samples by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-00273-CFC) Stipulation To Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 20-00273-CFC and C.A. No. 18-1675-CFC are consolidated for all purposes; All future filings shall be made in C.A. No. 18-1675-CFC. ( See stipulation for further details and deadlines). Ordered by Judge Colm F. Connolly on 3/30/2020. Associated Cases: 1:20-cv-00273-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Mar 25, 2020 | 217 | Motion for Discovery (2) Docket Text: Joint MOTION for Discovery Teleconference to Resolve Discovery Dispute - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. Motions referred to Christopher J. Burke.(Oakes, Robert) |
| Mar 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [216] SEALED Stipulation of Dismissal filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Party Wockhardt USA LLC, Wockhardt Bio AG terminated. Signed by Judge Colm F. Connolly on 3/23/2020. (fms) |
| Mar 20, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has reviewed the parties' March 17, 2020 letter requesting a discovery teleconference regarding various discovery disputes. (D.I.[212]) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order, (D.I. 45), will be modified as follows with regard to these disputes: (1) A discovery dispute teleconference is set for 4/6/2020 at 02:00 PM before Judge Christopher J. Burke.; (2) By no later than March 27, 2020, Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc. ("DRL") shall file with the Court a letter, not to exceed two (2) pages, in no less than 12-point font, outlining the issues as to the 1 dispute they are raising and their position on those issues, (D.I. 212 at 1).; (3) By no later than March 27, 2020, Plaintiffs shall file with the Court a letter, not to exceed three (3) pages, in no less than 12-point font, outlining the issues as to the 2 disputes they are raising and their position on those issues, (id.).; (4) By no later than April 3, 2020, Plaintiffs may file an answering letter brief, not to exceed two (2) pages, in no less than 12-point font, outlining their reasons for their opposition to DRL's opening letter brief.; (5) By no later than April 3, 2020, DRL may file an answering letter brief, not to exceed three (3) pages, in no less than 12-point font, outlining their reasons for their opposition to Plaintiffs' opening letter brief.; (6) It is possible that the Court may choose to resolve some or all of these disputes prior to the telephone conference. Ordered by Judge Christopher J. Burke on 3/20/2020. (mlc) |
| Mar 20, 2020 | 215 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Third Supplemental Response to Plaintiffs' First Set of Common Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Mar 18, 2020 | 213 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Individual Requests for Production of Documents and Things to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (No. 3) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 17, 2020 | 212 | Letter (1) Docket Text: Letter to Honorable Christopher J. Burke from Robert M. Oakes regarding requesting discovery teleconference. (Oakes, Robert) |
| Mar 16, 2020 | 210 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's Second Supplemental Response to Plaintiffs' First Set of Common Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Mar 13, 2020 | 209 | Order (3) Docket Text: CLAIM CONSTRUCTION ORDER. Signed by Judge Colm F. Connolly on 3/13/2020. (fms) |
| Mar 12, 2020 | 208 | Proposed Order (3) Docket Text: PROPOSED ORDER Claim Construction Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 9, 2020 | 207 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses (3/9/20) to Plaintiffs' First Set of Common Requests for Production of Documents and Things filed by Apotex Inc..(Haney, Megan) |
| Mar 6, 2020 | 202 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responses to Second Set of Common Requests for Production filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Mar 6, 2020 | 203 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiff's First Set of Common Requests for Production of Documents and Things filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Mar 6, 2020 | 204 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to Plaintiffs' Second Set of Common Requests for Production of Documents and Things filed by Apotex Inc..(Haney, Megan) |
| Mar 6, 2020 | 205 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Laboratories Ltd.'s and Dr. Reddy's Laboratories Inc.'s Objections and Responses to Plaintiffs' Second Set of Common Requests for Production of Documents and Things filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Mar 6, 2020 | 206 | Redacted Document (3) Docket Text: REDACTED VERSION of [195] Stipulation by Gilead Sciences, Inc.. (Gupta Fiorella, Nitika) |
| Mar 5, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 3/5/2020. (Court Reporter V. Gunning.) (nmf) |
| Mar 4, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [200] MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz filed by Accord Healthcare, Inc. Signed by Judge Colm F. Connolly on 3/4/2020. (nmf) |
| Mar 4, 2020 | 200 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by Accord Healthcare, Inc.. (Dorsney, Kenneth) |
| Mar 4, 2020 | 201 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Objections and Responses to Dr. Reddy's First Set of Interrogatories (CONFIDENTIAL) filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 3, 2020 | 198 | ANDA Form (1) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: see attached as to CA 19-1199. Date of Expiration of Patent: 2/2/2027.Thirty Month Stay Deadline: 11/12/2021. (Oakes, Robert) |
| Mar 3, 2020 | 199 | Letter (1) Docket Text: Letter to Honorable Colm F. Connolly from Robert M. Oakes regarding new actions. (Oakes, Robert) |
| Mar 2, 2020 | 196 | SO ORDERED (3) Docket Text: SO ORDERED, re [194] STIPULATION TO EXTEND TIME document production, fact discovery, contentions, expert reports to various filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 3/2/2020. (fms) |
| Mar 2, 2020 | 197 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of CONFIDENTIAL Plaintiff's Objections and Responses to Dr. Reddy's First Set of Interrogatories filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Feb 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [192] MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp, Esquire filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. Signed by Judge Colm F. Connolly on 2/28/2020. (fms) |
| Feb 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David M. Knapp for Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 28, 2020 | 194 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME document production, fact discovery, contentions, expert reports to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 27, 2020 | 192 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp, Esquire - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,. (Vrana, Robert) |
| Feb 27, 2020 | 193 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Wockhardt Second Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to Wockhardt (Nos. 1-11) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Moore, David) |
| Feb 25, 2020 | 190 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Twelve (12) Samples of Wockhardt's Regadenoson Solution, 0.4mg/5ml filed by Wockhardt Bio AG, Wockhardt USA LLC.(Moore, David) |
| Feb 25, 2020 | 191 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Objections and Responses (2/25/20) to Plaintiffs' Amended First Set of Common Requests for Production of Documents and Things filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Feb 18, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the case history in light of the February 14, 2020 referral, (D.I. 186), hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order, (D.I. 45 at para. 7), will be modified as follows: Should counsel find, after good faith efforts (including verbal communication among Delaware and Lead Counsel for all parties to the dispute) that they are unable to resolve a discovery matter, the parties involved in the discovery matter dispute shall submit a joint letter with the text set out in the Courts standard Rule 16 Scheduling Order for Patent cases, which can be found in the "Forms" tab of Magistrate Judge Burke's page on the District Court's website. The moving party (i.e., the party seeking relief from the Court) should also file a "Motion For Teleconference To Resolve Discovery Dispute." The suggested text for this motion can be found in the same Forms tab, under the heading "Discovery Matters -- Motion to Resolve Discovery Dispute." The Court will thereafter set a discovery dispute telephone conference. To the extent the parties here currently have an unresolved discovery dispute, they may utilize these procedures to bring the dispute before the Court in the future. Ordered by Judge Christopher J. Burke on 2/17/2020. (dlb) |
| Feb 14, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amanda L. Major for Astellas Pharma US, Inc. and Astellas US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Feb 14, 2020 | 186 | Order Referring Case to Magistrate Judge (1) Docket Text: ORDER REFERRING CASE to Magistrate Judge Christopher J. Burke for all disputes relating to discovery and the protective order. The March 12, 2020 Discovery Conference before Judge Connolly is cancelled. Signed by Judge Colm F. Connolly on 2/14/2020. (nmf) |
| Feb 13, 2020 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 3/12/2020 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Feb 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [185] MOTION for Pro Hac Vice Appearance of Attorney Emily R. Whelan filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 2/12/2020. (fms) |
| Feb 12, 2020 | 185 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Emily R. Whelan - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 7, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of D.I. [182] Joint Claim Construction Brief has been replaced with a corrected version per request of filer as there were a few cites omitted from the Table of Authorities of the original filing. (nmf) |
| Feb 5, 2020 | 181 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Common Requests for Production of Documents and Things filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Feb 5, 2020 | 182 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc.. (Oakes, Robert) (Main Document 182 replaced on 2/7/2020) (nmf, ). |
| Feb 5, 2020 | 183 | Main Document (15) Docket Text: APPENDIX re [182] Joint Claim Construction Brief by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Appendix XX, # (2) Appendix YY, # (3) Appendix ZZ, # (4) Appendix AAA, # (5) Appendix BBB, # (6) Appendix CCC, # (7) Appendix DDD, # (8) Appendix EEE, # (9) Appendix FFF, # (10) Appendix GGG, # (11) Appendix HHH, # (12) Appendix III, # (13) Appendix JJJ, # (14) Appendix KKK, # (15) Appendix LLL, # (16) Appendix MMM, # (17) Appendix NNN, # (18) Appendix OOO, # (19) Appendix PPP, # (20) Appendix QQQ, # (21) Appendix RRR, # (22) Appendix SSS, # (23) Appendix TTT, # (24) Appendix UUU, # (25) Appendix VVV, # (26) Appendix WWW, # (27) Appendix XXX, # (28) Appendix YYY, # (29) Appendix ZZZ)(Oakes, Robert) |
| Feb 5, 2020 | 183 | Appendix XX (10) |
| Feb 5, 2020 | 183 | Appendix YY (2) |
| Feb 5, 2020 | 183 | Appendix ZZ (13) |
| Feb 5, 2020 | 183 | Appendix AAA (35) |
| Feb 5, 2020 | 183 | Appendix BBB (31) |
| Feb 5, 2020 | 183 | Appendix CCC (25) |
| Feb 5, 2020 | 183 | Appendix DDD (7) |
| Feb 5, 2020 | 183 | Appendix EEE (29) |
| Feb 5, 2020 | 183 | Appendix FFF (37) |
| Feb 5, 2020 | 183 | Appendix GGG (12) |
| Feb 5, 2020 | 183 | Appendix HHH (11) |
| Feb 5, 2020 | 183 | Appendix III (5) |
| Feb 5, 2020 | 183 | Appendix JJJ (5) |
| Feb 5, 2020 | 183 | Appendix KKK (6) |
| Feb 5, 2020 | 183 | Appendix LLL (15) |
| Feb 5, 2020 | 183 | Appendix MMM (44) |
| Feb 5, 2020 | 183 | Appendix NNN (5) |
| Feb 5, 2020 | 183 | Appendix OOO (20) |
| Feb 5, 2020 | 183 | Appendix PPP (15) |
| Feb 5, 2020 | 183 | Appendix QQQ (7) |
| Feb 5, 2020 | 183 | Appendix RRR (10) |
| Feb 5, 2020 | 183 | Appendix SSS (6) |
| Feb 5, 2020 | 183 | Appendix TTT (3) |
| Feb 5, 2020 | 183 | Appendix UUU (14) |
| Feb 5, 2020 | 183 | Appendix VVV (18) |
| Feb 5, 2020 | 183 | Appendix WWW (14) |
| Feb 5, 2020 | 183 | Appendix XXX (7) |
| Feb 5, 2020 | 183 | Appendix YYY (17) |
| Feb 5, 2020 | 183 | Appendix ZZZ (17) |
| Feb 5, 2020 | 184 | Declaration (30) Docket Text: DECLARATION re [182] Joint Claim Construction Brief Claim Construction Declaration of Robin D. Rogers Ph.D In Support of Defendants' Answering Claim Construction Brief by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jan 31, 2020 | 179 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Joint Answering Claim Construction Brief, Joint Sur-Reply Claim Construction Brief and Appendices to Joint Sur-Reply Claim Construction Brief filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Jan 31, 2020 | 180 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's First Set of Interrogatories filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Jan 30, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Claim Construction Sur-Reply Brief and Appendix at D.I. Nos. [179] and [180] have been removed from the docket as they are to be served and not filed. (fms) |
| Jan 24, 2020 | 177 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Sun Pharma Global FZE and Sun Pharmaceutical First Set of Interrogatories and First Set of Requests for Production filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jan 24, 2020 | 178 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Common Interrogatories and First set of Common Requests for Production of Document and Things filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jan 21, 2020 | 176 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's First Supplemental Response to Plaintiffs' First Set of Common Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Jan 17, 2020 | 175 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Wockhardt's Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to Wockhardt (Nos. 1-11) filed by Wockhardt Bio AG, Wockhardt USA LLC.(O'Byrne, Stephanie) |
| Jan 9, 2020 | 173 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Limiteds Answering Claim Construction Brief filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Jan 9, 2020 | 174 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by David Ellis Moore on behalf of Wockhardt Bio AG, Wockhardt USA LLC (Moore, David) |
| Jan 8, 2020 | 172 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Answering Claim Construction Brief filed by Apotex Inc..(Phillips, John) |
| Dec 17, 2019 | 171 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Sun Pharma Global FZE and Sun Pharmaceutical Industries Limiteds First Set of Requests for Production of Documents and Things and 2) Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited's First Set of Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Dec 16, 2019 | 170 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Common Requests for Production of Documents and Things and 2) Defendants' First Set of Common Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Poff, Adam) |
| Dec 9, 2019 | 169 | Redacted Document (2) Docket Text: REDACTED VERSION of [167] Stipulation by Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 22, 2019 | 166 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Nov 8, 2019 | 165 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's First Set of Requests for Production filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Oct 31, 2019 | 164 | Motion for Miscellaneous Relief (1) Docket Text: MOTION for Claim Construction re [158] Claim Construction Chart,,,,,,,, - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Palapura, Bindu) |
| Oct 30, 2019 | 161 | SO ORDERED (2) Docket Text: SO ORDERED, re [160] Stipulation and Order Regarding Chemical Name filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 10/30/2019. (fms) |
| Oct 30, 2019 | 162 | Motion for Miscellaneous Relief (1) Docket Text: MOTION Claim Construction - filed by Accord Healthcare, Inc.. (Dorsney, Kenneth) |
| Oct 30, 2019 | 163 | Motion for Miscellaneous Relief (1) Docket Text: MOTION Motion for Claim Construction re [158] Claim Construction Chart,,,,,,,, - filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Phillips, John) |
| Oct 29, 2019 | 160 | Stipulation (2) Docket Text: STIPULATION re compound with chemical name regadenoson with Sun defendants by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 25, 2019 | 158 | Main Document (10) Docket Text: CLAIM Construction Chart by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Appendix A Disputed Terms and construction, # (2) Appendix B 301 Patent, # (3) Appendix C 183 Patent, # (4) Appendix D 883 Patent, # (5) Appendix E 301 Patent Prelim Amendment, # (6) Appendix F 301 Patent Second Prelim Amendment, # (7) Appendix G 301 Patent Amendment, # (8) Appendix H 183 Patent Application, # (9) Appendix I 183 Patent Second Prelim Amendment, # (10) Appendix J 183 Patent Amendment, # (11) Appendix K 883 Patent Application, # (12) Appendix L 883 Patent Prelim Amendment, # (13) Appendix M 883 Patent Amendment, # (14) Appendix N 883 Patent Amendment, # (15) Appendix O Patent 9,085,601, # (16) Appendix P Patent 6,403,567, # (17) Appendix Q Patent 7,671,192, # (18) Appendix R 601 Patent Application, # (19) Appendix S 601 Patent Prelim Amendment, # (20) Appendix T 601 Patent Amendment, # (21) Appendix U 601 Patent Office Action, # (22) Appendix V Patent Application 2,064,742, # (23) Appendix W EP Application 0 386 683, # (24) Appendix X WO 93_23401, # (25) Appendix Y WO 98_57651, # (26) Appendix Z WO 03_088978, # (27) Appendix AA Klotz article, # (28) Appendix BB Martin article, # (29) Appendix CC Matsuda Article, # (30) Appendix DD Riou Article, # (31) Appendix EE Guillory Article, # (32) Appendix FF Khankari Article, # (33) Appendix GG Hendel Article, # (34) Appendix HH Brittain Article, # (35) Appendix II 601 Patent Notice of Allowance, # (36) Appendix JJ 601 Patent Issue Notification, # (37) Appendix KK 301 Patent Reissue Declaration, # (38) Appendix LL Original 601 Patent, # (39) Appendix MM 301 Patent Non-Final Rejection, # (40) Appendix NN 301 Patent Interview Summary, # (41) Appendix OO 301 Patent Reissue Declaration, # (42) Appendix PP 301 Patent Notice of Allowance and Fee(s) Due, # (43) Appendix QQ 301 Patent Request for Continued Examination, # (44) Appendix RR 301 Patent Notice of Allowance, # (45) Appendix SS 301 Patent Issue Notification, # (46) Appendix TT Patent 7,732,595, # (47) Appendix UU Patent 7,956,179, # (48) Appendix VV Patent 8,268,988, # (49) Appendix WW 883 Patent Non-Final Rejection)(Oakes, Robert) |
| Oct 25, 2019 | 158 | Appendix A Disputed Terms and construction (34) |
| Oct 25, 2019 | 158 | Appendix B 301 Patent (25) |
| Oct 25, 2019 | 158 | Appendix C 183 Patent (24) |
| Oct 25, 2019 | 158 | Appendix D 883 Patent (22) |
| Oct 25, 2019 | 158 | Appendix E 301 Patent Prelim Amendment (7) |
| Oct 25, 2019 | 158 | Appendix F 301 Patent Second Prelim Amendment (8) |
| Oct 25, 2019 | 158 | Appendix G 301 Patent Amendment (8) |
| Oct 25, 2019 | 158 | Appendix H 183 Patent Application (63) |
| Oct 25, 2019 | 158 | Appendix I 183 Patent Second Prelim Amendment (10) |
| Oct 25, 2019 | 158 | Appendix J 183 Patent Amendment (6) |
| Oct 25, 2019 | 158 | Appendix K 883 Patent Application (51) |
| Oct 25, 2019 | 158 | Appendix L 883 Patent Prelim Amendment (7) |
| Oct 25, 2019 | 158 | Appendix M 883 Patent Amendment (18) |
| Oct 25, 2019 | 158 | Appendix N 883 Patent Amendment (6) |
| Oct 25, 2019 | 158 | Appendix O Patent 9,085,601 (20) |
| Oct 25, 2019 | 158 | Appendix P Patent 6,403,567 (24) |
| Oct 25, 2019 | 158 | Appendix Q Patent 7,671,192 (20) |
| Oct 25, 2019 | 158 | Appendix R 601 Patent Application (54) |
| Oct 25, 2019 | 158 | Appendix S 601 Patent Prelim Amendment (6) |
| Oct 25, 2019 | 158 | Appendix T 601 Patent Amendment (7) |
| Oct 25, 2019 | 158 | Appendix U 601 Patent Office Action (7) |
| Oct 25, 2019 | 158 | Appendix V Patent Application 2,064,742 (69) |
| Oct 25, 2019 | 158 | Appendix W EP Application 0 386 683 (7) |
| Oct 25, 2019 | 158 | Appendix X WO 93_23401 (38) |
| Oct 25, 2019 | 158 | Appendix Y WO 98_57651 (27) |
| Oct 25, 2019 | 158 | Appendix Z WO 03_088978 (55) |
| Oct 25, 2019 | 158 | Appendix AA Klotz article (10) |
| Oct 25, 2019 | 158 | Appendix BB Martin article (13) |
| Oct 25, 2019 | 158 | Appendix CC Matsuda Article (13) |
| Oct 25, 2019 | 158 | Appendix DD Riou Article (9) |
| Oct 25, 2019 | 158 | Appendix EE Guillory Article (47) |
| Oct 25, 2019 | 158 | Appendix FF Khankari Article (22) |
| Oct 25, 2019 | 158 | Appendix GG Hendel Article (8) |
| Oct 25, 2019 | 158 | Appendix HH Brittain Article (55) |
| Oct 25, 2019 | 158 | Appendix II 601 Patent Notice of Allowance (8) |
| Oct 25, 2019 | 158 | Appendix JJ 601 Patent Issue Notification (2) |
| Oct 25, 2019 | 158 | Appendix KK 301 Patent Reissue Declaration (8) |
| Oct 25, 2019 | 158 | Appendix LL Original 601 Patent (22) |
| Oct 25, 2019 | 158 | Appendix MM 301 Patent Non-Final Rejection (7) |
| Oct 25, 2019 | 158 | Appendix NN 301 Patent Interview Summary (5) |
| Oct 25, 2019 | 158 | Appendix OO 301 Patent Reissue Declaration (7) |
| Oct 25, 2019 | 158 | Appendix PP 301 Patent Notice of Allowance and Fee(s) Due (8) |
| Oct 25, 2019 | 158 | Appendix QQ 301 Patent Request for Continued Examination (4) |
| Oct 25, 2019 | 158 | Appendix RR 301 Patent Notice of Allowance (8) |
| Oct 25, 2019 | 158 | Appendix SS 301 Patent Issue Notification (2) |
| Oct 25, 2019 | 158 | Appendix TT Patent 7,732,595 (20) |
| Oct 25, 2019 | 158 | Appendix UU Patent 7,956,179 (24) |
| Oct 25, 2019 | 158 | Appendix VV Patent 8,268,988 (24) |
| Oct 25, 2019 | 158 | Appendix WW 883 Patent Non-Final Rejection (9) |
| Oct 25, 2019 | 159 | Motion for Miscellaneous Relief (3) Docket Text: MOTION Claim Construction - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 23, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notice of Subpoena previously filed at D.I. 157 has been deleted per request of filer. (nmf) |
| Oct 23, 2019 | 157 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of sample production filed by Wockhardt Bio AG, Wockhardt USA LLC.(Palapura, Bindu) |
| Oct 22, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [156] STIPULATION TO EXTEND TIME Joint Claim Construction Chart to October 25, 2019 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 10/22/2019. (fms) |
| Oct 21, 2019 | 155 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Objections and Responses (10/21/2019) to Plaintiffs' First Set of Individual Requests for Production of Documents and Things to Apotex; and (2) Apotex's Objections and Responses (10/21/2019) to Plaintiffs' Second Set of Individual Requests for Production of Documents and Things to Apotex filed by Apotex Inc..(Haney, Megan) |
| Oct 21, 2019 | 156 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Joint Claim Construction Chart to October 25, 2019 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 15, 2019 | 154 | Redacted Document (2) Docket Text: REDACTED VERSION of [148] Stipulation Regarding Product Samples by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Oct 11, 2019 | 151 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Apotex Inc.'s, Dr. Reddy's Laboratories Ltd.'s, and Dr. Reddy's Laboratories, Inc.'s Disclosure of Proposed Claim Constructions filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Oct 11, 2019 | 152 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE's Identification of Proposed Claim Constructions filed by Sun Pharma Global FZE.(Vrana, Robert) |
| Oct 11, 2019 | 153 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Identification of proposed claim constructions filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Oct 10, 2019 | 149 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Wockhardt's Disclosure of Proposed Claim Constructions filed by Wockhardt Bio AG, Wockhardt USA LLC.(Timlin, Tracey) |
| Oct 10, 2019 | 150 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Proposed Constructions for Terms Identified by Defendants as in Need of Construction filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Oct 3, 2019 | 147 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Wockhardt Defendants' Objections and Responses to Plaintiffs' First Set of Individual RFP of Documents and Things to Wockhardt (Confidential - Subject to Protective Order) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Palapura, Bindu) |
| Sep 26, 2019 | 146 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accord's Responses to Plaintiffs' Amended First Set of Interrogatories (Nos. 1-11); and (2) Accord's Responses to Plaintiffs' Amended First Set of Requests for Production (Nos. 1-30) filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Sep 23, 2019 | 145 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Proposed Claim Terms and Phrases filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Sep 20, 2019 | 139 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Identification of Terms/Phrases for Construction filed by Wockhardt Bio AG, Wockhardt USA LLC.(Palapura, Bindu) |
| Sep 20, 2019 | 140 | Redacted Document (15) Docket Text: REDACTED VERSION of [135] Answer to Counterclaim regarding Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Sep 20, 2019 | 141 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Accord's Proposed Claim Terms for Construction filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Sep 20, 2019 | 142 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Identification of Terms/Phrases for Construction filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 20, 2019 | 143 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiffs' First Set of Individual Requests for Production of Documents and Things filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 20, 2019 | 144 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc.'s, Dr. Reddy's Laboratories Ltd.'s, and Dr. Reddy's Laboratories, Inc.'s Initial List of Claim Terms or Phrases to be Construed filed by Apotex Inc., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 19, 2019 | 138 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiffs' Amended First Set of Common Interrogatories and (2) Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiffs' Amended First Set of Common Requests for Production of Documents and Things filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Sep 16, 2019 | 136 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,106,183 B2, 8,524, 883 B2, and RE 47, 301E filed by Apotex Inc..(Haney, Megan) |
| Sep 16, 2019 | 137 | Answer to Counterclaim (9) Docket Text: ANSWER to [106] Answer to Amended Complaint, Counterclaim as to Sun Pharmaceutical Industries Ltd. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 9, 2019 | 134 | SO ORDERED (5) Docket Text: SO ORDERED, re [128] Discovery Deposition Order. Signed by Judge Colm F. Connolly on 9/9/2019. (nmf) |
| Sep 6, 2019 | 133 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to Plaintiffs' Second Set of Individual Requests for Production of Documents and Things to Apotex filed by Apotex Inc..(Haney, Megan) |
| Sep 5, 2019 | 131 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions directed to Defendant Accord Healthcare, Inc. filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 5, 2019 | 132 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Preliminary Infringement Contentions directed to Defendants Dr. Reddys Laboratories, Ltd and Dr. Reddys Laboratories, Inc., filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 4, 2019 | 130 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Individual Requests for Production of Documents and Things to Wockhardt filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 30, 2019 | 129 | Main Document (37) Docket Text: REDACTED VERSION of [122] Answer to Complaint,, Counterclaim, by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Phillips, John) |
| Aug 30, 2019 | 129 | Exhibit 1 (22) |
| Aug 30, 2019 | 129 | Exhibit 2 (22) |
| Aug 30, 2019 | 129 | Exhibit 3 (20) |
| Aug 30, 2019 | 129 | Exhibit 4 (23) |
| Aug 30, 2019 | 129 | Exhibit 5 (53) |
| Aug 29, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [126] MOTION for Pro Hac Vice Appearance of Attorney Amanda Major filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 8/29/2019. (nmf) |
| Aug 29, 2019 | 128 | Proposed Order (5) Docket Text: PROPOSED ORDER Discovery Deposition Order (Addendum to Scheduling Order Paragraph 5(f) by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Gupta Fiorella, Nitika) |
| Aug 28, 2019 | 126 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amanda Major - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Gupta Fiorella, Nitika) |
| Aug 28, 2019 | 127 | Answer to Counterclaim (9) Docket Text: ANSWER to [124] Answer to Amended Complaint,, Counterclaim, of the Wockhardt defendants by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Gupta Fiorella, Nitika) |
| Aug 26, 2019 | 124 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [104] Amended Complaint [DEFENDANT SUN PHARMACEUTICAL INDUSTRIES LTD.'S ANSWER TO PLAINTIFFS' FIRST AMENDED COMPLAINT FOR PATENT INFRINGEMENT], COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by Sun Pharmaceutical Industries Ltd.,.(Vrana, Robert) |
| Aug 26, 2019 | 125 | Answer to Amended Complaint (26) Docket Text: ANSWER to Amended Complaint, re: [104] Amended Complaint [DEFENDANT SUN PHARMA GLOBAL FZE'S ANSWER TO PLAINTIFFS' FIRST AMENDED COMPLAINT FOR PATENT INFRINGEMENT] by Sun Pharma Global FZE.(Vrana, Robert) |
| Aug 22, 2019 | 121 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Nitika Gupta Fiorella on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Gupta Fiorella, Nitika) |
| Aug 22, 2019 | 123 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr Reddy's Laboratories Ltd for Dr. Reddy's Laboratories, Inc. filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Phillips, John) |
| Aug 21, 2019 | 116 | SO ORDERED (3) Docket Text: SO ORDERED, re [112] STIPULATION TO EXTEND TIME initial invalidity contentions, list of claim terms, proposed claim constructions, joint claim construction to various filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 8/21/2019. (fms) (fms). |
| Aug 21, 2019 | 117 | Order (3) Docket Text: SO ORDERED of D.I. 9 in C.A. 19-1160-CFC, STIPULATION and Order to Consolidate Action. C.A. No. 19-1160-CFC and C.A. No. 18-1675-CFC are consolidated for allpurposes;All filings shall be made in C.A. No. 18-1675-CFC; Signed by Judge Colm F. Connolly on 8/21/2019. (fms) |
| Aug 21, 2019 | 118 | SO ORDERED (3) Docket Text: SO ORDERED, re (12 in 1:19-cv-01199-CFC) Stipulation and Order to Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 19-1199-CFC and C.A. No. 18-1675-CFC are consolidated for allpurposes; All filings shall be made in C.A. No. 18-1675-CFC; Signed by Judge Colm F. Connolly on 8/21/2019. Associated Cases: 1:19-cv-01199-CFC, 1:18-cv-01675-CFC(fms) |
| Aug 21, 2019 | 119 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Dr. Reddy's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A)(1); (2) Dr. Reddy's Paragraph 3 Initial Disclosures; and (3) Dr. Reddy's Production of Core Technical Documents filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc..(Haney, Megan) |
| Aug 21, 2019 | 120 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Individual Requests for Production of Documents and Things to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 20, 2019 | 113 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended First Set of Common Interrogatories and Amended Common Requests for Production of Documents and Things filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 20, 2019 | 114 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses (August 20, 2019) to Plaintiffs' First Set of Individual Requests for Production of Documents and Things to Apotex filed by Apotex Inc..(Haney, Megan) |
| Aug 19, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tara M. Raghavan for Apotex Inc. and Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Aug 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [110] MOTION for Pro Hac Vice Appearance of Attorney Tara M. Raghavan filed by Sandoz Inc., Apotex Inc. Signed by Judge Colm F. Connolly on 8/16/2019. (fms) |
| Aug 15, 2019 | 110 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tara M. Raghavan - filed by Apotex Inc., Sandoz Inc.. (Haney, Megan) |
| Aug 15, 2019 | 111 | Redacted Document (5) Docket Text: REDACTED VERSION of [108] Stipulation by Sandoz Inc.. (Phillips, John) |
| Aug 15, 2019 | 112 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME initial invalidity contentions, list of claim terms, proposed claim constructions, joint claim construction to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 13, 2019 | 109 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amended Rule 26(a)(1) Initial Disclosures and Disclosures Pursuant to Paragraph 3 and 4(a) of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 7, 2019 | 106 | Answer to Amended Complaint (26) Docket Text: ANSWER to Amended Complaint, re: [88] Amended Complaint, , COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by Wockhardt Bio AG, Wockhardt USA LLC.(Palapura, Bindu) |
| Aug 7, 2019 | 107 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Individual Requests for Production of Documents and Things to Apotex filed by Astellas Pharma US, Inc., Gilead Sciences, Inc..(Oakes, Robert) |
| Aug 5, 2019 | 102 | Main Document (13) Docket Text: First AMENDED COMPLAINT against Sandoz Inc.- filed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Oakes, Robert) |
| Aug 5, 2019 | 102 | Exhibit A (22) |
| Aug 5, 2019 | 102 | Exhibit B (22) |
| Aug 5, 2019 | 102 | Exhibit C (20) |
| Aug 5, 2019 | 102 | Exhibit D (18) |
| Aug 5, 2019 | 103 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,133 ;US RE47301 E1 ;US 8,524,883 . (Oakes, Robert) |
| Aug 5, 2019 | 104 | Main Document (14) Docket Text: First AMENDED COMPLAINT against Sun Pharma Global FZE- filed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Oakes, Robert) |
| Aug 5, 2019 | 104 | Exhibit A (22) |
| Aug 5, 2019 | 104 | Exhibit B (22) |
| Aug 5, 2019 | 104 | Exhibit C (20) |
| Aug 5, 2019 | 104 | Exhibit D (18) |
| Aug 5, 2019 | 105 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE47301 E1 ;US 8,524,883 . (Oakes, Robert) |
| Aug 5, 2019 | 104 | Amended Complaint* (1) |
| Aug 5, 2019 | 102 | Amended Complaint* (1) |
| Aug 1, 2019 | 101 | Redacted Document (4) Docket Text: REDACTED VERSION of [96] Stipulation regarding Sandoz by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 30, 2019 | 99 | SO ORDERED (4) Docket Text: SO ORDERED, re [95] STIPULATION Plaintiffs' to Amend Complaints against Sun defendants filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Signed by Judge Colm F. Connolly on 7/29/2019. (nmf) |
| Jul 30, 2019 | 100 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Tracey Allen as co-counsel. Reason for request: no longer with firm. (Oakes, Robert) |
| Jul 29, 2019 | 95 | Stipulation (4) Docket Text: STIPULATION Plaintiffs' to Amend Complaints against Sun defendants and Propoed Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 29, 2019 | 97 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Sun Pharma Global FZE's Response to Plaintiffs' First Set of Common Interrogatories 2) Defendants' Objections and Responses to Plaintiff's First Set of Common Requests for Production of Documents and Things filed by Sun Pharma Global FZE.(Poff, Adam) |
| Jul 25, 2019 | 94 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Wockhardt's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-11) and Wockhardt's Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things filed by Wockhardt Bio AG, Wockhardt USA LLC.(Palapura, Bindu) |
| Jul 24, 2019 | 93 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Objections and Responses to Plaintiffs' First Set of Common Interrogatories; (2) Apotex's Objections and Responses to Plaintiffs' First Set of Common Requests for Production of Documents and Things; (3) Sandoz's Objections and Responses to Plaintiffs' First Set of Common Interrogatories; and (4) Sandoz's Objections and Responses to Plaintiffs' First Set of Common Requests for Production of Documents and Things filed by Apotex Inc., Sandoz Inc..(Phillips, John) |
| Jul 22, 2019 | 92 | Notice (Other) (4) Docket Text: NOTICE of [Change of Firm Affiliation] by Sun Pharma Global FZE (Vrana, Robert) |
| Jul 19, 2019 | 91 | Answer to Counterclaim (11) Docket Text: ANSWER to [81] Answer to Amended Complaint, Counterclaim Apotex Defendant Counterclaim by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 17, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [90] STIPULATION TO EXTEND TIME limitations on deposition discovery to August 29, 2019 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 7/17/2019. (fms) |
| Jul 17, 2019 | 88 | Main Document (14) Docket Text: First AMENDED COMPLAINT against Wockhardt Bio AG, Wockhardt USA LLC- filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Oakes, Robert) |
| Jul 17, 2019 | 88 | Exhibit A (22) |
| Jul 17, 2019 | 88 | Exhibit B (22) |
| Jul 17, 2019 | 88 | Exhibit C (20) |
| Jul 17, 2019 | 88 | Exhibit D (18) |
| Jul 17, 2019 | 89 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;RE47301 ;US 8,524,883 . (Oakes, Robert) |
| Jul 17, 2019 | 90 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME limitations on deposition discovery to August 29, 2019 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 17, 2019 | 88 | Amended Complaint* (1) |
| Jul 10, 2019 | 87 | SO ORDERED (4) Docket Text: SO ORDERED, re [85] STIPULATION for Plaintiffs to Amend Complaint against Wockhardt defendants. Signed by Judge Colm F. Connolly on 7/10/2019. (nmf) |
| Jul 8, 2019 | 85 | Stipulation (4) Docket Text: STIPULATION for Plaintiffs to Amend Complaint against Wockhardt defendants by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 8, 2019 | 86 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs Preliminary Infringement Contentions containing Sun Pharma confidential information; 2) Plaintiffs Preliminary Infringement Contentions containing Apotex confidential information; 3) Plaintiffs Preliminary Infringement Contentions containing Sandoz confidential information; 4) Plaintiffs Preliminary Infringement Contentions containing Wockhardt confidential information filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 5, 2019 | 84 | Redacted Document (29) Docket Text: REDACTED VERSION of [81] Answer to Amended Complaint, Counterclaim by Apotex Inc.. (Phillips, John) |
| Jul 3, 2019 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's [Confidential - Subject to Protective Order] Objections and Responses to Plaintiffs' First Set of Individual Requests for Production of Documents and Things to Apotex filed by Apotex Inc..(Phillips, John) |
| Jul 3, 2019 | 83 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sandoz's [Confidential - Subject to Protective Order] Objections and Responses to Plaintiffs' First Set of Individual Requests for Production of Documents and Things to Sandoz filed by Sandoz Inc..(Phillips, John) |
| Jun 19, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [80] STIPULATION TO EXTEND TIME for Defendant Apotex Inc. to file its Answer, Defenses and Counterclaims to the Amended Complaint (D.I. 75) to June 28, 2019 filed by Apotex Inc. Set/Reset Answer Deadlines: Apotex Inc. answer due 6/28/2019. Signed by Judge Colm F. Connolly on 6/19/2019. (fms) |
| Jun 19, 2019 | 80 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendant Apotex Inc. to file its Answer, Defenses and Counterclaims to the Amended Complaint (D.I. 75) to June 28, 2019 - filed by Apotex Inc.. (Haney, Megan) |
| Jun 17, 2019 | 79 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding Apotex's Motion to Dismiss (D.I. 71). (Phillips, John) |
| Jun 14, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Lestin L. Kenton for Wockhardt Bio AG, for Wockhardt USA LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 11, 2019 | 77 | Answering Brief in Opposition (9) Docket Text: ANSWERING BRIEF in Opposition re [71] MOTION to Dismiss for Failure to State a Claim filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..Reply Brief due date per Local Rules is 6/18/2019. (Oakes, Robert) |
| Jun 11, 2019 | 78 | Main Document (3) Docket Text: DECLARATION re [77] Answering Brief in Opposition Brittany Blueitt Amadi by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1-11)(Oakes, Robert) |
| Jun 11, 2019 | 78 | Exhibit 1-11 (34) |
| Jun 10, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [74] MOTION for Pro Hac Vice Appearance of Attorney Lestin L. Kenton, Jr., of Sterne, Kessler, Goldstein & Fox P.L.L.C. filed by Wockhardt USA LLC, Wockhardt Bio AG. Signed by Judge Colm F. Connolly on 6/10/2019. (fms) |
| Jun 7, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dennies Varughese, Pharm.D for Wockhardt Bio AG, for Wockhardt USA LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 7, 2019 | 74 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lestin L. Kenton, Jr., of Sterne, Kessler, Goldstein & Fox P.L.L.C. - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Palapura, Bindu) |
| Jun 7, 2019 | 75 | Main Document (15) Docket Text: First AMENDED COMPLAINT against Apotex Inc.- filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Oakes, Robert) |
| Jun 7, 2019 | 75 | Exhibit A (22) |
| Jun 7, 2019 | 75 | Exhibit B (22) |
| Jun 7, 2019 | 75 | Exhibit C (20) |
| Jun 7, 2019 | 75 | Exhibit D (18) |
| Jun 7, 2019 | 76 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883 . (Oakes, Robert) |
| Jun 7, 2019 | 75 | Amended Complaint* (1) |
| Jun 3, 2019 | 73 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs First Set of Individual Requests for Production to Apotex and Sandoz filed by Astellas Pharma US, Inc., Gilead Sciences, Inc..(Oakes, Robert) |
| May 28, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [70] MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D. of Sterne, Kessler, Goldstein & Fox P.L.L.C. filed by Wockhardt USA LLC, Wockhardt Bio AG. Signed by Judge Colm F. Connolly on 5/28/2019. (fms) |
| May 28, 2019 | 71 | Main Document (1) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by Apotex Inc.. (Attachments: # (1) Proposed Order)(Phillips, John) |
| May 28, 2019 | 71 | Proposed Order (1) |
| May 28, 2019 | 72 | Opening Brief in Support (7) Docket Text: OPENING BRIEF in Support re [71] MOTION to Dismiss for Failure to State a Claim filed by Apotex Inc..Answering Brief/Response due date per Local Rules is 6/11/2019. (Phillips, John) |
| May 24, 2019 | 66 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Bindu Ann George Palapura on behalf of Wockhardt Bio AG, Wockhardt USA LLC (Palapura, Bindu) |
| May 24, 2019 | 67 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Clarissa Rae Chenoweth on behalf of Wockhardt Bio AG, Wockhardt USA LLC (Chenoweth, Clarissa) |
| May 24, 2019 | 68 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Tracey E. Timlin on behalf of Wockhardt Bio AG, Wockhardt USA LLC (Timlin, Tracey) |
| May 24, 2019 | 69 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel for Defendants Wockhardt Bio AG and Wockhardt USA LLC by Wockhardt Bio AG, Wockhardt USA LLC (Renck, Richard) |
| May 24, 2019 | 70 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D. of Sterne, Kessler, Goldstein & Fox P.L.L.C. - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Palapura, Bindu) |
| May 20, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [65] STIPULATION TO EXTEND TIME for Defendant Apotex Inc. to answer the Complaint to May 29, 2019 filed by Apotex Inc. Set/Reset Answer Deadlines: Apotex Inc. answer due 5/29/2019. Signed by Judge Colm F. Connolly on 5/20/2019. (fms) |
| May 20, 2019 | 65 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendant Apotex Inc. to answer the Complaint to May 29, 2019 - filed by Apotex Inc.. (Haney, Megan) |
| May 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [64] STIPULATION TO EXTEND TIME Default Standard for Discovery Deadlines para 4.c and 4.d to to July 8, 2019 and August 22, 2019 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 5/16/2019. (fms) |
| May 15, 2019 | 64 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Default Standard for Discovery Deadlines para 4.c and 4.d to to July 8, 2019 and August 22, 2019 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| May 10, 2019 | 63 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Common Interrogatories and Request for Production filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| May 8, 2019 | 62 | Memorandum and Order (3) Docket Text: MEMORANDUM ORDER denying [13] MOTION to Dismiss for Improper Venue , or alternatively, based on the first-filed rule filed by Apotex Inc. Signed by Judge Colm F. Connolly on 5/8/2019. (nmf) |
| Apr 23, 2019 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sandoz Inc.'s Core Technical Documents filed by Sandoz Inc..(Haney, Megan) |
| Apr 23, 2019 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Apotex Inc.'s Core Technical Documents filed by Apotex Inc..(Haney, Megan) |
| Apr 22, 2019 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of PRIOR TO 6PM ON DECEMBER 4, 2018 Wockhardt Defendants Core Technical production bearing Bates range WOCK_0000001 to WOCK_0005114, all of which were labeled HIGHLY CONFIDENTIAL-OUTSIDE ATTORNEYS EYES ONLY PURSUANT TO DELAWARE LOCAL RULE 26.2 filed by Wockhardt Bio AG, Wockhardt USA LLC.(Renck, Richard) |
| Apr 22, 2019 | 59 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharma Global FZE's Core Technical Documents filed by Sun Pharma Global FZE.(Vrana, Robert) |
| Mar 25, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Paul J. Molino for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg) |
| Mar 22, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [57] MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino filed by Sandoz Inc., Apotex Inc. Signed by Judge Colm F. Connolly on 3/22/2019. (fms) |
| Mar 22, 2019 | 57 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino - filed by Apotex Inc., Sandoz Inc.. (Attachments: # (1) Certification of Paul J. Molino)(Haney, Megan) |
| Mar 22, 2019 | 57 | Certification of Paul J. Molino (1) |
| Mar 21, 2019 | 51 | Protective Order (29) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 3/20/2019. (fms) |
| Mar 21, 2019 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc.'s Paragraph 3 Initial Disclosures filed by Apotex Inc..(Haney, Megan) |
| Mar 21, 2019 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Sandoz Inc.'s First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A)(1); and (2) Sandoz Inc.'s Paragraph 3 Initial Disclosures filed by Sandoz Inc..(Haney, Megan) |
| Mar 21, 2019 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Astellas US LLC, Astellas Pharma US, Inc., and Gilead Sciences, Inc.s Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 21, 2019 | 55 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Disclosures of Sun Pharma Global FZE Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharma Global FZE.(Poff, Adam) |
| Mar 21, 2019 | 56 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Wockhardt Bio AG and Wockhardt USA LLC's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Wockhardt Bio AG, Wockhardt USA LLC.(Renck, Richard) |
| Mar 20, 2019 | 50 | Proposed Order (29) Docket Text: Joint PROPOSED ORDER Protective Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [49] STIPULATION TO EXTEND TIME proposed form of Protective Order to March 20, 2019 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 3/18/2019. (fms) |
| Mar 15, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The text of D.I. [48] has been corrected per request of filer. (nmf) |
| Mar 15, 2019 | 48 | Answer to Complaint (7) Docket Text: Plaintiff's First Amended Answer to Defendant's Counterclaims (Sandoz Inc.) filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC.(Oakes, Robert) Modified on 3/15/2019 (nmf). |
| Mar 15, 2019 | 49 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME proposed form of Protective Order to March 20, 2019 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 14, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [46] STIPULATION TO EXTEND TIME to serve disclosures pursuant to Paragraphs 3 and 4a of the Delaware Standard for Discovery, Including Electronically Stored Information to March 21, 2019 filed by Sandoz Inc., Apotex Inc. Signed by Judge Colm F. Connolly on 3/14/2019. (fms) |
| Mar 14, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [47] Stipulation for Plaintiffs to Amend Response to Sandoz Inc.'s Counterclaims filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 3/14/2019. (fms) |
| Mar 14, 2019 | 46 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to serve disclosures pursuant to Paragraphs 3 and 4a of the Delaware Standard for Discovery, Including Electronically Stored Information to March 21, 2019 - filed by Apotex Inc., Sandoz Inc.. (Haney, Megan) |
| Mar 14, 2019 | 47 | Stipulation (2) Docket Text: STIPULATION for Plaintiffs to Amend Response to Defendant Sandoz Inc.'s Counterclaims by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 5, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Mar 5, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 3/5/2019. (dlb) |
| Mar 4, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (27 in 1:18-cv-01677-CFC, 31 in 1:18-cv-01678-CFC, 44 in 1:18-cv-01675-CFC, 31 in 1:18-cv-01676-CFC) STIPULATION TO EXTEND TIME to file a proposed form of Protective Order to March 15, 2019 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 3/4/2019. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms) |
| Mar 4, 2019 | 45 | Scheduling Order (10) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These cases are consolidated for purposes of discovery and all papers shall be filed in Civil Action No. 18-1675-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/5/2019. Amended Pleadings due by 12/5/2019. Discovery due by 6/8/2020. A Markman Hearing is set for 3/5/2020 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 6/3/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 6/14/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/4/2019. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(nmf) |
| Mar 1, 2019 | 44 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to file a proposed form of Protective Order to March 15, 2019 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Feb 28, 2019 | 43 | Main Document (10) Docket Text: Amended PROPOSED ORDER Scheduling Order re (21 in 1:18-cv-01677-CFC, 37 in 1:18-cv-01675-CFC, 26 in 1:18-cv-01678-CFC, 25 in 1:18-cv-01676-CFC) Proposed Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Cover letter to Hon. Colm F. Connolly)(Oakes, Robert) |
| Feb 28, 2019 | 43 | Cover letter to Hon. Colm F. Connolly (1) |
| Feb 22, 2019 | 42 | Letter (1) Docket Text: Letter to Honorable Colm F. Connolly from Robert M. Oakes regarding protective order deadline. (Oakes, Robert) |
| Feb 21, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Cynthia H. Sun,Xiaomei Cai for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Feb 21, 2019 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A)(1) filed by Apotex Inc..(Haney, Megan) |
| Feb 21, 2019 | 41 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fed. R. Civ. P. 26(a) Initial Disclosures filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Feb 19, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (26 in 1:18-cv-01676-CFC) MOTION for Pro Hac Vice Appearance of Attorney Cynthia H. Sun and Xiaomei Cai filed by Sandoz Inc., (39 in 1:18-cv-01675-CFC) MOTION for Pro Hac Vice Appearance of Attorney Cynthia H. Sun and Xiaomei Cai filed by Apotex Inc. Signed by Judge Colm F. Connolly on 2/19/2019. Associated Cases: 1:18-cv-01676-CFC, 1:18-cv-01675-CFC(nmf) |
| Feb 18, 2019 | 39 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Cynthia H. Sun and Xiaomei Cai - filed by Apotex Inc.. (Haney, Megan) |
| Feb 12, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 2/12/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-01676-CFC, 1:18-cv-01675-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(nmf) |
| Feb 12, 2019 | 38 | Main Document (2) Docket Text: REDACTED VERSION of [31] Notice (Other), Notice of Subsequent Authority by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A)(Oakes, Robert) |
| Feb 12, 2019 | 38 | Exhibit A (15) |
| Feb 8, 2019 | 37 | Main Document (19) Docket Text: PROPOSED ORDER Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Letter to Judge Connolly from Robert Oakes)(Oakes, Robert) |
| Feb 8, 2019 | 37 | Letter to Judge Connolly from Robert Oakes (1) |
| Feb 7, 2019 | 34 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Robert M. Oakes on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Oakes, Robert) |
| Feb 7, 2019 | 35 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by William Chad Shear on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Shear, William) |
| Feb 7, 2019 | 36 | Notice (Other) (4) Docket Text: NOTICE of Withdrawal of Counsel by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Fahnestock, Derek) |
| Feb 6, 2019 | 32 | Main Document (14) Docket Text: REDACTED VERSION of [30] Reply Brief, by Apotex Inc.. (Attachments: # (1) Exhibit 5, # (2) Exhibit 6, # (3) Exhibit 7, # (4) Exhibit 8, # (5) Exhibit 9)(Phillips, John) |
| Feb 6, 2019 | 32 | Exhibit 5 (22) |
| Feb 6, 2019 | 32 | Exhibit 6 (30) |
| Feb 6, 2019 | 32 | Exhibit 7 (23) |
| Feb 6, 2019 | 32 | Exhibit 8 (2) |
| Feb 6, 2019 | 32 | Exhibit 9 (2) |
| Feb 6, 2019 | 33 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by Apotex Inc. re [13] MOTION to Dismiss for Improper Venue , or alternatively, based on the first-filed rule. (Phillips, John) |
| Feb 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Robert M. Galvin,Tracey C. Allen for Astellas US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jan 24, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (22 in 1:18-cv-01678-CFC, 29 in 1:18-cv-01675-CFC, 21 in 1:18-cv-01676-CFC, 17 in 1:18-cv-01677-CFC) MOTION for Pro Hac Vice Appearance of Attorney Alison Burton filed by Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 1/24/2019. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms) |
| Jan 22, 2019 | 26 | Redacted Document (28) Docket Text: REDACTED VERSION of [23] Answering Brief in Opposition, to Motion to Dismiss for Improper Venue, or alternatively, based on the first-filed rule by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Fahnestock, Derek) |
| Jan 22, 2019 | 27 | Main Document (5) Docket Text: REDACTED VERSION of [24] Declaration of Brittany Blueitt Amadi by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibits 1-6)(Fahnestock, Derek) |
| Jan 22, 2019 | 27 | Exhibits 1-6 (59) |
| Jan 22, 2019 | 28 | Redacted Document (7) Docket Text: REDACTED VERSION of [25] Declaration of Walt Johnston by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Fahnestock, Derek) |
| Jan 22, 2019 | 29 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alison Burton - filed by Astellas Pharma US, Inc., Astellas US LLC. (Fahnestock, Derek) |
| Jan 3, 2019 | 22 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 2/12/2019 at 03:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(nmf) |
| Dec 28, 2018 | 21 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding corrected version of the proposed order submitted in connection with Apotex Inc.'s Motion to Dismiss (D.I. 13). (Attachments: # (1) Proposed Order)(Phillips, John) |
| Dec 28, 2018 | 21 | Proposed Order (2) |
| Dec 27, 2018 | 20 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Derek J. Fahnestock regarding Joint Scheduling Conference - re (14 in 1:18-cv-01677-CFC, 14 in 1:18-cv-01677-CFC, 18 in 1:18-cv-01678-CFC, 18 in 1:18-cv-01678-CFC, 19 in 1:18-cv-01675-CFC, 19 in 1:18-cv-01675-CFC, 15 in 1:18-cv-01676-CFC, 15 in 1:18-cv-01676-CFC) Order,,, Set Deadlines,,. (Fahnestock, Derek) |
| Dec 17, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles T. Cox, Jr. and Amy K. Wigmore for Astellas Pharma US, Inc. and Astellas US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(ceg) |
| Dec 17, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brittany B. Amadi and Kevin M. Yurkerwich for Astellas Pharma US, Inc. and Astellas US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(ceg) |
| Dec 12, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] STIPULATION TO EXTEND TIME Briefing on Apotex Inc.'s Motion to Dismiss to Plaintiffs' Response to January 14, 2019; Defendant's Reply to January 30, 2019 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Set Briefing Schedule: re [13] MOTION to Dismiss for Improper Venue , or alternatively, based on the first-filed rule. (Answering Brief due 1/14/2019., Reply Brief due 1/30/2019.). Signed by Judge Colm F. Connolly on 12/12/2018. (fms) |
| Dec 12, 2018 | 19 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before December 27, 2018, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/27/2018.) Signed by Judge Colm F. Connolly on 12/11/2018. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(nmf) |
| Dec 11, 2018 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Briefing on Apotex Inc.'s Motion to Dismiss to Plaintiffs' Response to January 14, 2019; Defendant's Reply to January 30, 2019 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Fahnestock, Derek) |
| Dec 4, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Manuel J. Velez for Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01678-CFC, 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC(crb) |
| Dec 4, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Lisa M. Ferri for Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(crb) |
| Dec 4, 2018 | 17 | Main Document (24) Docket Text: REDACTED VERSION of [14] Opening Brief in Support, by Apotex Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Phillips, John) |
| Dec 4, 2018 | 17 | Exhibit 1 (16) |
| Dec 4, 2018 | 17 | Exhibit 2 (2) |
| Dec 4, 2018 | 17 | Exhibit 3 (1) |
| Dec 4, 2018 | 17 | Exhibit 4 (18) |
| Dec 3, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:18-cv-01678-CFC, 12 in 1:18-cv-01676-CFC, 12 in 1:18-cv-01677-CFC, 12 in 1:18-cv-01675-CFC) MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Tracey C. Allen, Brittany Amadi, Charles T. Cox, Jr., Robert M. Galvin and Kevin M. Yurkerwich filed by Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 12/3/2018. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms) |
| Nov 30, 2018 | 12 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Tracey C. Allen, Brittany Amadi, Charles T. Cox, Jr., Robert M. Galvin and Kevin M. Yurkerwich - filed by Astellas Pharma US, Inc., Astellas US LLC. (Fahnestock, Derek) |
| Nov 30, 2018 | 13 | Main Document (1) Docket Text: MOTION to Dismiss for Improper Venue , or alternatively, based on the first-filed rule - filed by Apotex Inc.. (Attachments: # (1) Text of Proposed Order)(Phillips, John) |
| Nov 30, 2018 | 13 | Text of Proposed Order (2) |
| Nov 30, 2018 | 15 | Notice (Other) (1) Docket Text: NOTICE of Compendium of Selected Authorities Submitted In Support of Apotex's Motion to Dismiss by Apotex Inc. re [14] Opening Brief in Support, (Phillips, John) |
| Nov 30, 2018 | 16 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings Inc. for Apotex Inc. filed by Apotex Inc.. (Phillips, John) |
| Nov 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (11 in 1:18-cv-01676-CFC, 11 in 1:18-cv-01677-CFC, 11 in 1:18-cv-01675-CFC, 14 in 1:18-cv-01678-CFC) MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez filed by Gilead Sciences, Inc., Signed by Judge Colm F. Connolly on 11/26/2018. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms) Modified on 11/26/2018 (fms). |
| Nov 26, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The docket text of the Motion for Pro Hac Vice Appearance of Lisa M. Ferri and Manuel J. Velez has been corrected to reflect that the motion is only filed on behalf of Gilead Sciences, Inc. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms) |
| Nov 20, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William A. Rakoczy,Joseph T. Jaros,Christopher P. Galligan for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Nov 20, 2018 | 11 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez - filed by Gilead Sciences, Inc. (Fahnestock, Derek) Modified on 11/26/2018 (fms). |
| Nov 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, and Chris P. Galligan filed by Apotex Inc. Signed by Judge Colm F. Connolly on 11/15/2018. (fms) |
| Nov 15, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, and Chris P. Galligan - filed by Apotex Inc.. (Haney, Megan) |
| Nov 14, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to November 30, 2018 filed by Apotex Inc., Set/Reset Answer Deadlines: Apotex Inc. answer due 11/30/2018. Signed by Judge Colm F. Connolly on 11/14/2018. (fms) |
| Nov 13, 2018 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to November 30, 2018 - filed by Apotex Inc.. (Phillips, John) |
| Oct 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC (rjb) |
| Oct 29, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Gilead Sciences, Inc., Astellas US LLC, Astellas Pharma US, Inc.. Apotex Inc. served on 10/26/2018, answer due 11/16/2018. (Fahnestock, Derek) |
| Oct 29, 2018 | 8 | Declaration (9) Docket Text: DECLARATION of Mailing (as to service on Apotex Inc.) by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Fahnestock, Derek) |
| Oct 26, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Apotex Inc. on 10/26/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Oct 25, 2018 | 1 | Main Document (10) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2489807.) - filed by Gilead Sciences, Inc., Astellas US LLC, Astellas Pharma US, Inc.. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(nmg) |
| Oct 25, 2018 | 1 | Exhibit A-C (60) |
| Oct 25, 2018 | 1 | Civil Cover Sheet (1) |
| Oct 25, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Oct 25, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ATTACHED. Date of Expiration of Patent: 2/2/2027. (nmg) |
| Oct 25, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,106,183 ;9,085,601. (nmg) |
| Oct 25, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (nmg) |
| Oct 25, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (nmg) |
| Oct 25, 2018 | 1 | Complaint* (1) |
